disease_area	nct	year	intervention_name	drug	regulatory_status	approval_year	patient_years	gen_assoc	target_gene	target_status	classification	priority
parkinson	NCT00004576	2000	ly300164	talampanel	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00006077	2000	ns2330	tesofensine	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00006337	2000	kw-6002	istradefylline	approved	2019	NA	NA	ADORA2A	approved	pre-approval	6
alzheimer	NCT00007189	2001	celecoxib (celebrex)	celecoxib	approved	NA	NA	NA	PTGS2	approved	repurposing	3
parkinson	NCT00009048	2001	emd 128130	sarizotan	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT00009191	2005	sertraline [zoloft]	sertraline	approved	NA	NA	NA	SLC6A4	approved	repurposing	3
alzheimer	NCT00010803	2000	ginkgo biloba	ginkgo biloba	supplement	NA	32979.67145790554	NA	NA	non	novel, unsup	2
alzheimer	NCT00013650	2001	cyclophosphamate	cyclophosphamide	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT00015548	2001	citalopram	citalopram	approved	NA	NA	NA	SLC6A4	approved	repurposing	3
alzheimer	NCT00018291	2001	gabapentin	gabapentin	approved	NA	NA	NA	CACNA2D1	approved	repurposing	3
ftd/als	NCT00021697	2001	avp-923	dextromethorphan,quinidine	combination	NA	NA	NA	SIGMAR1	approved	combination	4
alzheimer	NCT00021723	2001	an-1792 also known as aip-001	an1792	experimental	NA	NA	OMIM	APP	non	novel, supported	1
alzheimer	NCT00024531	2000	atorvastatin calcium	atorvastatin	approved	NA	NA	NA	HMGCR	approved	repurposing	3
huntington	NCT00026988	2001	creatine	creatine	supplement	NA	NA	NA	CKM	approved	metoo	5
huntington	NCT00029874	2001	minocycline	minocycline	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT00030979	2002	donepezil	donepezil	approved	NA	NA	NA	ACHE	approved	repurposing	3
alzheimer	NCT00034762	2000	risperidone	risperidone	approved	NA	985.4976043805613	NA	HTR2A	approved	repurposing	3
ftd/als	NCT00035815	2003	insulin like growth factor, type 1	myotrophin	experimental	NA	1485.3388090349076	NA	IGF1	non	novel, unsup	2
alzheimer	NCT00036114	2000	aripiprazole	aripiprazole	approved	NA	NA	NA	DRD2	approved	repurposing	3
parkinson	NCT00036205	2000	sumanirole	sumanirole	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT00036218	2001	sumanirole	sumanirole	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT00036296	2006	talampanel	talampanel	experimental	NA	3.7344284736481863	NA	NA	non	novel, unsup	2
ftd/als	NCT00036413	2002	tch346	omigapil	experimental	NA	32.8870636550308	NA	NA	non	novel, unsup	2
parkinson	NCT00040209	2002	jp 1730	fipamezole	experimental	NA	NA	NA	ADRA2A	approved	metoo	5
parkinson	NCT00040404	2002	cep-1347 10mg	cep-1347	experimental	NA	2756.1779603011637	NA	NA	non	novel, unsup	2
alzheimer	NCT00040443	2002	cx516	cx516	experimental	NA	379.46611909650926	NA	NA	non	novel, unsup	2
alzheimer	NCT00041678	2000	aripiprazole	aripiprazole	approved	NA	NA	NA	DRD2	approved	repurposing	3
other/unspecified	NCT00042172	2002	donepezil	donepezil	approved	NA	NA	NA	ACHE	approved	repurposing	3
other/unspecified	NCT00043849	2002	quetiapine	quetiapine	approved	NA	NA	NA	HTR2A	approved	repurposing	3
ftd/als	NCT00047723	2003	minocycline	minocycline	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT00051909	2002	ly451395	mibampator	experimental	NA	NA	NA	GRIA1	approved	metoo	5
alzheimer	NCT00053599	2002	simvastatin	simvastatin	approved	NA	NA	NA	HMGCR	approved	repurposing	3
alzheimer	NCT00056225	2003	folate	folic acid	supplement	NA	1500.561259411362	NA	NA	non	novel, unsup	2
alzheimer	NCT00056329	2002	multivitamin	multivitamin	supplement	NA	3529.226557152635	NA	NA	non	novel, unsup	2
other/unspecified	NCT00056524	2003	avp-923	dextromethorphan,quinidine	combination	NA	NA	NA	SIGMAR1	approved	combination	4
parkinson	NCT00058838	2003	sumanirole	sumanirole	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT00062738	2003	nortriptyline	nortriptyline	approved	NA	290.5735797399042	NA	SLC6A2	approved	repurposing	3
parkinson	NCT00063193	2003	minocycline	minocycline	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT00063310	2003	leuprolide acetate	leuprolide	approved	NA	NA	NA	GNRHR	approved	repurposing	3
alzheimer	NCT00065169	2000	celecoxib	celecoxib	approved	NA	NA	NA	PTGS2	approved	repurposing	3
alzheimer	NCT00065767	2001	raloxifene	raloxifene	approved	NA	NA	NA	ESR1	approved	repurposing	3
alzheimer	NCT00066157	2001	medroxyprogesterone	medroxyprogesterone	approved	NA	262.4065708418891	NA	PGR	approved	repurposing	3
ftd/als	NCT00069186	2003	creatine monohydrate	creatine	supplement	NA	NA	NA	CKM	approved	metoo	5
alzheimer	NCT00069849	2003	abt-089	pozanicline	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00070928	2000	valerian	valerian	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00070941	2003	sam-e	ademetionine	supplement	NA	210.32443531827516	NA	NA	non	novel, unsup	2
ftd/als	NCT00070993	2002	creatine monohydrate	creatine	supplement	NA	NA	NA	CKM	approved	metoo	5
alzheimer	NCT00071721	2003	valproate	valproic acid	approved	NA	1930.7022587268993	NA	HDAC9	approved	repurposing	3
ftd/als	NCT00072709	2003	tch346	omigapil	experimental	NA	689.4099931553731	NA	NA	non	novel, unsup	2
alzheimer	NCT00073658	2000	citalopram	citalopram	approved	NA	NA	NA	SLC6A4	approved	repurposing	3
alzheimer	NCT00074529	2003	mk0677	ibutamoren	experimental	NA	1153.6646132785763	NA	GHSR	non	novel, unsup	2
alzheimer	NCT00076440	2003	leuprolide acetate	leuprolide	approved	NA	NA	NA	GNRHR	approved	repurposing	3
parkinson	NCT00076492	2004	coq10	ubidecarenone	supplement	NA	NA	NA	NDUFV3	approved	metoo	5
ftd/als	NCT00076687	2003	botulinum toxin type a	botulinum toxin a	approved	NA	904.3258042436687	NA	SNAP25	approved	repurposing	3
alzheimer	NCT00082602	2004	galantamine er	galantamine	approved	2001	76.12594113620807	NA	ACHE	approved	post-approval	7
alzheimer	NCT00083421	2004	ono-2506po	arundic acid	experimental	NA	1992.8131416837782	NA	NA	non	novel, unsup	2
alzheimer	NCT00083590	2004	huperzine a	huperzine a	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT00086138	2004	sertraline (zoloft)	sertraline	approved	NA	654.9103353867214	NA	SLC6A4	approved	repurposing	3
parkinson	NCT00086190	2005	paroxetine	paroxetine	approved	NA	508.1724845995893	NA	SLC6A4	approved	repurposing	3
parkinson	NCT00086294	2004	acp-103	pimavanserin	approved	NA	NA	NA	HTR2A	approved	repurposing	3
parkinson	NCT00087542	2004	acp-103	pimavanserin	approved	NA	NA	NA	HTR2A	approved	repurposing	3
alzheimer	NCT00087724	2004	fk962	fk962	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT00087789	2004	cere-110: adeno-associated virus delivery of ngf	cere-110	experimental	NA	59.13757700205339	NA	NGF	non	novel, unsup	2
alzheimer	NCT00088387	2004	divalproex	valproic acid	approved	NA	NA	NA	HDAC9	approved	repurposing	3
alzheimer	NCT00088673	2004	3aps	tramiprosate	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00089622	2004	lisuride transdermal system	lisuride	approved	NA	NA	NA	DRD4	approved	repurposing	3
alzheimer	NCT00090116	2003	neramexane	neramexane	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT00090402	2004	lipoic acid	lipoic acid	supplement	NA	129.94661190965093	NA	NA	non	novel, unsup	2
alzheimer	NCT00093951	2004	sgs742	sgs742	experimental	NA	NA	NA	GABRB1	approved	metoo	5
huntington	NCT00095355	2004	divalproex	valproic acid	approved	NA	NA	NA	HDAC9	approved	repurposing	3
alzheimer	NCT00095719	2003	aripiprazole	aripiprazole	approved	NA	NA	NA	DRD2	approved	repurposing	3
parkinson	NCT00095810	2003	aripiprazole	aripiprazole	approved	NA	NA	NA	DRD2	approved	repurposing	3
alzheimer	NCT00096473	2001	donepezil hydrochloride	donepezil	approved	1996	1068.35318275154	NA	ACHE	approved	post-approval	7
alzheimer	NCT00097916	2004	memantine hcl	memantine	approved	2003	53.711156741957566	NA	GRIN1	approved	post-approval	7
alzheimer	NCT00099242	2003	rivastigmine transdermal patch	rivastigmine	approved	2000	NA	NA	ACHE	approved	post-approval	7
parkinson	NCT00099268	2004	carbidopa/levodopa/entacapone	carbidopa,levodopa	combination	NA	3112.7556468172484	NA	DRD1	approved	combination	4
alzheimer	NCT00099710	2003	curcumin c3 complex	curcumin	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT00100282	2003	ppi-1019 (apan)	apan	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT00100334	2004	ppi-1019 (apan)	apan	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT00103649	2003	xaliproden (sr57746a)	xaliproden	experimental	NA	5113.155373032169	NA	NA	non	novel, unsup	2
alzheimer	NCT00104013	2003	xaliproden (sr57746a)	xaliproden	experimental	NA	5820	NA	NA	non	novel, unsup	2
alzheimer	NCT00104273	2004	rasagiline	rasagiline	approved	NA	NA	NA	MAOB	approved	repurposing	3
alzheimer	NCT00104442	2003	rivastigmine	rivastigmine	approved	2000	NA	NA	ACHE	approved	post-approval	7
alzheimer	NCT00105105	2003	mifepristone	mifepristone	approved	NA	NA	NA	PGR	approved	repurposing	3
parkinson	NCT00105508	2004	sarizotan	sarizotan	approved	NA	714.8418891170431	NA	NA	non	repurposing	3
parkinson	NCT00105521	2004	sarizotan	sarizotan	approved	NA	596.0465434633812	NA	NA	non	repurposing	3
alzheimer	NCT00105547	2005	mpc-7869	flurizan	experimental	NA	5190.9650924024645	OMIM	PSEN1	non	novel, supported	1
ftd/als	NCT00107770	2005	sodium phenylbutyrate	sodium phenylbutyrate	approved	NA	96.70088980150582	NA	NA	non	repurposing	3
parkinson	NCT00108667	2005	talampanel	talampanel	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT00110552	2005	salvia officinalis (sage)	salvia officinalis	supplement	NA	1026.88295687885	NA	NA	non	novel, unsup	2
parkinson	NCT00111982	2003	liatermin	liatermin	experimental	NA	73.81793292265571	NA	GDNF	non	novel, unsup	2
alzheimer	NCT00112073	2005	bapineuzumab	bapineuzumab	experimental	NA	858.4804928131417	OMIM	APP	non	novel, supported	1
parkinson	NCT00115427	2003	liatermin (r-methugdnf)	liatermin	experimental	NA	NA	NA	GDNF	non	novel, unsup	2
alzheimer	NCT00117403	2006	vitamin e, vitamin c, and alpha-lipoic acid	vitamin e	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00125138	2005	melperone hcl	melperone	experimental	NA	247.63860369609856	NA	DRD2	approved	metoo	5
ftd/als	NCT00125203	2003	botulinum toxin type b (myobloc)	botulinum toxin b	approved	NA	NA	NA	VAMP1	approved	repurposing	3
parkinson	NCT00125567	2005	levodopa/carbidopa	carbidopa,levodopa	combination	NA	798.5872689938399	NA	DRD1	approved	combination	4
ftd/als	NCT00127114	2005	amantadine	amantadine	approved	NA	0	NA	GRIN3A	approved	repurposing	3
parkinson	NCT00129181	2005	cabergoline	cabergoline	approved	NA	59.95893223819302	NA	DRD2	approved	repurposing	3
alzheimer	NCT00130429	2004	pym50028	smilagenin	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00134251	2005	slv308	pardoprunox	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT00134953	2003	rivastigmine	rivastigmine	approved	2000	NA	NA	ACHE	approved	post-approval	7
parkinson	NCT00134966	2005	capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)	carbidopa,levodopa	combination	NA	1027.1676933607118	NA	DRD1	approved	combination	4
ftd/als	NCT00136110	2005	sodium valproate	valproic acid	approved	NA	303.1211498973306	NA	HDAC9	approved	repurposing	3
parkinson	NCT00139867	2004	parcopa	carbidopa,levodopa	combination	NA	NA	NA	DRD1	approved	combination	4
parkinson	NCT00139880	2005	parcopa	carbidopa,levodopa	combination	NA	NA	NA	DRD1	approved	combination	4
ftd/als	NCT00140218	2005	r(+) pramipexole dihydrochloride monohydrate	pramipexole	approved	NA	40	NA	DRD3	approved	repurposing	3
ftd/als	NCT00140452	2005	thalidomide	thalidomide	approved	NA	NA	NA	CRBN	approved	repurposing	3
alzheimer	NCT00141661	2005	pf-04494700 - high dose arm	azeliragon	experimental	NA	44.57494866529774	NA	AGER	non	novel, unsup	2
alzheimer	NCT00142324	2003	donepezil	donepezil	approved	1996	NA	NA	ACHE	approved	post-approval	7
alzheimer	NCT00142805	2004	ketasyn™ (ac-1202)	tricaprylin	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00143026	2005	carbidopa, levodopa, entacapone	carbidopa,levodopa	combination	NA	168.76112251882273	NA	DRD1	approved	combination	4
parkinson	NCT00144300	2005	mirapex	pramipexole	approved	1997	NA	NA	DRD3	approved	post-approval	7
parkinson	NCT00145171	2001	apomorphine hcl injection	apomorphine	approved	2004	NA	NA	DRD4	approved	pre-approval	6
huntington	NCT00146211	2005	ethyl-epa (miraxion™)	icosapent	supplement	NA	548.6652977412731	NA	PTGS2	approved	metoo	5
parkinson	NCT00148486	2003	ns 2330	tesofensine	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00148512	2003	1. tesofensine (ns 2330)	tesofensine	experimental	NA	488.87611225188226	NA	NA	non	novel, unsup	2
alzheimer	NCT00151333	2005	sra-333	lecozotan	experimental	NA	NA	NA	HTR1A	approved	metoo	5
alzheimer	NCT00151398	2005	lecozotan sr	lecozotan	experimental	NA	571.7946611909651	NA	HTR1A	approved	metoo	5
alzheimer	NCT00151502	2002	atorvastatin	atorvastatin	approved	NA	NA	NA	HMGCR	approved	repurposing	3
alzheimer	NCT00153010	2003	ns 2330 (tesofensine)	tesofensine	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT00154635	2005	dcb-ad1	reynoutria multiflora	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT00160147	2005	bifeprunox	bifeprunox	experimental	NA	125.01026694045174	NA	NA	non	novel, unsup	2
parkinson	NCT00160576	2003	levetiracetam	levetiracetam	approved	NA	NA	NA	SV2A	approved	repurposing	3
alzheimer	NCT00161473	2001	prazosin	prazosin	approved	NA	207.9671457905544	NA	ADRA1A	approved	repurposing	3
parkinson	NCT00163085	2005	nr2b nmda antagonist cp-101,606 (traxoprodil)	traxoprodil	experimental	NA	NA	NA	GRIN2B	approved	metoo	5
alzheimer	NCT00164749	2004	curcumin and ginkgo extract	curcumin	supplement	NA	62.8829568788501	NA	NA	non	novel, unsup	2
alzheimer	NCT00165659	2002	donepezil hydrochloride	donepezil	approved	1996	NA	NA	ACHE	approved	post-approval	7
alzheimer	NCT00165724	2004	donepezil hydrochloride	donepezil	approved	1996	284.9609856262834	NA	ACHE	approved	post-approval	7
alzheimer	NCT00165750	2005	donepezil hydrochloride	donepezil	approved	1996	146.8583162217659	NA	ACHE	approved	post-approval	7
parkinson	NCT00165789	2005	e2007	perampanel	approved	NA	74.94866529774127	NA	GRIA1	approved	repurposing	3
parkinson	NCT00165815	2002	aricept	donepezil	approved	NA	NA	NA	ACHE	approved	repurposing	3
parkinson	NCT00174239	2004	cabergoline	cabergoline	approved	NA	NA	NA	DRD2	approved	repurposing	3
alzheimer	NCT00174382	2005	donepezil	donepezil	approved	1996	422.217659137577	NA	ACHE	approved	post-approval	7
alzheimer	NCT00174525	2005	aab-001	aab-001	experimental	NA	NA	OMIM	APP	non	novel, supported	1
parkinson	NCT00180037	2003	coenzyme q10 nanodispersion (nanoquinone)	ubidecarenone	supplement	NA	NA	NA	NDUFV3	approved	metoo	5
ftd/als	NCT00187525	2004	memantine	memantine	approved	NA	NA	NA	GRIN1	approved	repurposing	3
huntington	NCT00190450	2002	graft intracerebral of foetal neurons	fetal neuron graft	experimental	NA	643.4168377823408	NA	NA	non	novel, unsup	2
alzheimer	NCT00191009	2003	atomoxetine hydrochloride	atomoxetine	approved	NA	NA	NA	SLC6A2	approved	repurposing	3
parkinson	NCT00195143	2003	surgical infusion of aav-gad into the subthalamic nucleus	aav-gad	experimental	NA	NA	NA	GAD1	non	novel, unsup	2
parkinson	NCT00199355	2005	istradefylline (kw-6002)	istradefylline	approved	2019	NA	NA	ADORA2A	approved	pre-approval	6
parkinson	NCT00199368	2004	istradefylline ( kw-6002)	istradefylline	approved	2019	NA	NA	ADORA2A	approved	pre-approval	6
parkinson	NCT00199381	2005	istradefylline	istradefylline	approved	2019	1512.3449691991786	NA	ADORA2A	approved	pre-approval	6
alzheimer	NCT00199394	2004	istradefylline (kw-6002)	istradefylline	approved	NA	NA	NA	ADORA2A	approved	repurposing	3
parkinson	NCT00199407	2004	istradefylline (kw-6002)	istradefylline	approved	2019	NA	NA	ADORA2A	approved	pre-approval	6
parkinson	NCT00199420	2004	istradefylline (kw-6002)	istradefylline	approved	2019	NA	NA	ADORA2A	approved	pre-approval	6
parkinson	NCT00199433	2005	istradefylline (kw-6002)	istradefylline	approved	2019	NA	NA	ADORA2A	approved	pre-approval	6
parkinson	NCT00200447	2004	carbidopa/l-dopa	carbidopa,levodopa	combination	NA	1.51129363449692	NA	DRD1	approved	combination	4
parkinson	NCT00200525	2001	apomorphine hcl injection	apomorphine	approved	2004	NA	NA	DRD4	approved	pre-approval	6
ftd/als	NCT00200538	2005	memantine	memantine	approved	NA	NA	NA	GRIN1	approved	repurposing	3
alzheimer	NCT00202124	2001	tryptophan	tryptophan	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00203034	2000	1.0 mg rasagiline mesylate	rasagiline	approved	2006	1259.958932238193	NA	MAOB	approved	pre-approval	6
parkinson	NCT00203125	2000	tyramine	tyramine	experimental	NA	123.77823408624229	NA	NA	non	novel, unsup	2
parkinson	NCT00203138	2004	rasagiline mesylate	rasagiline	approved	2006	764.8952772073922	NA	MAOB	approved	pre-approval	6
parkinson	NCT00203164	2002	rasagiline mesylate	rasagiline	approved	2006	1101.535934291581	NA	MAOB	approved	pre-approval	6
parkinson	NCT00203177	2001	rasagiline mesylate	rasagiline	approved	2006	NA	NA	MAOB	approved	pre-approval	6
alzheimer	NCT00203320	2005	etanercept given by perispinal administration	etanercept	approved	NA	NA	NA	TNF	approved	repurposing	3
alzheimer	NCT00203359	2004	etanercept given by perispinal administration	etanercept	approved	NA	NA	NA	TNF	approved	repurposing	3
parkinson	NCT00203957	2005	istradefylline	istradefylline	approved	2019	19.21971252566735	NA	ADORA2A	approved	pre-approval	6
parkinson	NCT00206687	2003	spheramine (bay86-5280)	spheramine	experimental	NA	662.4722792607803	NA	DRD1	approved	metoo	5
parkinson	NCT00208611	2006	vitamin b12 supplementation	cyanocobalamin	supplement	NA	194.9158110882957	NA	MTR	approved	metoo	5
alzheimer	NCT00208819	2003	divalproex	valproic acid	approved	NA	NA	NA	HDAC9	approved	repurposing	3
parkinson	NCT00209508	2002	gpi 1485	gpi 1485	experimental	NA	NA	NA	FKBP1A	approved	metoo	5
alzheimer	NCT00211159	2000	epax 1050tg	omega-3 fatty acids	supplement	NA	NA	NA	PPARG	approved	metoo	5
parkinson	NCT00211224	2000	riluzole	riluzole	approved	NA	NA	NA	SCN5A	approved	repurposing	3
parkinson	NCT00211588	2004	galantamine	galantamine	approved	NA	NA	NA	ACHE	approved	repurposing	3
huntington	NCT00212316	2005	sodium phenylbutyrate	sodium phenylbutyrate	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT00212693	2004	ono-2506po	arundic acid	experimental	NA	NA	NA	NA	non	novel, unsup	2
ftd/als	NCT00214110	2001	tamoxifen	tamoxifen	approved	NA	NA	NA	ESR1	approved	repurposing	3
parkinson	NCT00215904	2003	d-serine (~2g/day)	serine	supplement	NA	61.752224503764545	NA	NA	non	novel, unsup	2
alzheimer	NCT00216502	2001	galantamine hydrobromide	galantamine	approved	2001	1079.978097193703	NA	ACHE	approved	post-approval	7
alzheimer	NCT00216515	2004	galantamine hydrobromide	galantamine	approved	2001	170.34907597535934	NA	ACHE	approved	post-approval	7
alzheimer	NCT00216593	2003	galantamine hydrobromide	galantamine	approved	2001	1763.3949349760437	NA	ACHE	approved	post-approval	7
alzheimer	NCT00217763	2005	3aps	tramiprosate	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT00219232	2003	rivastigmine transdermal patch	rivastigmine	approved	2000	2961.062286105407	NA	ACHE	approved	post-approval	7
parkinson	NCT00219284	2005	carbidopa/levodopa/entacapone	carbidopa,levodopa	combination	NA	1255.148528405202	NA	DRD1	approved	combination	4
parkinson	NCT00220272	2004	sr57667b	paliroden	experimental	NA	578.6858316221766	NA	NA	non	novel, unsup	2
parkinson	NCT00224263	2005	lingzhi (ganoderma)	ganoderma	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT00224497	2005	sb-742457	intepirdine	experimental	NA	NA	NA	HTR6	approved	metoo	5
parkinson	NCT00228150	2003	sr57667b	paliroden	experimental	NA	1551.8685831622176	NA	NA	non	novel, unsup	2
alzheimer	NCT00229333	2004	escitalopram	escitalopram	approved	NA	NA	NA	SLC6A4	approved	repurposing	3
parkinson	NCT00229736	2004	aav-haadc-2	aav-haadc-2	experimental	NA	83.28542094455852	NA	DDC	approved	metoo	5
ftd/als	NCT00230074	2004	tch346	omigapil	experimental	NA	88.15879534565366	NA	NA	non	novel, unsup	2
alzheimer	NCT00230568	2005	aricept	donepezil	approved	1996	199.8631074606434	NA	ACHE	approved	post-approval	7
ftd/als	NCT00231140	2005	thalidomide (drug)	thalidomide	approved	NA	NA	NA	CRBN	approved	repurposing	3
alzheimer	NCT00231946	2005	vp4896	leuprolide	approved	NA	NA	NA	GNRHR	approved	repurposing	3
alzheimer	NCT00232570	2005	quetiapine	quetiapine	approved	NA	NA	NA	HTR2A	approved	repurposing	3
alzheimer	NCT00234637	2003	rivastigmine, memantine	rivastigmine,memantine	combination	NA	322.8254620123203	NA	GRIN1	approved	combination	4
parkinson	NCT00234676	2003	premarin ®	conjugated estrogens	approved	NA	55.540041067761805	NA	ESR1	approved	repurposing	3
alzheimer	NCT00235716	2007	dl-alpha-tocopherol	tocopherol	supplement	NA	3168.6351813826145	NA	NA	non	novel, unsup	2
alzheimer	NCT00236431	2001	galantamine hydrobromide	galantamine	approved	2001	2747.356605065024	NA	ACHE	approved	post-approval	7
alzheimer	NCT00236574	2001	galantamine hydrobromide	galantamine	approved	2001	2437.3333333333335	NA	ACHE	approved	post-approval	7
parkinson	NCT00239564	2005	ipx054 100 mg	carbidopa,levodopa	combination	NA	25.987679671457904	NA	DRD1	approved	combination	4
alzheimer	NCT00239746	2005	ibuprofen	ibuprofen	approved	NA	NA	NA	PTGS2	approved	repurposing	3
parkinson	NCT00240409	2003	bromocriptine	bromocriptine	approved	NA	226.0807665982204	NA	DRD2	approved	repurposing	3
alzheimer	NCT00240695	2003	galantamine hydrobromide	galantamine	approved	2001	725.4866529774127	NA	ACHE	approved	post-approval	7
parkinson	NCT00242008	2004	rotigotine	rotigotine	approved	2007	NA	NA	DRD3	approved	pre-approval	6
alzheimer	NCT00242593	2006	rosiglitazone	rosiglitazone	approved	NA	NA	NA	PPARG	approved	repurposing	3
ftd/als	NCT00243932	2005	coenzyme q10	ubidecarenone	supplement	NA	539.4250513347023	NA	NDUFV3	approved	metoo	5
parkinson	NCT00243945	2004	rotigotine	rotigotine	approved	2007	33.66461327857632	NA	DRD3	approved	pre-approval	6
parkinson	NCT00243971	2004	spm 962	rotigotine	approved	2007	NA	NA	DRD3	approved	pre-approval	6
ftd/als	NCT00244244	2005	arimoclomol	arimoclomol	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT00244322	2005	ly450139 dihydrate	semagacestat	experimental	NA	NA	OMIM	PSEN1	non	novel, supported	1
parkinson	NCT00244387	2004	spm 962	rotigotine	approved	2007	674.6666666666666	NA	DRD3	approved	pre-approval	6
alzheimer	NCT00245206	2005	aripiprazole	aripiprazole	approved	NA	2097.5277207392196	NA	DRD2	approved	repurposing	3
parkinson	NCT00247247	2002	comtess®	entacapone	approved	1999	NA	NA	COMT	approved	post-approval	7
parkinson	NCT00250393	2005	istradefylline (kw-6002)	istradefylline	approved	2019	NA	NA	ADORA2A	approved	pre-approval	6
parkinson	NCT00252850	2005	cere-120: aav2-ntn	cere-120	experimental	NA	NA	NA	NRTN	non	novel, unsup	2
parkinson	NCT00253084	2005	cd-ld ir	carbidopa,levodopa	combination	NA	24.969199178644764	NA	DRD1	approved	combination	4
alzheimer	NCT00253214	2001	galantamine hydrobromide	galantamine	approved	2001	1297.3333333333333	NA	ACHE	approved	post-approval	7
alzheimer	NCT00254033	2003	dextroamphetamine	dextroamphetamine	approved	NA	NA	NA	SLC18A2	approved	repurposing	3
alzheimer	NCT00255086	2005	memantine	memantine	approved	2003	80.84599589322382	NA	GRIN1	approved	post-approval	7
parkinson	NCT00256204	2005	rasagiline mesylate	rasagiline	approved	2006	4204.221765913758	NA	MAOB	approved	pre-approval	6
alzheimer	NCT00257673	2005	mem 1003	mem 1003	experimental	NA	350.217659137577	NA	CACNA1C	approved	metoo	5
alzheimer	NCT00257712	2006	th9507 human growth hormone releasing hormone (ghrh)	tesamorelin	approved	NA	880.1615331964408	NA	GHRHR	approved	repurposing	3
alzheimer	NCT00260624	2003	escitalopram (lexapro)	escitalopram	approved	NA	NA	NA	SLC6A4	approved	repurposing	3
parkinson	NCT00260793	2005	ropinirole hydrochloride	ropinirole	approved	1997	NA	NA	DRD3	approved	post-approval	7
alzheimer	NCT00265148	2004	rosiglitazone	rosiglitazone	approved	NA	333.36071184120465	NA	PPARG	approved	repurposing	3
alzheimer	NCT00267163	2000	donepezil	donepezil	approved	1996	437.0047912388775	NA	ACHE	approved	post-approval	7
parkinson	NCT00269516	2006	pardoprunox	pardoprunox	experimental	NA	702.1601642710473	NA	NA	non	novel, unsup	2
huntington	NCT00271596	2005	20mg daily citalopram	citalopram	approved	NA	197.9548254620123	NA	SLC6A4	approved	repurposing	3
parkinson	NCT00272688	2006	levodopa (drug), intraduodenal administration	levodopa	approved	1975	33.29226557152635	NA	DRD1	approved	post-approval	7
parkinson	NCT00275275	2006	mirapex	pramipexole	approved	1997	142.1245722108145	NA	DRD3	approved	post-approval	7
alzheimer	NCT00276510	2002	egb 761® (tanakan®)	ginkgo biloba	supplement	NA	22299.08281998631	NA	NA	non	novel, unsup	2
huntington	NCT00277355	2006	minocycline	minocycline	approved	NA	294.9486652977413	NA	NA	non	repurposing	3
alzheimer	NCT00277810	2006	lecozotan sr (sra-333)	lecozotan	experimental	NA	563.3127994524299	NA	HTR1A	approved	metoo	5
parkinson	NCT00279825	2006	cd-ld cr	carbidopa,levodopa	combination	NA	30.62012320328542	NA	DRD1	approved	combination	4
alzheimer	NCT00285025	2005	sr57667b	paliroden	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT00285077	2004	sr57667b	paliroden	experimental	NA	1041.0677618069815	NA	NA	non	novel, unsup	2
parkinson	NCT00286897	2006	e2007	perampanel	approved	NA	1049.3963039014375	NA	GRIA1	approved	repurposing	3
parkinson	NCT00286949	2005	atomoxetine	atomoxetine	approved	NA	41.75770020533881	NA	SLC6A2	approved	repurposing	3
alzheimer	NCT00287742	2002	risperidone	risperidone	approved	NA	32.97741273100616	NA	HTR2A	approved	repurposing	3
parkinson	NCT00291733	2006	levetiracetam	levetiracetam	approved	NA	NA	NA	SV2A	approved	repurposing	3
parkinson	NCT00292227	2006	moxifloxacin infusion	moxifloxacin	approved	NA	97.16632443531827	NA	NA	non	repurposing	3
parkinson	NCT00294554	2006	memantine	memantine	approved	NA	53.38809034907597	NA	GRIN1	approved	repurposing	3
parkinson	NCT00296192	2006	rotigotine nasal spray	rotigotine	approved	2007	26.940451745379878	NA	DRD3	approved	pre-approval	6
parkinson	NCT00296946	2004	ipratropium bromide (drug)	ipratropium	approved	NA	NA	NA	CHRM1	approved	repurposing	3
parkinson	NCT00296959	2004	topiramate (drug)	topiramate	approved	NA	NA	NA	GABRA1	approved	repurposing	3
parkinson	NCT00297778	2006	pramipexole	pramipexole	approved	1997	NA	NA	DRD3	approved	post-approval	7
ftd/als	NCT00298597	2006	erythropoetin (epo)	erythromycin	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT00299988	2006	intravenous immunoglobulin	human immunoglobulin g	approved	NA	99.87679671457906	NA	NA	non	repurposing	3
alzheimer	NCT00301574	2001	galantamine	galantamine	approved	2001	1128.892539356605	NA	ACHE	approved	post-approval	7
alzheimer	NCT00303277	2002	pravastatin	pravastatin	approved	NA	93.33333333333333	NA	HMGCR	approved	repurposing	3
parkinson	NCT00304161	2004	atomoxetine	atomoxetine	approved	NA	243.03901437371664	NA	SLC6A2	approved	repurposing	3
parkinson	NCT00305331	2006	domperidone (drug)	domperidone	approved	NA	NA	NA	DRD2	approved	repurposing	3
alzheimer	NCT00305903	2006	rivastigmine, memantine	rivastigmine,memantine	combination	NA	NA	NA	GRIN1	approved	combination	4
alzheimer	NCT00306124	2006	levodopa	levodopa	approved	NA	NA	NA	DRD1	approved	repurposing	3
parkinson	NCT00307450	2006	levetiracetam	levetiracetam	approved	NA	NA	NA	SV2A	approved	repurposing	3
parkinson	NCT00314288	2002	sarizotan hcl	sarizotan	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT00314912	2006	tramiprosate (3aps)	acamprosate	approved	NA	NA	NA	GRM5	approved	repurposing	3
parkinson	NCT00321854	2006	pramipexole	pramipexole	approved	1997	NA	NA	DRD3	approved	post-approval	7
alzheimer	NCT00322036	2006	mpc-7869	flurizan	experimental	NA	2069.8151950718684	OMIM	PSEN1	non	novel, supported	1
alzheimer	NCT00322153	2005	memantine er	memantine	approved	2003	1749.7275838466803	NA	GRIN1	approved	post-approval	7
other/unspecified	NCT00324454	2006	levetiracetam	levetiracetam	approved	NA	41.724845995893226	NA	SV2A	approved	repurposing	3
parkinson	NCT00324896	2006	eszopiclone	eszopiclone	approved	NA	92.56673511293634	NA	GABRA1	approved	repurposing	3
alzheimer	NCT00325728	2006	ramelteon	ramelteon	approved	NA	104.74469541409994	NA	MTNR1A	approved	repurposing	3
ftd/als	NCT00326625	2006	40 mg glatiramer acetate	glatiramer	approved	NA	732.5010266940452	NA	NA	non	repurposing	3
parkinson	NCT00329056	2006	mitoq	mitoq	supplement	NA	192.39425051334703	NA	NA	non	novel, unsup	2
alzheimer	NCT00329082	2006	ly2062430	solanezumab	experimental	NA	50.03422313483915	OMIM	APP	non	novel, supported	1
ftd/als	NCT00330681	2006	mci-186	edaravone	approved	2017	481.6536618754278	NA	NA	non	pre-approval	6
parkinson	NCT00331149	2006	ropinirole immediate release	ropinirole	approved	1997	408.50102669404515	NA	DRD3	approved	post-approval	7
alzheimer	NCT00334568	2004	rosiglitazone xr (extended release) oral tablets	rosiglitazone	approved	NA	30.94866529774127	NA	PPARG	approved	repurposing	3
alzheimer	NCT00334906	2005	memantine hcl	memantine	approved	2003	NA	NA	GRIN1	approved	post-approval	7
parkinson	NCT00335166	2006	pardaprunox	pardoprunox	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00335374	2007	pardoprunox	pardoprunox	experimental	NA	253.29500342231347	NA	NA	non	novel, unsup	2
parkinson	NCT00346827	2006	apomorphine nasal powder	apomorphine	approved	2004	39.030800821355236	NA	DRD4	approved	post-approval	7
alzheimer	NCT00348140	2006	rosiglitazone extended release 2mg	rosiglitazone	approved	NA	3946.819986310746	NA	PPARG	approved	repurposing	3
alzheimer	NCT00348192	2006	sb-742457	intepirdine	experimental	NA	NA	NA	HTR6	approved	metoo	5
alzheimer	NCT00348309	2006	rosiglitazone extended release 2mg	rosiglitazone	approved	NA	3837.7878165639972	NA	PPARG	approved	repurposing	3
ftd/als	NCT00349622	2006	ceftriaxone	ceftriaxone	approved	NA	3251.4579055441477	NA	NA	non	repurposing	3
ftd/als	NCT00353665	2005	memantine (ebixa)	memantine	approved	NA	220.78028747433265	NA	GRIN1	approved	repurposing	3
ftd/als	NCT00355576	2006	celecoxib	celecoxib	approved	NA	71.57837097878166	NA	PTGS2	approved	repurposing	3
alzheimer	NCT00357357	2006	hf0220	hf0220	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00359723	2004	methylphenidate	methylphenidate	approved	NA	21.639972621492127	NA	SLC6A3	approved	repurposing	3
alzheimer	NCT00359944	2006	ac-3933	radequinil	experimental	NA	441.48665297741275	NA	GABRA1	approved	metoo	5
parkinson	NCT00360308	2006	e2007	perampanel	approved	NA	1023.3839835728953	NA	GRIA1	approved	repurposing	3
parkinson	NCT00360412	2006	e2007	perampanel	approved	NA	1495.8412046543463	NA	GRIA1	approved	repurposing	3
alzheimer	NCT00362024	2006	mk0952	mk0952	experimental	NA	23.983572895277206	NA	PDE4A	approved	metoo	5
parkinson	NCT00363727	2003	ropinirole controlled-release (requip cr) for rls	ropinirole	approved	1997	436.0246406570842	NA	DRD3	approved	post-approval	7
alzheimer	NCT00366483	2006	lecozotan sr	lecozotan	experimental	NA	NA	NA	HTR1A	approved	metoo	5
parkinson	NCT00368108	2006	2 mg perampanel	perampanel	approved	NA	1066.4914442162901	NA	GRIA1	approved	repurposing	3
alzheimer	NCT00368459	2006	raloxifene	raloxifene	approved	NA	227.564681724846	NA	ESR1	approved	repurposing	3
huntington	NCT00368849	2005	atomoxetine	atomoxetine	approved	NA	45.01026694045174	NA	SLC6A2	approved	repurposing	3
alzheimer	NCT00369603	2006	aricept	donepezil	approved	1996	4.336755646817249	NA	ACHE	approved	post-approval	7
alzheimer	NCT00371059	2007	memantine	memantine	approved	2003	NA	NA	GRIN1	approved	post-approval	7
ftd/als	NCT00372879	2006	vitamin e	vitamin e	supplement	NA	117.31143052703628	NA	NA	non	novel, unsup	2
parkinson	NCT00373087	2006	entacapone	entacapone	approved	1999	185.13347022587268	NA	COMT	approved	post-approval	7
alzheimer	NCT00375557	2006	divalproex er	valproic acid	approved	NA	0	NA	HDAC9	approved	repurposing	3
parkinson	NCT00375778	2005	memantine (drug)	memantine	approved	NA	NA	NA	GRIN1	approved	repurposing	3
ftd/als	NCT00376051	2006	citalopram	citalopram	approved	NA	NA	NA	SLC6A4	approved	repurposing	3
alzheimer	NCT00377715	2005	dimebon	dimebon	approved	NA	NA	NA	HRH1	approved	repurposing	3
alzheimer	NCT00380276	2006	mpc-7869	flurizan	experimental	NA	NA	OMIM	PSEN1	non	novel, supported	1
alzheimer	NCT00380302	2006	ave1625	ave1625	experimental	NA	134.3901437371663	NA	CNR1	approved	metoo	5
alzheimer	NCT00381238	2006	rosiglitazone	rosiglitazone	approved	NA	86.64476386036961	NA	PPARG	approved	repurposing	3
alzheimer	NCT00381381	2006	donepezil	donepezil	approved	1996	514.8665297741273	NA	ACHE	approved	post-approval	7
parkinson	NCT00381472	2003	ropinirole	ropinirole	approved	1997	NA	NA	DRD3	approved	post-approval	7
alzheimer	NCT00384423	2006	prx-03140	prx-03140	experimental	NA	NA	NA	HTR4	approved	metoo	5
alzheimer	NCT00385684	2007	hydrocodone/apap	hydrocodone,acetaminophen	combination	NA	73.33333333333333	NA	OPRM1	approved	combination	4
huntington	NCT00387270	2006	dimebon	dimebon	approved	NA	3.7207392197125255	NA	HRH1	approved	repurposing	3
alzheimer	NCT00391833	2004	panax ginseng	ginseng	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00391898	2006	levodopa/carbidopa	carbidopa,levodopa	combination	NA	158.39835728952772	NA	DRD1	approved	combination	4
alzheimer	NCT00392912	2007	androgel (solvay pharmaceuticals)	testosterone	approved	NA	32.498288843258045	NA	AR	approved	repurposing	3
parkinson	NCT00393562	2006	methylphenidate	methylphenidate	approved	NA	0	NA	SLC6A3	approved	repurposing	3
ftd/als	NCT00397423	2006	granulocyte colony stimulating factor	g-csf	approved	NA	26.611909650924023	NA	CSF3R	approved	repurposing	3
alzheimer	NCT00397891	2006	bapineuzumab	bapineuzumab	experimental	NA	266.9952087611225	OMIM	APP	non	novel, supported	1
parkinson	NCT00399477	2006	rasagiline mesylate plus mirapex	pramipexole,rasagiline	combination	NA	149.48665297741272	NA	DRD3	approved	combination	4
parkinson	NCT00400634	2006	cere-120 (adeno-associated virus serotype 2 [aav2]-neurturin [ntn])	cere-120	experimental	NA	116.07939767282683	NA	NRTN	non	novel, unsup	2
alzheimer	NCT00401167	2006	memantine	memantine	approved	2003	NA	NA	GRIN1	approved	post-approval	7
parkinson	NCT00402233	2006	pramipexole	pramipexole	approved	1997	NA	NA	DRD3	approved	post-approval	7
ftd/als	NCT00403104	2006	ono-2506po	arundic acid	experimental	NA	875.0718685831622	NA	NA	non	novel, unsup	2
alzheimer	NCT00403520	2006	experimental 1	donepezil	approved	1996	899.5482546201232	NA	ACHE	approved	post-approval	7
parkinson	NCT00406029	2006	other parkinson's disease treatments	pramipexole,entacapone	combination	NA	494.57084188911705	NA	DRD3	approved	combination	4
parkinson	NCT00406588	2007	levodopa (pardoprunox)	levodopa	approved	1975	344.87337440109513	NA	DRD1	approved	post-approval	7
parkinson	NCT00407095	2007	pardoprunox	pardoprunox	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00407212	2002	tch346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt)	omigapil	experimental	NA	551.3182751540041	NA	NA	non	novel, unsup	2
alzheimer	NCT00408525	2006	donepezil	donepezil	approved	1996	234.943189596167	NA	ACHE	approved	post-approval	7
parkinson	NCT00408915	2006	continuous subcutaneous lisuride infusion	lisuride	approved	NA	NA	NA	DRD4	approved	repurposing	3
ftd/als	NCT00409721	2007	memantine	memantine	approved	NA	NA	NA	GRIN1	approved	repurposing	3
alzheimer	NCT00411580	2005	cad106	cad106	experimental	NA	203.09924709103353	NA	NA	non	novel, unsup	2
alzheimer	NCT00414622	2006	dmxb-a	gts-21	experimental	NA	NA	NA	CHRNA4	approved	metoo	5
ftd/als	NCT00415519	2006	mci-186	edaravone	approved	2017	39.56194387405886	NA	NA	non	pre-approval	6
ftd/als	NCT00416169	2003	galantamine hydrobromide	galantamine	approved	NA	47.931553730321696	NA	ACHE	approved	repurposing	3
alzheimer	NCT00417482	2004	risperidone	risperidone	approved	NA	1199.5071868583161	NA	HTR2A	approved	repurposing	3
alzheimer	NCT00420420	2006	mk0249	mk0249	experimental	NA	251.92607802874744	NA	HRH3	approved	metoo	5
alzheimer	NCT00422981	2007	al-108	al-108	experimental	NA	143.90143737166323	NA	NA	non	novel, unsup	2
alzheimer	NCT00423085	2007	rivastigmine transdermal patch	rivastigmine	approved	2000	2789.2511978097195	NA	ACHE	approved	post-approval	7
alzheimer	NCT00423228	2007	zt-1	huperzine	experimental	NA	493.1416837782341	NA	NA	non	novel, unsup	2
ftd/als	NCT00424463	2007	mci-186	edaravone	approved	2017	421.7138945927447	NA	NA	non	pre-approval	6
parkinson	NCT00427011	2007	e2007	perampanel	approved	NA	29.089664613278575	NA	GRIA1	approved	repurposing	3
alzheimer	NCT00428090	2007	rosiglitazone	rosiglitazone	approved	NA	1312.1752224503764	NA	PPARG	approved	repurposing	3
alzheimer	NCT00428389	2007	rivastigmine 10 cm^2 transdermal patch	rivastigmine	approved	2000	284.0574948665298	NA	ACHE	approved	post-approval	7
alzheimer	NCT00432081	2000	indomethacin	indomethacin	approved	NA	NA	NA	PTGS2	approved	repurposing	3
parkinson	NCT00434304	2007	ropinirole prolonged release/extended release(pr/xr)	ropinirole	approved	1997	118.99247091033538	NA	DRD3	approved	post-approval	7
parkinson	NCT00437125	2007	duloxetine hydrochloride	duloxetine	approved	NA	352.643394934976	NA	SLC6A4	approved	repurposing	3
parkinson	NCT00438607	2007	biib014	vipadenant	experimental	NA	166.113620807666	NA	ADORA2A	approved	metoo	5
alzheimer	NCT00439166	2007	doxycycline	doxycycline	approved	NA	383.025325119781	NA	NA	non	repurposing	3
alzheimer	NCT00440050	2007	dha (docosahexaenoic acid)	docosahexaenoic acid	approved	NA	902.5051334702259	NA	PPARA	approved	repurposing	3
parkinson	NCT00442780	2007	biib014	vipadenant	experimental	NA	48.09856262833676	NA	ADORA2A	approved	metoo	5
alzheimer	NCT00443417	2007	sk-pc-b70m	sk-pc-b70m	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00443872	2007	orally disintegrating selegiline (zelapar)	selegiline	approved	1996	135.13210130047912	NA	MAOB	approved	post-approval	7
ftd/als	NCT00444613	2007	e0302 (mecobalamin)	mecobalamin	approved	NA	2704.186173853525	NA	MTR	approved	repurposing	3
ftd/als	NCT00445172	2008	e0302 (mecobalamin)	mecobalamin	approved	NA	1236.7145790554414	NA	MTR	approved	repurposing	3
parkinson	NCT00449865	2007	creatine	creatine	supplement	NA	12478.954140999316	NA	CKM	approved	metoo	5
parkinson	NCT00451633	2007	e2007	perampanel	approved	NA	NA	NA	GRIA1	approved	repurposing	3
alzheimer	NCT00454870	2007	mem 3454	rg3487	experimental	NA	NA	NA	CHRNA7	approved	metoo	5
alzheimer	NCT00455000	2007	pf-04360365	ponezumab	experimental	NA	92.68993839835728	OMIM	APP	non	novel, supported	1
parkinson	NCT00455507	2007	istradefylline	istradefylline	approved	2019	515.8028747433265	NA	ADORA2A	approved	pre-approval	6
parkinson	NCT00456586	2002	kw-6002 (istradefylline)	istradefylline	approved	2019	NA	NA	ADORA2A	approved	pre-approval	6
parkinson	NCT00456794	2002	istradefylline (kw-6002)	istradefylline	approved	2019	NA	NA	ADORA2A	approved	pre-approval	6
parkinson	NCT00459420	2007	caffeine 100-200 mg bid	caffeine	approved	NA	246.45037645448323	NA	ADORA1	approved	repurposing	3
alzheimer	NCT00459550	2007	gsk933776	gsk933776	experimental	NA	210.8145106091718	OMIM	APP	non	novel, supported	1
parkinson	NCT00460148	2007	ropinirole	ropinirole	approved	1997	9.352498288843258	NA	DRD3	approved	post-approval	7
parkinson	NCT00461942	2006	green tea polyphenols (egcg/ecg)	epigallocatechin gallate	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00462007	2006	stalevo	carbidopa,levodopa,entacapone	combination	NA	143.57289527720738	NA	DRD1	approved	combination	4
parkinson	NCT00462254	2007	ramelteon	ramelteon	approved	NA	4.008213552361396	NA	MTNR1A	approved	repurposing	3
alzheimer	NCT00464334	2007	v950	v950	experimental	NA	416.04928131416835	OMIM	APP	non	novel, supported	1
parkinson	NCT00465452	2007	continuous release dopamine agonists	ropinirole	approved	1997	NA	NA	DRD3	approved	post-approval	7
parkinson	NCT00466167	2007	pramipexol extended release	pramipexole	approved	1997	NA	NA	DRD3	approved	post-approval	7
alzheimer	NCT00469456	2007	memantine	memantine	approved	2003	420.80766598220396	NA	GRIN1	approved	post-approval	7
alzheimer	NCT00470418	2007	nic5-15	nic5-15	experimental	NA	47.43326488706366	OMIM	APP	non	novel, supported	1
alzheimer	NCT00471211	2006	pbt2	pbt2	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00472355	2005	apomorphine	apomorphine	approved	2004	0	NA	DRD4	approved	post-approval	7
parkinson	NCT00474058	2007	rotigotine	rotigotine	approved	2007	526.4613278576318	NA	DRD3	approved	post-approval	7
alzheimer	NCT00476008	2007	memantine	memantine	approved	2003	315.23613963039014	NA	GRIN1	approved	post-approval	7
alzheimer	NCT00477659	2007	donepezil hcl (aricept)	donepezil	approved	1996	15.21697467488022	NA	ACHE	approved	post-approval	7
parkinson	NCT00477672	2007	pimavanserin tartrate (acp-103)	pimavanserin	approved	NA	620.8843258042436	NA	HTR2A	approved	repurposing	3
parkinson	NCT00477802	2007	botulinum toxin type a	botulinum toxin a	approved	NA	12.70362765229295	NA	SNAP25	approved	repurposing	3
alzheimer	NCT00478205	2007	aricept (donepezil ir 10 mg)	donepezil	approved	1996	NA	NA	ACHE	approved	post-approval	7
alzheimer	NCT00479219	2007	gsi-953	begacestat	experimental	NA	7.121149897330596	OMIM	PSEN1	non	novel, supported	1
parkinson	NCT00479401	2007	pramipexol extended release	pramipexole	approved	1997	NA	NA	DRD3	approved	post-approval	7
alzheimer	NCT00479557	2007	acc-001	vanutide cridificar	experimental	NA	487.8631074606434	OMIM	APP	non	novel, supported	1
alzheimer	NCT00481520	2007	sam-531	cerlapirdine	experimental	NA	NA	NA	HTR6	approved	metoo	5
alzheimer	NCT00483028	2004	donezepil (aricept)	donepezil	approved	1996	NA	NA	ACHE	approved	post-approval	7
parkinson	NCT00485069	2007	rop+l-dopa	ropinirole,levodopa	combination	NA	307.7946611909651	NA	DRD1	approved	combination	4
alzheimer	NCT00486044	2005	simvastatin	simvastatin	approved	NA	445.8398357289528	NA	HMGCR	approved	repurposing	3
alzheimer	NCT00488670	2010	escitalopram	escitalopram	approved	NA	NA	NA	SLC6A4	approved	repurposing	3
parkinson	NCT00489255	2007	tigan®	trimethobenzamide	approved	NA	565.700205338809	NA	NA	non	repurposing	3
alzheimer	NCT00490568	2007	rosiglitazone xr	rosiglitazone	approved	NA	2652	NA	PPARG	approved	repurposing	3
parkinson	NCT00491998	2006	v1512 and entacapone	entacapone,v1512	combination	NA	NA	NA	COMT	approved	combination	4
alzheimer	NCT00495417	2007	affitope ad01	ad01	experimental	NA	50.06981519507187	OMIM	APP	non	novel, supported	1
huntington	NCT00495820	2007	methylphenidate	methylphenidate	approved	NA	170.02053388090349	NA	SLC6A3	approved	repurposing	3
huntington	NCT00497159	2007	dimebon	dimebon	approved	NA	83.71252566735113	NA	HRH1	approved	repurposing	3
alzheimer	NCT00498602	2007	acc-001	vanutide cridificar	experimental	NA	840.6297056810404	OMIM	APP	non	novel, supported	1
alzheimer	NCT00500500	2005	egb 761® (tanakan®)	ginkgo biloba	supplement	NA	110.06160164271047	NA	NA	non	novel, unsup	2
alzheimer	NCT00501111	2007	azd3480	ispronicline	experimental	NA	716.2847364818617	NA	CHRNA4	approved	metoo	5
parkinson	NCT00501969	2004	rotigotine	rotigotine	approved	2007	1711.937029431896	NA	DRD3	approved	pre-approval	6
alzheimer	NCT00505167	2007	donepezil	donepezil	approved	1996	90.94045174537987	NA	ACHE	approved	post-approval	7
parkinson	NCT00505622	2007	perampanel	perampanel	approved	NA	246.95414099931554	NA	GRIA1	approved	repurposing	3
parkinson	NCT00505687	2005	rotigotine	rotigotine	approved	2007	712.4271047227926	NA	DRD3	approved	pre-approval	6
parkinson	NCT00505843	2007	mk0657	rislenemdaz	experimental	NA	13.60164271047228	NA	GRIN2B	approved	metoo	5
alzheimer	NCT00506415	2007	rivastigmine 10 cm^2	rivastigmine	approved	2000	6201.560574948665	NA	ACHE	approved	post-approval	7
huntington	NCT00514774	2007	ursodiol	ursodiol	approved	NA	NA	NA	AKR1C2	approved	repurposing	3
alzheimer	NCT00515333	2004	trx0014	methylene blue	approved	NA	1076.2245037645448	NA	GUCY1A2	approved	repurposing	3
parkinson	NCT00515437	2007	botulinum toxin type b (myobloc)	botulinum toxin b	approved	NA	63.27720739219713	NA	VAMP1	approved	repurposing	3
parkinson	NCT00517842	2005	vineuro	vineuro	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00519532	2007	rotigotine	rotigotine	approved	2007	154.08624229979466	NA	DRD3	approved	post-approval	7
parkinson	NCT00522379	2007	rotigotine	rotigotine	approved	2007	2056	NA	DRD3	approved	post-approval	7
alzheimer	NCT00523666	2006	galantamine (reminyl®)	galantamine	approved	2001	NA	NA	ACHE	approved	post-approval	7
parkinson	NCT00524914	2007	apomorphine	apomorphine	approved	2004	7.972621492128679	NA	DRD4	approved	post-approval	7
parkinson	NCT00526630	2007	methylphenidate (mpd)	methylphenidate	approved	NA	42.19028062970568	NA	SLC6A3	approved	repurposing	3
alzheimer	NCT00531804	2006	gantenerumab	gantenerumab	experimental	NA	225.0513347022587	OMIM	APP	non	novel, supported	1
parkinson	NCT00537017	2007	other parkinson's disease treatments	pramipexole,entacapone	combination	NA	278.65845311430525	NA	DRD3	approved	combination	4
parkinson	NCT00537485	2007	spm 962	rotigotine	approved	2007	405.0924024640657	NA	DRD3	approved	post-approval	7
alzheimer	NCT00539305	2009	testosterone gel	testosterone	approved	NA	62.340862422997944	NA	AR	approved	repurposing	3
ftd/als	NCT00542412	2001	riluzole	riluzole	approved	1995	1620.8624229979466	NA	SCN5A	approved	post-approval	7
alzheimer	NCT00544791	2007	melatonin	melatonin	supplement	NA	NA	NA	MTNR1A	approved	metoo	5
ftd/als	NCT00545974	2007	memantine	memantine	approved	NA	418.69404517453796	NA	GRIN1	approved	repurposing	3
other/unspecified	NCT00547911	2007	carbidopa	carbidopa	approved	NA	77.00479123887749	NA	DDC	approved	repurposing	3
alzheimer	NCT00548145	2007	pitavastatin	pitavastatin	approved	NA	164.5886379192334	NA	HMGCR	approved	repurposing	3
alzheimer	NCT00549601	2007	rivastigmine capsules (6 mg to 12 mg/day)	rivastigmine	approved	2000	224.71184120465435	NA	ACHE	approved	post-approval	7
parkinson	NCT00550238	2007	pimavanserin tartrate (acp-103)	pimavanserin	approved	NA	5009.100616016427	NA	HTR2A	approved	repurposing	3
alzheimer	NCT00550420	2007	rosiglitazone xr	rosiglitazone	approved	NA	453.11430527036276	NA	PPARG	approved	repurposing	3
alzheimer	NCT00551161	2007	memantine	memantine	approved	2003	52.0082135523614	NA	GRIN1	approved	post-approval	7
alzheimer	NCT00555204	2007	abt-089	pozanicline	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00558025	2007	pramipexole extended release	pramipexole	approved	1997	NA	NA	DRD3	approved	post-approval	7
parkinson	NCT00558337	2007	levodopa-carbidopa	carbidopa,levodopa	combination	NA	84.56673511293634	NA	DRD1	approved	combination	4
parkinson	NCT00559871	2007	fipamezole	fipamezole	experimental	NA	284.8459958932238	NA	ADRA2A	approved	metoo	5
parkinson	NCT00560508	2007	pramipexole extended release	pramipexole	approved	1997	NA	NA	DRD3	approved	post-approval	7
alzheimer	NCT00561392	2007	rivastigmine 5 and 10 cm^2 patch	rivastigmine	approved	2000	208.42710472279262	NA	ACHE	approved	post-approval	7
parkinson	NCT00562198	2008	sinemet 200mg/50mg	carbidopa,levodopa	combination	NA	NA	NA	DRD1	approved	combination	4
alzheimer	NCT00566397	2007	pf-04494700	azeliragon	experimental	NA	1206.2751540041068	NA	AGER	non	novel, unsup	2
parkinson	NCT00566462	2007	perampanel	perampanel	approved	NA	1.1690622861054072	NA	GRIA1	approved	repurposing	3
alzheimer	NCT00566501	2007	10 mg ir donepezil (immediate release)	donepezil	approved	1996	2440	NA	ACHE	approved	post-approval	7
alzheimer	NCT00568776	2007	elnd005	scyllo-inositol	experimental	NA	852.4188911704313	NA	NA	non	novel, unsup	2
alzheimer	NCT00571064	2008	donepezil hcl	donepezil	approved	1996	126.6776180698152	NA	ACHE	approved	post-approval	7
parkinson	NCT00571285	2007	vitamin d3	vitamin d	supplement	NA	255.80835044490075	NA	NA	non	novel, unsup	2
ftd/als	NCT00573443	2007	dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg	dextromethorphan	approved	2010	571.2251882272416	NA	SIGMAR1	approved	pre-approval	6
alzheimer	NCT00574132	2007	bapineuzumab 0.5 mg/kg	bapineuzumab	experimental	NA	5990.866529774127	OMIM	APP	non	novel, supported	1
alzheimer	NCT00575055	2007	bapineuzumab 0.5 mg/kg	bapineuzumab	experimental	NA	4858.43394934976	OMIM	APP	non	novel, supported	1
parkinson	NCT00577460	2007	pramipexole	pramipexole	approved	1997	NA	NA	DRD3	approved	post-approval	7
alzheimer	NCT00580931	2008	nicotinamide	nicotinamide	approved	NA	324.8459958932238	NA	BST1	approved	repurposing	3
alzheimer	NCT00581867	2007	insulin aspart	insulin	approved	NA	142.07802874743325	NA	INSR	approved	repurposing	3
parkinson	NCT00582673	2007	afq056	mavoglurant	experimental	NA	NA	NA	GRM5	approved	metoo	5
alzheimer	NCT00582855	2007	aqw051	aqw051	experimental	NA	NA	NA	CHRNA7	approved	metoo	5
parkinson	NCT00584025	2007	levetiracetam	levetiracetam	approved	NA	0	NA	SV2A	approved	repurposing	3
parkinson	NCT00584090	2007	solifenacin succinate (vesicare)	solifenacin	approved	NA	NA	NA	CHRM3	approved	repurposing	3
alzheimer	NCT00586430	2005	lorazepam	lorazepam	approved	NA	56.87063655030801	NA	GABRA1	approved	repurposing	3
parkinson	NCT00590122	2006	carbidopa-levodopa	carbidopa,levodopa	combination	NA	NA	NA	DRD1	approved	combination	4
huntington	NCT00592995	2007	creatine monohydrate	creatine	supplement	NA	304.18617385352496	NA	CKM	approved	metoo	5
parkinson	NCT00593606	2007	rotigotine	rotigotine	approved	2007	51.94250513347023	NA	DRD3	approved	post-approval	7
parkinson	NCT00594464	2007	rotigotine	rotigotine	approved	2007	9.314168377823409	NA	DRD3	approved	post-approval	7
alzheimer	NCT00594568	2008	ly450139	semagacestat	experimental	NA	4864.536618754278	OMIM	PSEN1	non	novel, supported	1
ftd/als	NCT00594737	2007	memantine hydrochloride	memantine	approved	NA	79.35660506502396	NA	GRIN1	approved	repurposing	3
alzheimer	NCT00596024	2007	lutein/zeaxanthin	lutein	supplement	NA	4.747433264887063	NA	NA	non	novel, unsup	2
alzheimer	NCT00597376	2007	cerefolin nac (a medical food)	levomefolic acid	supplement	NA	363.6084873374401	NA	NA	non	novel, unsup	2
parkinson	NCT00600093	2008	amantadine	amantadine	approved	2003	NA	NA	GRIN3A	approved	post-approval	7
ftd/als	NCT00600873	2007	r(+) pramipexole dihydrochloride monohydrate	pramipexole	approved	NA	14.209445585215606	NA	DRD3	approved	repurposing	3
parkinson	NCT00601523	2008	pramipexole	pramipexole	approved	1997	NA	NA	DRD3	approved	post-approval	7
parkinson	NCT00601978	2008	carbidopa/levodopa	carbidopa,levodopa	combination	NA	0	NA	DRD1	approved	combination	4
alzheimer	NCT00602680	2008	ssr180711c	ssr180711c	experimental	NA	0.49828884325804246	NA	CHRNB2	approved	metoo	5
ftd/als	NCT00604591	2011	tolcapone	tolcapone	approved	NA	91.07186858316221	NA	COMT	approved	repurposing	3
parkinson	NCT00605553	2008	tozadenant	tozadenant	experimental	NA	32.4435318275154	NA	ADORA2A	approved	metoo	5
parkinson	NCT00605683	2007	safinamide (as add-on therapy)	safinamide	approved	2017	2940.939082819986	NA	MAOB	approved	pre-approval	6
alzheimer	NCT00606164	2008	bryostatin for injection	bryostatin 1	experimental	NA	NA	NA	PRKCA	approved	metoo	5
alzheimer	NCT00606476	2006	bapineuzumab (aab-001)	bapineuzumab	experimental	NA	1115.9315537303216	OMIM	APP	non	novel, supported	1
alzheimer	NCT00607308	2008	pf-04360365	ponezumab	experimental	NA	53.27857631759069	OMIM	APP	non	novel, supported	1
parkinson	NCT00607451	2008	neu-120	neu-120	experimental	NA	67.92060232717317	NA	NA	non	novel, unsup	2
parkinson	NCT00608231	2008	dexmedetomidine hydrochloride infusion	dexmedetomidine	approved	NA	0	NA	ADRA2A	approved	repurposing	3
huntington	NCT00608881	2008	coenzyme q10	ubidecarenone	supplement	NA	4363.457905544148	NA	NDUFV3	approved	metoo	5
alzheimer	NCT00608946	2004	copper	copper	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00610103	2007	apomorphine hydrochloride	apomorphine	approved	2004	14.674880219028063	NA	DRD4	approved	post-approval	7
ftd/als	NCT00614926	2006	modafinil	modafinil	approved	NA	66.67214236824093	NA	SLC6A3	approved	repurposing	3
parkinson	NCT00615472	2003	isoflurane	isoflurane	approved	NA	434.9404517453799	NA	GABRA1	approved	repurposing	3
alzheimer	NCT00620191	2008	metformin	metformin	approved	NA	320	NA	PRKAB1	approved	repurposing	3
alzheimer	NCT00621647	2002	quetiapine fumarate	quetiapine	approved	NA	388.3860369609856	NA	HTR2A	approved	repurposing	3
alzheimer	NCT00622713	2008	rivastigmine transdermal patch	rivastigmine	approved	2000	228.4681724845996	NA	ACHE	approved	post-approval	7
parkinson	NCT00623103	2008	rivastigmine capsule	rivastigmine	approved	NA	NA	NA	ACHE	approved	repurposing	3
parkinson	NCT00623324	2008	aplindore	aplindore	experimental	NA	NA	NA	DRD2	approved	metoo	5
parkinson	NCT00623363	2007	piclozotan	piclozotan	experimental	NA	33.782340862423	NA	HTR1A	approved	metoo	5
alzheimer	NCT00624026	2007	memantine-hcl	memantine	approved	2003	116.0082135523614	NA	GRIN1	approved	post-approval	7
alzheimer	NCT00626210	2008	modafinil	modafinil	approved	NA	9.330595482546201	NA	SLC6A3	approved	repurposing	3
parkinson	NCT00627588	2008	prosavin	prosavin	experimental	NA	68.74743326488706	NA	TH	approved	metoo	5
parkinson	NCT00627640	2009	safinimide 50-100 mg/day	safinamide	approved	2017	1689.4620123203285	NA	MAOB	approved	pre-approval	6
alzheimer	NCT00627848	2007	rivastigmine	rivastigmine	approved	2000	35.09924709103354	NA	ACHE	approved	post-approval	7
alzheimer	NCT00628017	2003	omega-3 polyunsaturated fatty acids ( epa+dha)	DHA,EPA	approved	NA	99.49349760438056	NA	PPARA	approved	repurposing	3
parkinson	NCT00629161	2008	traditional chinese medicinal mixture (composed of roucongrong and adjuvant)	roucongrong	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00630500	2006	memantine	memantine	approved	NA	230.80082135523614	NA	GRIN1	approved	repurposing	3
alzheimer	NCT00630851	2002	donepezil (aricept)	donepezil	approved	1996	498.34086242299793	NA	ACHE	approved	post-approval	7
huntington	NCT00632645	2009	olanzapine	olanzapine	approved	NA	1453.305954825462	NA	HTR2A	approved	repurposing	3
parkinson	NCT00632736	2004	ropinirole xl (formerly cr)	ropinirole	approved	1997	2546.694045174538	NA	DRD3	approved	post-approval	7
parkinson	NCT00632762	2007	mantadix	amantadine	approved	2003	NA	NA	GRIN3A	approved	post-approval	7
alzheimer	NCT00633841	2008	affitope ad02	affitope ad02	experimental	NA	37.97946611909651	OMIM	APP	non	novel, supported	1
ftd/als	NCT00635960	2007	growth hormone (somatropin)	somatropin	approved	NA	NA	NA	GHR	approved	repurposing	3
alzheimer	NCT00637442	2008	reminyl retard	galantamine	approved	2001	NA	NA	ACHE	approved	post-approval	7
parkinson	NCT00640159	2007	zelapar	selegiline	approved	1996	NA	NA	MAOB	approved	post-approval	7
parkinson	NCT00640952	2006	acamprosate	acamprosate	approved	NA	0	NA	GRM5	approved	repurposing	3
parkinson	NCT00641186	2004	sodium oxybate	sodium oxybate	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT00642356	2008	carbidopa/levodopa/entacapone	carbidopa,levodopa	combination	NA	16.32854209445585	NA	DRD1	approved	combination	4
parkinson	NCT00642889	2005	safinamide	safinamide	approved	2017	472.33401779603014	NA	MAOB	approved	pre-approval	6
parkinson	NCT00642928	2007	bf 2.649 10 mg	pitolisant	approved	NA	180.07392197125256	NA	HRH3	approved	repurposing	3
parkinson	NCT00643045	2004	safinamide	safinamide	approved	2017	693.7659137577002	NA	MAOB	approved	pre-approval	6
parkinson	NCT00643890	2008	bilateral surgical infusion of aav-gad into the subthalamic nucleus	aav-gad	experimental	NA	NA	NA	GAD1	non	novel, unsup	2
alzheimer	NCT00645190	2004	galantamine hbr	galantamine	approved	2001	198.3709787816564	NA	ACHE	approved	post-approval	7
parkinson	NCT00646204	2006	memantine	memantine	approved	NA	NA	NA	GRIN1	approved	repurposing	3
ftd/als	NCT00647296	2008	kns-760704	dexpramipexole	experimental	NA	161.69199178644763	NA	NA	non	novel, unsup	2
alzheimer	NCT00649220	2008	memantine	memantine	approved	2003	17.426420260095824	NA	GRIN1	approved	post-approval	7
parkinson	NCT00650104	2002	ropinirole xl (formerly cr)	ropinirole	approved	1997	519.3593429158111	NA	DRD3	approved	post-approval	7
parkinson	NCT00656253	2008	herbal medicinal mixture (roucongrong, heshouwu etc.)	roucongrong,heshouwu	supplement	NA	395.378507871321	NA	NA	non	novel, unsup	2
parkinson	NCT00658567	2008	pimavanserin tartrate (acp-103)	pimavanserin	approved	NA	215.52361396303903	NA	HTR2A	approved	repurposing	3
alzheimer	NCT00663026	2008	bapineuzumab	bapineuzumab	experimental	NA	151.18685831622176	OMIM	APP	non	novel, supported	1
alzheimer	NCT00663936	2008	t-817ma	edonerpic	experimental	NA	1180.5284052019165	NA	NA	non	novel, unsup	2
parkinson	NCT00664209	2008	clartihromycin, amoxicillin, and omeprazole	clarithromycin	approved	NA	282.6338124572211	NA	NA	non	repurposing	3
huntington	NCT00665223	2008	acr16	pridopidine	experimental	NA	1383.085557837098	NA	SIGMAR1	approved	metoo	5
parkinson	NCT00666653	2003	pramipexole	pramipexole	approved	1997	49.828884325804246	NA	DRD3	approved	post-approval	7
alzheimer	NCT00667810	2008	bapineuzumab	bapineuzumab	experimental	NA	4654.858316221766	OMIM	APP	non	novel, supported	1
parkinson	NCT00669461	2009	lubiprostone	lubiprostone	approved	NA	1.2511978097193703	NA	CLCN2	approved	repurposing	3
alzheimer	NCT00672945	2008	prx-03140	prx-03140	experimental	NA	NA	NA	HTR4	approved	metoo	5
alzheimer	NCT00675090	2008	gsk239512	gsk239512	experimental	NA	36.87337440109514	NA	HRH3	approved	metoo	5
alzheimer	NCT00675623	2008	dimebon	dimebon	approved	NA	NA	NA	HRH1	approved	repurposing	3
alzheimer	NCT00676143	2008	bapineuzumab	bapineuzumab	experimental	NA	5318.54893908282	OMIM	APP	non	novel, supported	1
alzheimer	NCT00678431	2008	resveratrol with glucose, and malate	resveratrol	supplement	NA	92.18069815195072	NA	NA	non	novel, unsup	2
alzheimer	NCT00679627	2008	galantamine	galantamine	approved	2001	8029.924709103354	NA	ACHE	approved	post-approval	7
alzheimer	NCT00684944	2007	trx0014	methylene blue	approved	NA	357.388090349076	NA	GUCY1A2	approved	repurposing	3
alzheimer	NCT00687141	2007	azd0328	azd0328	experimental	NA	65.3141683778234	NA	CHRNA7	approved	metoo	5
alzheimer	NCT00688207	2008	rosiglitazone (extended release)	rosiglitazone	approved	NA	5.864476386036961	NA	PPARG	approved	repurposing	3
ftd/als	NCT00690118	2008	pioglitazone	pioglitazone	approved	NA	456.28747433264886	NA	PPARG	approved	repurposing	3
alzheimer	NCT00693004	2008	prx-03140	prx-03140	experimental	NA	NA	NA	HTR4	approved	metoo	5
parkinson	NCT00696215	2007	rasagiline	rasagiline	approved	2006	NA	NA	MAOB	approved	post-approval	7
ftd/als	NCT00696332	2008	talampanel	talampanel	experimental	NA	928.9883641341547	NA	NA	non	novel, unsup	2
alzheimer	NCT00702780	2008	escitalopram	escitalopram	approved	NA	209.48939082819987	NA	SLC6A4	approved	repurposing	3
alzheimer	NCT00703430	2008	memantine	memantine	approved	2003	NA	NA	GRIN1	approved	post-approval	7
alzheimer	NCT00704782	2008	dimebon	dimebon	approved	NA	116.63244353182752	NA	HRH1	approved	repurposing	3
ftd/als	NCT00706147	2009	arimoclomol	arimoclomol	experimental	NA	297.6536618754278	NA	NA	non	novel, unsup	2
alzheimer	NCT00708552	2008	sb-742457	intepirdine	experimental	NA	966.7022587268993	NA	HTR6	approved	metoo	5
alzheimer	NCT00710684	2008	sb-742457 15mg	intepirdine	experimental	NA	1620.7419575633128	NA	HTR6	approved	metoo	5
alzheimer	NCT00711204	2008	donepezil hydrochloride (aricept)	donepezil	approved	1996	NA	NA	ACHE	approved	post-approval	7
huntington	NCT00712426	2009	creatine monohydrate	creatine	supplement	NA	2949.3333333333335	NA	CKM	approved	metoo	5
alzheimer	NCT00722046	2008	pf-04360365 0.1 mg/kg	ponezumab	experimental	NA	527.4579055441478	OMIM	APP	non	novel, supported	1
huntington	NCT00724048	2008	acr16 10 mg	pridopidine	experimental	NA	604.7118412046543	NA	SIGMAR1	approved	metoo	5
alzheimer	NCT00731224	2008	rivastigmine transdermal patch	rivastigmine	approved	2000	1234.9349760438056	NA	ACHE	approved	post-approval	7
alzheimer	NCT00733642	2008	pf-04360365 1 mg/kg	ponezumab	experimental	NA	13.716632443531827	OMIM	APP	non	novel, supported	1
alzheimer	NCT00733863	2008	cad106	cad106	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT00736775	2008	anti-abeta	anti-abeta antibody	experimental	NA	NA	OMIM	APP	non	novel, supported	1
other/unspecified	NCT00738062	2008	droxidopa	droxidopa	approved	NA	300.3285420944558	NA	ADRA1A	approved	repurposing	3
alzheimer	NCT00739037	2008	paz-417	aleplasinin	experimental	NA	NA	NA	SERPINE1	approved	metoo	5
parkinson	NCT00740714	2008	coenzyme q10 with vitamin e	ubidecarenone	supplement	NA	1598.3572895277207	NA	NDUFV3	approved	metoo	5
alzheimer	NCT00742417	2007	albutein 5%	albumin	approved	NA	153.9712525667351	NA	NA	non	repurposing	3
alzheimer	NCT00743743	2008	longevinex brand resveratrol supplement	resveratrol	approved	NA	0	NA	NA	non	repurposing	3
alzheimer	NCT00744978	2009	varenicline	varenicline	approved	NA	88.18069815195072	NA	CHRNA4	approved	repurposing	3
parkinson	NCT00745030	2008	rozerem	ramelteon	approved	NA	4.501026694045175	NA	MTNR1A	approved	repurposing	3
ftd/als	NCT00748501	2008	sb-509	sb-509	experimental	NA	78.60369609856262	NA	VEGFA	approved	metoo	5
alzheimer	NCT00749216	2008	solanezumab	solanezumab	experimental	NA	27.37577002053388	OMIM	APP	non	novel, supported	1
alzheimer	NCT00750529	2008	galantamine and donepezil	galantamine,donepezil	combination	NA	72.48459958932239	NA	ACHE	approved	combination	4
alzheimer	NCT00751907	2006	atorvastatin	atorvastatin	approved	NA	13.316906228610542	NA	HMGCR	approved	repurposing	3
alzheimer	NCT00752232	2008	acc-001	vanutide cridificar	experimental	NA	143.24435318275155	OMIM	APP	non	novel, supported	1
ftd/als	NCT00753571	2008	cistanche total glycosides	cistanche total glycosides	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00753636	2008	dynacirc cr (isradipine)	isradipine	approved	NA	56.95003422313484	NA	CACNA1C	approved	repurposing	3
parkinson	NCT00755027	2008	rasagiline	rasagiline	approved	2006	229.86995208761124	NA	MAOB	approved	post-approval	7
parkinson	NCT00758368	2009	apomorphine	apomorphine	approved	2004	0	NA	DRD4	approved	post-approval	7
parkinson	NCT00758849	2008	fipamezole	fipamezole	experimental	NA	NA	NA	ADRA2A	approved	metoo	5
parkinson	NCT00761137	2008	0 mg tropicamide	tropicamide	approved	NA	42.75975359342916	NA	CHRM4	approved	repurposing	3
parkinson	NCT00761436	2000	spheramine (bay86-5280)	spheramine	experimental	NA	73.47843942505133	NA	DRD1	approved	metoo	5
alzheimer	NCT00762411	2008	ly450139	semagacestat	experimental	NA	2865.3305954825464	OMIM	PSEN1	non	novel, supported	1
alzheimer	NCT00766363	2008	evp-6124 (0.1 mg/day)	encenicline	experimental	NA	20.257357973990416	NA	CHRNA7	approved	metoo	5
parkinson	NCT00767091	2009	rivastigmine	rivastigmine	approved	NA	113.45653661875428	NA	ACHE	approved	repurposing	3
parkinson	NCT00767546	2009	botulinum toxin	botulinum toxin a	approved	NA	NA	NA	SNAP25	approved	repurposing	3
alzheimer	NCT00768261	2004	donepezil (aricept®)	donepezil	approved	1996	191.66324435318276	NA	ACHE	approved	post-approval	7
alzheimer	NCT00777608	2008	donepezil 10 mg	donepezil	approved	1996	141.04312114989733	NA	ACHE	approved	post-approval	7
parkinson	NCT00782340	2008	droxidopa	droxidopa	approved	NA	525.6399726214921	NA	ADRA1A	approved	repurposing	3
ftd/als	NCT00790582	2008	lithium carbonate	lithium	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT00792662	2008	methylphenidate	methylphenidate	approved	NA	0	NA	SLC6A3	approved	repurposing	3
parkinson	NCT00794313	2009	topiramate	topiramate	approved	NA	2.242299794661191	NA	GABRA1	approved	repurposing	3
alzheimer	NCT00795418	2008	cad106	cad106	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT00795730	2009	nsa-789	nsa-789	experimental	NA	NA	NA	NA	non	novel, unsup	2
ftd/als	NCT00800501	2008	snn0029	snn0029	experimental	NA	44.94455852156057	NA	VEGFA	approved	metoo	5
alzheimer	NCT00800709	2008	memantine	memantine	approved	2003	NA	NA	GRIN1	approved	post-approval	7
alzheimer	NCT00804271	2008	memantine	memantine	approved	2003	446.6666666666667	NA	GRIN1	approved	post-approval	7
parkinson	NCT00806468	2009	desmotabs	desmopressin	approved	NA	1.998631074606434	NA	AVPR2	approved	repurposing	3
parkinson	NCT00809302	2008	aplindore mr tablets or placebo	aplindore	experimental	NA	7.490759753593429	NA	DRD2	approved	metoo	5
alzheimer	NCT00809510	2009	abt-089	pozanicline	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT00810147	2009	bms-708163	avagacestat	experimental	NA	277.52224503764546	OMIM	PSEN1	non	novel, supported	1
alzheimer	NCT00812565	2009	octagam 10%	octagam 10%	experimental	NA	91.6249144421629	NA	NA	non	novel, unsup	2
ftd/als	NCT00812851	2005	dronabinol	dronabinol	approved	NA	72.0164271047228	NA	CNR1	approved	repurposing	3
alzheimer	NCT00814346	2008	egb761®	ginkgo biloba	supplement	NA	183.65776865160848	NA	NA	non	novel, unsup	2
alzheimer	NCT00814502	2008	zolpidem cr	zolpidem	approved	NA	99.98631074606433	NA	GABRA1	approved	repurposing	3
alzheimer	NCT00814801	2007	galantamine 16 mg/day	galantamine	approved	2001	917.8370978781657	NA	ACHE	approved	post-approval	7
ftd/als	NCT00818389	2009	lithium carbonate	lithium	approved	NA	62.784394250513344	NA	NA	non	repurposing	3
parkinson	NCT00822913	2008	intravesical injection of botulinum a toxin	botulinum toxin a	approved	NA	NA	NA	SNAP25	approved	repurposing	3
parkinson	NCT00823836	2009	ropinirole ir	ropinirole	approved	1997	529.1718001368926	NA	DRD3	approved	post-approval	7
alzheimer	NCT00829374	2009	dimebon	dimebon	approved	NA	2759.794661190965	NA	HRH1	approved	repurposing	3
alzheimer	NCT00829816	2008	dimebon	dimebon	approved	NA	76.57221081451061	NA	HRH1	approved	repurposing	3
parkinson	NCT00833690	2009	inosine	inosine	approved	NA	262.62833675564684	NA	NA	non	repurposing	3
alzheimer	NCT00838110	2009	dimebon	dimebon	approved	NA	678.5160848733744	NA	HRH1	approved	repurposing	3
alzheimer	NCT00842673	2009	st101	st101	experimental	NA	265.39630390143736	NA	NA	non	novel, unsup	2
alzheimer	NCT00842816	2009	st101	st101	experimental	NA	470.8829568788501	NA	NA	non	novel, unsup	2
alzheimer	NCT00843518	2009	ly451395	mibampator	experimental	NA	307.1868583162218	NA	GRIA1	approved	metoo	5
parkinson	NCT00845000	2009	sch 420814 10 mg	preladenant	experimental	NA	12.747433264887064	NA	ADORA2A	approved	metoo	5
parkinson	NCT00853879	2006	b6, b12, l-methylfolate	levomefolic acid	supplement	NA	524.8459958932239	NA	NA	non	novel, unsup	2
parkinson	NCT00855686	2007	memantine	memantine	approved	NA	398.2724161533196	NA	GRIN1	approved	repurposing	3
alzheimer	NCT00857233	2004	memantine	memantine	approved	2003	1880.7967145790553	NA	GRIN1	approved	post-approval	7
alzheimer	NCT00857649	2003	memantine	memantine	approved	2003	2491.318275154004	NA	GRIN1	approved	post-approval	7
alzheimer	NCT00862940	2005	memantine	memantine	approved	2003	991.9671457905545	NA	GRIN1	approved	post-approval	7
parkinson	NCT00865579	2009	safinamide	safinamide	approved	2017	3053.656399726215	NA	MAOB	approved	pre-approval	6
alzheimer	NCT00866060	2008	donepezil	donepezil	approved	1996	NA	NA	ACHE	approved	post-approval	7
parkinson	NCT00866502	2009	snn0031	snn0031	experimental	NA	23.983572895277206	NA	PDGFB	non	novel, unsup	2
alzheimer	NCT00867828	2009	neptune krill oil	krill oil	supplement	NA	292.26557152635183	NA	NA	non	novel, unsup	2
ftd/als	NCT00868166	2009	olesoxime	olesoxime	experimental	NA	1237.7713894592744	NA	NA	non	novel, unsup	2
parkinson	NCT00869791	2008	ipx066	carbidopa,levodopa	combination	NA	15.671457905544148	NA	DRD1	approved	combination	4
parkinson	NCT00873392	2009	transdermal nicotine	nicotine	approved	NA	169.74674880219027	NA	CHRNA4	approved	repurposing	3
alzheimer	NCT00874939	2009	mk-0249 25 mg	mk-0249	experimental	NA	0.15331964407939766	NA	HRH3	approved	metoo	5
parkinson	NCT00875316	2009	cogane™ (pym50028)	smilagenin	experimental	NA	NA	NA	NA	non	novel, unsup	2
ftd/als	NCT00875446	2009	gsk1223249	gsk1223249	experimental	NA	176.6570841889117	NA	RTN4	non	novel, unsup	2
ftd/als	NCT00876772	2011	olanzapine	olanzapine	approved	NA	NA	NA	HTR2A	approved	repurposing	3
alzheimer	NCT00876863	2008	cere-110: adeno-associated virus delivery of ngf	cere-110	experimental	NA	332.16700889801507	NA	NGF	non	novel, unsup	2
ftd/als	NCT00877604	2008	tauroursodeoxycholic acid (tudca)	tudca	supplement	NA	130.321697467488	NA	NA	non	novel, unsup	2
alzheimer	NCT00880412	2008	eht 0202 etazolate	eht 0202	experimental	NA	262.6666666666667	NA	NA	non	novel, unsup	2
parkinson	NCT00880620	2009	ipx066 145 mg ld	carbidopa,levodopa	combination	NA	603.9671457905545	NA	DRD1	approved	combination	4
alzheimer	NCT00884507	2009	ro5313534	rg3487	experimental	NA	584.6981519507187	NA	CHRNA7	approved	metoo	5
ftd/als	NCT00886977	2009	yam80	yam80	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00888004	2009	afq056	mavoglurant	experimental	NA	NA	NA	GRM5	approved	metoo	5
parkinson	NCT00888186	2008	levodopa/carbidopa	carbidopa,levodopa	combination	NA	1.2320328542094456	NA	DRD1	approved	combination	4
alzheimer	NCT00890890	2009	avagacestat	avagacestat	experimental	NA	1095.9233401779602	OMIM	PSEN1	non	novel, supported	1
parkinson	NCT00892450	2009	oxybutynin and darifenacin	oxybutynin,darifenacin	approved	NA	64.03285420944559	NA	CHRM3	approved	repurposing	3
alzheimer	NCT00895895	2009	sam-531 1.5 mg	cerlapirdine	experimental	NA	1051.2799452429842	NA	HTR6	approved	metoo	5
alzheimer	NCT00898807	2009	citalopram	citalopram	approved	NA	775.5728952772074	NA	SLC6A4	approved	repurposing	3
parkinson	NCT00902941	2009	azilect 1mg	rasagiline	approved	2006	93.64544832306639	NA	MAOB	approved	post-approval	7
parkinson	NCT00903838	2009	pardoprunox	pardoprunox	experimental	NA	61.489390828199866	NA	NA	non	novel, unsup	2
alzheimer	NCT00904683	2009	ly2062430	solanezumab	experimental	NA	3208.980150581793	OMIM	APP	non	novel, supported	1
alzheimer	NCT00905372	2009	ly2062430	solanezumab	experimental	NA	NA	OMIM	APP	non	novel, supported	1
parkinson	NCT00906763	2009	chocolate	chocolate	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT00906828	2008	levodopa/carbidopa	carbidopa,levodopa	combination	NA	NA	NA	DRD1	approved	combination	4
other/unspecified	NCT00907595	2009	ramelteon	ramelteon	approved	NA	0	NA	MTNR1A	approved	repurposing	3
parkinson	NCT00907972	2009	vitamin d3	vitamin d	supplement	NA	76.69815195071868	NA	NA	non	novel, unsup	2
parkinson	NCT00908076	2009	lubiprostone	lubiprostone	approved	NA	129.62628336755648	NA	CLCN2	approved	repurposing	3
parkinson	NCT00909545	2009	isradipine cr 10mg	isradipine	approved	NA	256.13963039014374	NA	CACNA1C	approved	repurposing	3
parkinson	NCT00909883	2009	botulinum toxin: xeomin	botulinum toxin a	approved	NA	NA	NA	SNAP25	approved	repurposing	3
alzheimer	NCT00911807	2004	cerebrolysin + donepezil	donepezil	combination	1996	759.2772073921972	NA	ACHE	approved	post-approval	7
alzheimer	NCT00912288	2009	dimebon 20 mg po tid	dimebon	approved	NA	78.64202600958248	NA	HRH1	approved	repurposing	3
parkinson	NCT00912808	2005	donepezil	donepezil	approved	NA	76.76112251882273	NA	ACHE	approved	repurposing	3
parkinson	NCT00914095	2009	methylphenidate	methylphenidate	approved	NA	149.42915811088295	NA	SLC6A3	approved	repurposing	3
parkinson	NCT00914134	2009	levodopa infusion	levodopa	approved	1975	21.026694045174537	NA	DRD1	approved	post-approval	7
parkinson	NCT00914602	2009	sinemet®	carbidopa,levodopa	combination	NA	NA	NA	DRD1	approved	combination	4
alzheimer	NCT00916383	2009	350 mg donepezil transdermal patch	donepezil	approved	1996	4.158795345653662	NA	ACHE	approved	post-approval	7
alzheimer	NCT00916617	2009	bapineuzumab	bapineuzumab	experimental	NA	201.65913757700204	OMIM	APP	non	novel, supported	1
parkinson	NCT00918177	2009	ap09004	ap09004	experimental	NA	NA	NA	NA	non	novel, unsup	2
ftd/als	NCT00919555	2008	pioglitazone and tretinoin	pioglitazone	approved	NA	104.94729637234771	NA	PPARG	approved	repurposing	3
huntington	NCT00920699	2010	coq10	ubidecarenone	supplement	NA	187.02258726899385	NA	NDUFV3	approved	metoo	5
huntington	NCT00920946	2009	dimebon	dimebon	approved	NA	NA	NA	HRH1	approved	repurposing	3
parkinson	NCT00921128	2009	muscimol	muscimol	experimental	NA	0	NA	NA	non	novel, unsup	2
ftd/als	NCT00925847	2009	lithium	lithium	approved	NA	42.12731006160164	NA	NA	non	repurposing	3
alzheimer	NCT00930059	2009	pf-04447943	pf-04447943	experimental	NA	197.86447638603696	NA	PDE9A	non	novel, unsup	2
ftd/als	NCT00931944	2009	kns-760704	dexpramipexole	experimental	NA	296	NA	NA	non	novel, unsup	2
alzheimer	NCT00933608	2009	memantine	memantine	approved	2003	36.86242299794661	NA	GRIN1	approved	post-approval	7
alzheimer	NCT00934050	2009	elnd005 (scyllo-inositol)	scyllo-inositol	experimental	NA	205.8590006844627	NA	NA	non	novel, unsup	2
alzheimer	NCT00937352	2009	bapineuzumab	bapineuzumab	experimental	NA	2840.70636550308	OMIM	APP	non	novel, supported	1
alzheimer	NCT00939783	2009	dimebon	dimebon	approved	NA	593.472963723477	NA	HRH1	approved	repurposing	3
alzheimer	NCT00939822	2009	simvastatin	simvastatin	approved	NA	396.331279945243	NA	HMGCR	approved	repurposing	3
alzheimer	NCT00940589	2009	circadin	melatonin	supplement	NA	267.41683778234085	NA	MTNR1A	approved	metoo	5
parkinson	NCT00943748	2009	deferiprone	deferiprone	approved	NA	79.94524298425736	NA	NA	non	repurposing	3
alzheimer	NCT00945672	2009	pf-04360365 10 mg/kg	ponezumab	experimental	NA	65.93839835728953	OMIM	APP	non	novel, supported	1
parkinson	NCT00947037	2012	ap-cd/ld	ap-cd/ld	experimental	NA	NA	NA	DDC	approved	metoo	5
alzheimer	NCT00948259	2008	np031112	tideglusib	experimental	NA	27.515400410677618	NA	GSK3B	non	novel, unsup	2
alzheimer	NCT00948766	2009	rivastigmine 13.3 mg/24 h (15 cm^2)	rivastigmine	approved	2000	2089.681040383299	NA	ACHE	approved	post-approval	7
alzheimer	NCT00948909	2009	abt-126	abt-126	experimental	NA	297.06776180698154	NA	CHRNA7	approved	metoo	5
alzheimer	NCT00951834	2009	epigallocatechin-gallate	epigallocatechin gallate	experimental	NA	112.05749486652978	NA	NA	non	novel, unsup	2
alzheimer	NCT00954590	2009	dimebon (latrepirdine)	dimebon	approved	NA	NA	NA	HRH1	approved	repurposing	3
parkinson	NCT00955045	2002	istradefylline	istradefylline	approved	2019	NA	NA	ADORA2A	approved	pre-approval	6
parkinson	NCT00955318	2009	kw-6500	apomorphine	approved	2004	154.66666666666666	NA	DRD4	approved	post-approval	7
alzheimer	NCT00955409	2009	acc-001	vanutide cridificar	experimental	NA	204.10677618069815	OMIM	APP	non	novel, supported	1
parkinson	NCT00955526	2009	istradefylline	istradefylline	approved	2019	592.3066392881587	NA	ADORA2A	approved	pre-approval	6
alzheimer	NCT00956410	2009	cad106	cad106	experimental	NA	36.681724845995895	NA	NA	non	novel, unsup	2
parkinson	NCT00957203	2009	istradefylline	istradefylline	approved	2019	743.7535934291581	NA	ADORA2A	approved	pre-approval	6
parkinson	NCT00957918	2009	nicotine	nicotine	approved	NA	59.61670088980151	NA	CHRNA4	approved	repurposing	3
alzheimer	NCT00959192	2009	acc-001	vanutide cridificar	experimental	NA	109.42642026009582	OMIM	APP	non	novel, supported	1
alzheimer	NCT00960531	2009	acc-001 (10 mcg) + qs-21	vanutide cridificar	experimental	NA	707.0225872689938	OMIM	APP	non	novel, supported	1
ftd/als	NCT00965497	2009	escitalopram	escitalopram	approved	NA	8.648870636550308	NA	SLC6A4	approved	repurposing	3
alzheimer	NCT00965588	2009	ub 311	ub-311	experimental	NA	41.04312114989733	OMIM	APP	non	novel, supported	1
parkinson	NCT00974974	2009	ipx066	carbidopa,levodopa	combination	NA	704.0821355236139	NA	DRD1	approved	combination	4
alzheimer	NCT00976118	2006	masitinib (ab1010)	masitinib	experimental	NA	102.02327173169063	NA	NA	non	novel, unsup	2
huntington	NCT00980694	2009	ubiquinol	ubiquinol	supplement	NA	16.985626283367555	NA	NA	non	novel, unsup	2
alzheimer	NCT00980785	2009	ramipril	ramipril	approved	NA	31.468856947296374	OTG	ACE	approved	repurposing	3
ftd/als	NCT00982150	2009	talampanel	talampanel	experimental	NA	333.3552361396304	NA	NA	non	novel, unsup	2
alzheimer	NCT00982202	2002	pioglitazone	pioglitazone	approved	NA	75.01711156741958	NA	PPARG	approved	repurposing	3
parkinson	NCT00985517	2009	cere-120: adeno-associated virus delivery of neurturin	cere-120	experimental	NA	458.80903490759755	NA	NRTN	non	novel, unsup	2
parkinson	NCT00986245	2009	ropinirole prolonged release	ropinirole	approved	1997	102.37371663244353	NA	DRD3	approved	post-approval	7
parkinson	NCT00986414	2009	afq056	mavoglurant	experimental	NA	NA	NA	GRM5	approved	metoo	5
parkinson	NCT00988117	2010	rivastigmine patch 9.5 cm2	rivastigmine	approved	NA	14.989733059548255	NA	ACHE	approved	repurposing	3
alzheimer	NCT00988598	2009	pf-04447943	pf-04447943	experimental	NA	11.211498973305956	NA	PDE9A	non	novel, unsup	2
alzheimer	NCT00996918	2009	bapineuzumab 0.5 mg/kg	bapineuzumab	experimental	NA	577.8726899383984	OMIM	APP	non	novel, supported	1
alzheimer	NCT00998764	2009	bapineuzumab 0.5 mg/kg	bapineuzumab	experimental	NA	1441.7631759069131	OMIM	APP	non	novel, supported	1
alzheimer	NCT01001637	2009	curcumin formulation	curcumin	supplement	NA	NA	NA	NA	non	novel, unsup	2
ftd/als	NCT01002300	2009	intranasal oxytocin	oxytocin	approved	NA	27.991786447638603	NA	OXTR	approved	repurposing	3
alzheimer	NCT01005862	2010	pf-04360365	ponezumab	experimental	NA	42.587268993839835	OMIM	APP	non	novel, supported	1
parkinson	NCT01007630	2009	rasagiline	rasagiline	approved	2006	NA	NA	MAOB	approved	post-approval	7
parkinson	NCT01007864	2010	piribedil	piribedil	experimental	NA	153.1006160164271	NA	NA	non	novel, unsup	2
alzheimer	NCT01009255	2009	gsk239512	gsk239512	experimental	NA	200.15879534565366	NA	HRH3	approved	metoo	5
parkinson	NCT01010802	2008	erythropoietin human recombinant (eporh)	erythromycin	approved	NA	7.474332648870637	NA	NA	non	repurposing	3
alzheimer	NCT01013610	2009	lnk-754	lonafarnib	approved	NA	NA	NA	FNTA	approved	repurposing	3
parkinson	NCT01014858	2013	donepezil	donepezil	approved	NA	106.53524982888433	NA	ACHE	approved	repurposing	3
parkinson	NCT01016470	2009	viusid/alzer	viusid/alzer	supplement	NA	157.97399041752226	NA	NA	non	novel, unsup	2
parkinson	NCT01018264	2010	solifenacin succinate (vesicare)	solifenacin	approved	NA	105.34976043805612	NA	CHRM3	approved	repurposing	3
alzheimer	NCT01018875	2009	abt-288	abt-288	experimental	NA	282.91307323750857	NA	HRH3	approved	metoo	5
alzheimer	NCT01019421	2009	lu ae58054	idalopirdine	experimental	NA	NA	NA	HTR6	approved	metoo	5
huntington	NCT01019473	2009	afq056	mavoglurant	experimental	NA	NA	NA	GRM5	approved	metoo	5
ftd/als	NCT01020331	2005	memantine	memantine	approved	NA	86.68035592060232	NA	GRIN1	approved	repurposing	3
parkinson	NCT01023282	2009	acr325	acr325	experimental	NA	31.080082135523615	NA	NA	non	novel, unsup	2
alzheimer	NCT01023425	2008	donepezil	donepezil	approved	1996	83.77823408624229	NA	ACHE	approved	post-approval	7
alzheimer	NCT01023867	2007	donepezil	donepezil	approved	1996	286.2258726899384	NA	ACHE	approved	post-approval	7
alzheimer	NCT01024660	2009	donepezil	donepezil	approved	1996	NA	NA	ACHE	approved	post-approval	7
alzheimer	NCT01025466	2008	rivastigmine transdermal patch	rivastigmine	approved	2000	274.1026694045174	NA	ACHE	approved	post-approval	7
parkinson	NCT01026428	2009	safinamide + levodopa	safinamide	approved	2017	NA	NA	MAOB	approved	pre-approval	6
parkinson	NCT01028586	2009	safinamide, mao-b inhibitor	safinamide	approved	2017	NA	NA	MAOB	approved	pre-approval	6
alzheimer	NCT01028911	2009	pf-03654746	pf-03654746	experimental	NA	3.7207392197125255	NA	HRH3	approved	metoo	5
alzheimer	NCT01029132	2007	galantamine	galantamine	approved	2001	165.1581108829569	NA	ACHE	approved	post-approval	7
alzheimer	NCT01035138	2009	semagacestat	semagacestat	experimental	NA	239.50718685831623	OMIM	PSEN1	non	novel, supported	1
parkinson	NCT01036139	2009	bf2.649 (pitolisant)	pitolisant	approved	NA	714.6666666666666	NA	HRH3	approved	repurposing	3
parkinson	NCT01039090	2009	continuous apomorphine infusion	apomorphine	approved	2004	125.97125256673512	NA	DRD4	approved	post-approval	7
alzheimer	NCT01039701	2009	azd1446	azd1446	experimental	NA	57.46201232032854	NA	CHRNA4	approved	metoo	5
ftd/als	NCT01041222	2010	isis 333611	tofersen	experimental	NA	65.95482546201232	OMIM	SOD1	non	novel, supported	1
alzheimer	NCT01044758	2009	levetiracetam 125mg	levetiracetam	approved	NA	247.85215605749485	NA	SV2A	approved	repurposing	3
alzheimer	NCT01047254	2010	elontril	bupropion	approved	NA	494.5106091718001	NA	SLC6A3	approved	repurposing	3
alzheimer	NCT01047579	2010	rivastigmine transdermal	rivastigmine	approved	2000	89.36344969199179	NA	ACHE	approved	post-approval	7
parkinson	NCT01048229	2008	pramipexole	pramipexole	approved	1997	158.2258726899384	NA	DRD3	approved	post-approval	7
parkinson	NCT01049984	2009	rasagiline	rasagiline	approved	2006	929.4455852156058	NA	MAOB	approved	post-approval	7
parkinson	NCT01052831	2009	naltrexone	naltrexone	approved	NA	154.1409993155373	NA	OPRD1	approved	repurposing	3
alzheimer	NCT01054976	2006	galantamine	galantamine	approved	2001	231.47433264887064	NA	ACHE	approved	post-approval	7
parkinson	NCT01055379	2010	rasagiline	rasagiline	approved	2006	NA	NA	MAOB	approved	post-approval	7
alzheimer	NCT01055392	2007	lithium carbonate	lithium	approved	NA	NA	NA	NA	non	repurposing	3
other/unspecified	NCT01056965	2010	davunetide (al-108, nap)	davunetide	experimental	NA	34.98973305954826	NA	MAPT	non	novel, unsup	2
parkinson	NCT01058291	2010	kw-6500	apomorphine	approved	2004	23.170431211498972	NA	DRD4	approved	post-approval	7
alzheimer	NCT01058941	2010	lipoic acid and fish oil concentrate	lipoic acid	supplement	NA	284.6926762491444	NA	NA	non	novel, unsup	2
parkinson	NCT01060878	2010	pym50028	smilagenin	experimental	NA	885.4893908281998	NA	NA	non	novel, unsup	2
parkinson	NCT01063621	2010	kw-6500	apomorphine	approved	2004	58.39835728952772	NA	DRD4	approved	post-approval	7
parkinson	NCT01066442	2010	bf2.649 (pitolisant)	pitolisant	approved	NA	660.7310061601643	NA	HRH3	approved	repurposing	3
alzheimer	NCT01066481	2010	pf-01913539 5 mg	dimebon	experimental	NA	0	NA	HRH1	approved	metoo	5
alzheimer	NCT01066546	2010	dimebon tablet for oral administration	dimebon	approved	NA	1.2457221081451062	NA	HRH1	approved	repurposing	3
alzheimer	NCT01068353	2011	etanercept	etanercept	approved	NA	NA	NA	TNF	approved	repurposing	3
alzheimer	NCT01072812	2010	posiphen® tartrate capsules	posiphen	experimental	NA	2.0533880903490758	OMIM	APP	non	novel, supported	1
alzheimer	NCT01073228	2010	evp-6124	encenicline	experimental	NA	751.3730321697467	NA	CHRNA7	approved	metoo	5
alzheimer	NCT01075763	2004	interferon beta-1a	interferon beta-1a	approved	NA	146.8418891170431	NA	IFNAR1	approved	repurposing	3
alzheimer	NCT01078168	2010	acitretin	acitretin	approved	NA	69.6892539356605	NA	RXRA	approved	repurposing	3
alzheimer	NCT01082965	2010	donepezil	donepezil	approved	1996	36.02464065708419	NA	ACHE	approved	post-approval	7
ftd/als	NCT01083667	2009	pyrimethamine	pyrimethamine	approved	NA	207.90143737166323	NA	DHFR	approved	repurposing	3
huntington	NCT01085266	2010	dimebon (latrepirdine)	dimebon	approved	NA	NA	NA	HRH1	approved	repurposing	3
ftd/als	NCT01089010	2010	250 mg ck-2017357	tirasemtiv	experimental	NA	44.941820670773446	NA	TNNC1	approved	metoo	5
ftd/als	NCT01091142	2010	np001	np001	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT01092065	2010	afq056 with l-dopa	mavoglurant,levodopa	combination	NA	30.666666666666668	NA	GRM5	approved	combination	4
alzheimer	NCT01093664	2009	affitope ad02	affitope ad02	experimental	NA	14.948665297741274	OMIM	APP	non	novel, supported	1
alzheimer	NCT01094340	2010	thalidomide	thalidomide	approved	NA	NA	NA	CRBN	approved	repurposing	3
parkinson	NCT01096186	2010	ipx066 145 mg	carbidopa,levodopa	combination	NA	978.0780287474332	NA	DRD1	approved	combination	4
alzheimer	NCT01097096	2010	cad106	cad106	experimental	NA	487.50718685831623	NA	NA	non	novel, unsup	2
alzheimer	NCT01099332	2009	gastro-retentive zinc cysteine tablet	zinc cysteine	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT01108029	2009	memantine	memantine	approved	NA	27.980835044490075	NA	GRIN1	approved	repurposing	3
parkinson	NCT01113320	2010	safinamide	safinamide	approved	2017	45.55783709787816	NA	MAOB	approved	pre-approval	6
alzheimer	NCT01117818	2010	active: affitope ad02	affitope ad02	experimental	NA	1088.6926762491444	OMIM	APP	non	novel, supported	1
alzheimer	NCT01117948	2009	lornoxicam	lornoxicam	approved	NA	345.9630390143737	NA	PTGS1	approved	repurposing	3
parkinson	NCT01119131	2011	vitamin d3	vitamin d	supplement	NA	370.81724845995893	NA	NA	non	novel, unsup	2
alzheimer	NCT01119638	2008	escitalopram	escitalopram	approved	NA	83.23066392881589	NA	SLC6A4	approved	repurposing	3
alzheimer	NCT01120002	2010	tamibarotene	tamibarotene	experimental	NA	NA	NA	RARA	approved	metoo	5
alzheimer	NCT01125631	2010	pf-04360365 8.5 mg/kg	ponezumab	experimental	NA	10.009582477754963	OMIM	APP	non	novel, supported	1
alzheimer	NCT01125683	2010	azd1446	azd1446	experimental	NA	NA	NA	CHRNA4	approved	metoo	5
alzheimer	NCT01126099	2010	prazosin	prazosin	approved	NA	80	NA	ADRA1A	approved	repurposing	3
alzheimer	NCT01127633	2010	solanezumab	solanezumab	experimental	NA	8991.315537303217	OMIM	APP	non	novel, supported	1
parkinson	NCT01130493	2010	cle	carbidopa,levodopa,entacapone	combination	NA	183.709787816564	NA	DRD1	approved	combination	4
alzheimer	NCT01137526	2010	abt-384	abt-384	experimental	NA	311.40862422997947	NA	HSD11B1	approved	metoo	5
alzheimer	NCT01142258	2010	trazodone	trazodone	approved	NA	96.8104038329911	NA	HTR2A	approved	repurposing	3
alzheimer	NCT01145482	2010	insulin	insulin	approved	NA	45.01026694045174	NA	INSR	approved	repurposing	3
alzheimer	NCT01152216	2010	dimebon	dimebon	approved	NA	NA	NA	HRH1	approved	repurposing	3
parkinson	NCT01154166	2010	requip pr	ropinirole	approved	1997	561.47022587269	NA	DRD3	approved	post-approval	7
parkinson	NCT01155466	2010	preladenant 10 mg tablet	preladenant	experimental	NA	1895.7426420260097	NA	ADORA2A	approved	metoo	5
parkinson	NCT01155479	2010	preladenant 10 mg tablet	preladenant	experimental	NA	3094.6803559206023	NA	ADORA2A	approved	metoo	5
alzheimer	NCT01163825	2008	nerve growth factor	ngf	experimental	NA	NA	NA	NGFR	non	novel, unsup	2
parkinson	NCT01168596	2009	rasagiline	rasagiline	approved	2006	72.4435318275154	NA	MAOB	approved	post-approval	7
parkinson	NCT01171313	2010	sinemet (comparator)	carbidopa,levodopa	combination	NA	49.637234770705	NA	DRD1	approved	combination	4
alzheimer	NCT01172145	2005	modafinil	modafinil	approved	NA	47.70431211498973	NA	SLC6A3	approved	repurposing	3
parkinson	NCT01172379	2004	e2007	perampanel	approved	NA	NA	NA	GRIA1	approved	repurposing	3
parkinson	NCT01173731	2010	afq056	mavoglurant	experimental	NA	198.0451745379877	NA	GRM5	approved	metoo	5
parkinson	NCT01174004	2010	pimavanserin tartrate	pimavanserin	approved	NA	465.2867898699521	NA	HTR2A	approved	repurposing	3
parkinson	NCT01174810	2010	exenatide	exenatide	approved	NA	NA	NA	GLP1R	approved	repurposing	3
parkinson	NCT01176240	2010	droxidopa	droxidopa	approved	NA	544.558521560575	NA	ADRA1A	approved	repurposing	3
parkinson	NCT01177319	2003	glutathione	glutathione	supplement	NA	69.92470910335386	NA	NA	non	novel, unsup	2
parkinson	NCT01178047	2011	rasagiline	rasagiline	approved	2006	1.0841889117043122	NA	MAOB	approved	post-approval	7
alzheimer	NCT01181921	2011	galantamine	galantamine	approved	2001	0.08487337440109514	NA	ACHE	approved	post-approval	7
parkinson	NCT01187966	2007	safinamide	safinamide	approved	2017	1395.6960985626283	NA	MAOB	approved	pre-approval	6
parkinson	NCT01190553	2010	amantadine	amantadine	approved	2003	NA	NA	GRIN3A	approved	post-approval	7
parkinson	NCT01190735	2010	caffeine alkaloid	caffeine	approved	NA	14.105407255304586	NA	ADORA1	approved	repurposing	3
parkinson	NCT01191944	2010	pramipexole extended release tablet	pramipexole	approved	1997	673.6481861738536	NA	DRD3	approved	post-approval	7
alzheimer	NCT01193608	2010	aab-003 (pf-05236812)	AAB-003	experimental	NA	271.2881587953457	OMIM	APP	non	novel, supported	1
parkinson	NCT01211587	2010	safinamide	safinamide	approved	2017	NA	NA	MAOB	approved	pre-approval	6
parkinson	NCT01215227	2010	preladenant	preladenant	experimental	NA	2230.4421629021217	NA	ADORA2A	approved	metoo	5
parkinson	NCT01216904	2010	nicotine patch	nicotine	approved	NA	NA	NA	CHRNA4	approved	repurposing	3
alzheimer	NCT01224106	2010	gantenerumab	gantenerumab	experimental	NA	7785.464750171116	OMIM	APP	non	novel, supported	1
parkinson	NCT01227265	2010	preladenant	preladenant	experimental	NA	1145.5277207392196	NA	ADORA2A	approved	metoo	5
alzheimer	NCT01227564	2011	acc-001 10 μg/ qs-21 50 μg	vanutide cridificar	experimental	NA	189.04312114989733	OMIM	APP	non	novel, supported	1
parkinson	NCT01227655	2011	benserazide	benserazide	approved	NA	570.5023956194387	NA	DDC	approved	repurposing	3
parkinson	NCT01227681	2010	g-csf	g-csf	approved	NA	14.00684462696783	NA	CSF3R	approved	repurposing	3
parkinson	NCT01229332	2011	carbidopa	carbidopa	approved	1975	19.975359342915812	NA	DDC	approved	post-approval	7
alzheimer	NCT01230853	2010	active comparator a	lecanemab	experimental	NA	200.41067761806983	OMIM	APP	non	novel, supported	1
ftd/als	NCT01232738	2011	rasagiline	rasagiline	approved	NA	50.95687885010267	NA	MAOB	approved	repurposing	3
alzheimer	NCT01238991	2010	acc-001	vanutide cridificar	experimental	NA	159.0362765229295	OMIM	APP	non	novel, supported	1
parkinson	NCT01244269	2010	methylphenidate	methylphenidate	approved	NA	2.9897330595482545	NA	SLC6A3	approved	repurposing	3
alzheimer	NCT01245530	2008	inm-176	angelica gigas	supplement	NA	768.8980150581793	NA	NA	non	novel, unsup	2
alzheimer	NCT01249196	2010	sk-pc-b70m	sk-pc-b70m	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT01254448	2010	tc-5619	bradanicline	experimental	NA	25.177275838466805	NA	NA	non	novel, unsup	2
alzheimer	NCT01254773	2010	experimental bapineuzumab	bapineuzumab	experimental	NA	328.17522245037645	OMIM	APP	non	novel, supported	1
alzheimer	NCT01255046	2015	sta-1	sta-1	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT01255163	2010	exendin-4 sc	exenatide	approved	NA	341.60985626283366	NA	GLP1R	approved	repurposing	3
parkinson	NCT01256905	2010	armodafinil	armodafinil	approved	NA	NA	NA	SLC6A3	approved	repurposing	3
ftd/als	NCT01257581	2011	tamoxifen	tamoxifen	approved	NA	115.48254620123203	NA	ESR1	approved	repurposing	3
ftd/als	NCT01259050	2010	zinc and copper	zinc,copper	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT01264861	2011	safinamide	safinamide	approved	2017	4.503764544832307	NA	MAOB	approved	pre-approval	6
alzheimer	NCT01266525	2011	sar110894	sar110894	experimental	NA	557.700205338809	NA	HRH3	approved	metoo	5
parkinson	NCT01268891	2011	azilect®	rasagiline	approved	2006	NA	NA	MAOB	approved	post-approval	7
alzheimer	NCT01276353	2011	e2020	donepezil	approved	1996	56.18069815195072	NA	ACHE	approved	post-approval	7
ftd/als	NCT01277315	2011	anakinra	anakinra	approved	NA	NA	NA	IL1R1	approved	repurposing	3
parkinson	NCT01280123	2011	pioglitazone	pioglitazone	approved	NA	665.2156057494866	NA	PPARG	approved	repurposing	3
ftd/als	NCT01281189	2011	dexpramipexole	dexpramipexole	experimental	NA	1577.4757015742641	NA	NA	non	novel, unsup	2
ftd/als	NCT01281631	2011	np001	np001	experimental	NA	215.21697467488022	NA	NA	non	novel, unsup	2
alzheimer	NCT01282619	2010	huperzine a	huperzine a	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT01283594	2011	tozadenant (syn115) 120 mg bid	tozadenant	experimental	NA	666.9404517453798	NA	ADORA2A	approved	metoo	5
alzheimer	NCT01284387	2011	acc-001 (vanutide cridificar)	vanutide cridificar	experimental	NA	388.7802874743326	OMIM	APP	non	novel, supported	1
ftd/als	NCT01285583	2010	tro19622	olesoxime	experimental	NA	383.5920602327173	NA	NA	non	novel, unsup	2
parkinson	NCT01286935	2007	safinamide	safinamide	approved	2017	1632.37234770705	NA	MAOB	approved	pre-approval	6
parkinson	NCT01291537	2011	duodopa	carbidopa	approved	1975	NA	NA	DDC	approved	post-approval	7
parkinson	NCT01294800	2011	preladenant	preladenant	experimental	NA	1018.8911704312115	NA	ADORA2A	approved	metoo	5
parkinson	NCT01296464	2011	carbidopa	carbidopa	approved	1975	NA	NA	DDC	approved	post-approval	7
alzheimer	NCT01300728	2011	newgam 10% ivig	octagam 10%	experimental	NA	463.55099247091033	NA	NA	non	novel, unsup	2
parkinson	NCT01300819	2011	rotigotine	rotigotine	approved	2007	610.570841889117	NA	DRD3	approved	post-approval	7
alzheimer	NCT01302340	2011	delta-thc	dronabinol	approved	NA	49.51129363449692	NA	CNR1	approved	repurposing	3
alzheimer	NCT01303744	2011	chf 5074 1x	chf 5074	experimental	NA	104.34496919917865	OMIM	PSEN1	non	novel, supported	1
huntington	NCT01306929	2011	pridopidine	pridopidine	experimental	NA	1609.7741273100617	NA	SIGMAR1	approved	metoo	5
alzheimer	NCT01309763	2010	affitope ad03	ad03	experimental	NA	30.357289527720738	OMIM	APP	non	novel, supported	1
parkinson	NCT01313819	2011	pk-merz® 200mg/500ml inj(amantadine) , normal saline 500ml inj	amantadine	approved	2003	NA	NA	GRIN3A	approved	post-approval	7
parkinson	NCT01313845	2011	amantadine sulfate	amantadine	approved	2003	61.20739219712526	NA	GRIN3A	approved	post-approval	7
alzheimer	NCT01324518	2011	orm-12741	orm-12741	experimental	NA	150.30800821355237	NA	ADRA2C	approved	metoo	5
parkinson	NCT01327859	2003	prior donepezil 5mg	donepezil	approved	NA	1190.488706365503	NA	ACHE	approved	repurposing	3
parkinson	NCT01331122	2012	droxidopa	droxidopa	approved	NA	0	NA	ADRA1A	approved	repurposing	3
parkinson	NCT01336088	2011	adx48621	dipraglurant	experimental	NA	69.53593429158111	NA	NA	non	novel, unsup	2
parkinson	NCT01338896	2011	rotigotine transdermal patch	rotigotine	approved	2007	9.352498288843258	NA	DRD3	approved	post-approval	7
parkinson	NCT01340885	2011	exelon	rivastigmine	approved	NA	NA	NA	ACHE	approved	repurposing	3
parkinson	NCT01341080	2010	varenicline	varenicline	approved	NA	NA	NA	CHRNA4	approved	repurposing	3
parkinson	NCT01341431	2011	bee venom	bee venom	experimental	NA	137.7138945927447	NA	NA	non	novel, unsup	2
alzheimer	NCT01343966	2011	mabt5102a	crenezumab	experimental	NA	1269.4866529774126	OMIM	APP	non	novel, supported	1
alzheimer	NCT01350362	2011	tideglusib	tideglusib	experimental	NA	459.9425051334702	NA	GSK3B	non	novel, unsup	2
alzheimer	NCT01354444	2011	carvedilol	carvedilol	approved	NA	162.05065023956195	NA	ADRB1	approved	repurposing	3
alzheimer	NCT01354691	2011	ladostigil hemitartrate	lagostigil	experimental	NA	417.6837782340862	NA	NA	non	novel, unsup	2
huntington	NCT01357681	2011	(2)-epigallocatechin-3-gallate (egcg)	epigallocatechin gallate	supplement	NA	197.81519507186857	NA	NA	non	novel, unsup	2
alzheimer	NCT01362686	2011	donepezil	donepezil	approved	1996	900.2053388090349	NA	ACHE	approved	post-approval	7
alzheimer	NCT01369225	2011	aab-003 (pf-05236812)	AAB-003	experimental	NA	160.44900752908967	OMIM	APP	non	novel, supported	1
parkinson	NCT01370811	2011	oc oral solution treatment a	oxybutynin,clonidine	combination	NA	26.086242299794662	NA	CHRM3	approved	combination	4
alzheimer	NCT01374438	2011	msdc-0160	msdc-0160	experimental	NA	53.19644079397673	NA	MPC1	non	novel, unsup	2
ftd/als	NCT01378676	2011	ck-2017357 (part a)	tirasemtiv	experimental	NA	36.75838466803559	NA	TNNC1	approved	metoo	5
alzheimer	NCT01380288	2011	rivastigmine patch	rivastigmine	approved	2000	1975.359342915811	NA	ACHE	approved	post-approval	7
parkinson	NCT01382342	2011	rasagiline	rasagiline	approved	2006	133.60711841204653	NA	MAOB	approved	post-approval	7
ftd/als	NCT01384162	2009	snn0029	snn0029	experimental	NA	94.98973305954826	NA	VEGFA	approved	metoo	5
parkinson	NCT01385592	2011	afq056	mavoglurant	experimental	NA	65.13347022587268	NA	GRM5	approved	metoo	5
parkinson	NCT01385735	2011	rasagiline	rasagiline	approved	2006	NA	NA	MAOB	approved	post-approval	7
ftd/als	NCT01386333	2011	oxytocin	oxytocin	approved	NA	NA	NA	OXTR	approved	repurposing	3
alzheimer	NCT01388478	2011	r-pramipexole	pramipexole	approved	NA	55.030800821355236	NA	DRD3	approved	repurposing	3
parkinson	NCT01397422	2011	ads-5102 (extended release amantadine hcl)	amantadine	approved	2003	187.01984941820672	NA	GRIN3A	approved	post-approval	7
alzheimer	NCT01397539	2011	biib037	aducanumab	experimental	NA	114.92402464065708	OMIM	APP	non	novel, supported	1
alzheimer	NCT01397578	2011	mabt5102a	crenezumab	experimental	NA	242.41752224503765	OMIM	APP	non	novel, supported	1
parkinson	NCT01398748	2012	intranasal glutathione - (in)gsh	glutathione	approved	NA	119.05817932922656	NA	NA	non	repurposing	3
alzheimer	NCT01399125	2011	rivastigmine capsules	rivastigmine	approved	2000	919.0143737166325	NA	ACHE	approved	post-approval	7
parkinson	NCT01399905	2009	carbidopa	carbidopa	approved	1975	30.31895961670089	NA	DDC	approved	post-approval	7
alzheimer	NCT01404169	2011	e2020	donepezil	approved	1996	780.1779603011636	NA	ACHE	approved	post-approval	7
alzheimer	NCT01406145	2011	asp0777	asp0777	experimental	NA	23.16221765913758	NA	GRIN2A	approved	metoo	5
alzheimer	NCT01409564	2010	cilostazol	cilostazol	approved	NA	145.7138945927447	NA	PDE3A	approved	repurposing	3
alzheimer	NCT01409694	2011	vitamin d	vitamin d	supplement	NA	390.06160164271046	NA	NA	non	novel, unsup	2
alzheimer	NCT01409915	2011	sagramostim	sargramostim	approved	NA	350.9924709103354	NA	CSF2RA	approved	repurposing	3
parkinson	NCT01411137	2011	ipx066	carbidopa,levodopa	combination	NA	68.04654346338124	NA	DRD1	approved	combination	4
huntington	NCT01411150	2009	creatine monohydrate	creatine	supplement	NA	126.8227241615332	NA	CKM	approved	metoo	5
parkinson	NCT01416818	2008	bupleurum+ginkgo	ginko biloba,bupleurum	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT01421056	2011	chf 5074 1x	chf 5074	experimental	NA	99.07186858316221	OMIM	PSEN1	non	novel, supported	1
parkinson	NCT01421719	2009	cystoscopic injection of botox into the urinary bladder	botulinum toxin a	approved	NA	48.186173853524984	NA	SNAP25	approved	repurposing	3
alzheimer	NCT01424436	2010	gsk933776	gsk933776	experimental	NA	29.54688569472964	OMIM	APP	non	novel, supported	1
parkinson	NCT01427517	2011	n-acetylcysteine	acetylcysteine	approved	NA	12.788501026694044	NA	GSS	approved	repurposing	3
alzheimer	NCT01428362	2011	vi-1121	vi-1121	experimental	NA	122.08350444900753	NA	NA	non	novel, unsup	2
alzheimer	NCT01428453	2011	250mg rilapladib	rilapladib	experimental	NA	171.78370978781658	NA	PLA2G7	non	novel, unsup	2
alzheimer	NCT01429623	2012	ladostigil hemitartrate	lagostigil	experimental	NA	962.4640657084188	NA	NA	non	novel, unsup	2
alzheimer	NCT01436045	2011	insulin glulisine	insulin	approved	NA	20.993839835728952	NA	INSR	approved	repurposing	3
parkinson	NCT01437189	2011	sertraline	sertraline	approved	NA	NA	NA	SLC6A4	approved	repurposing	3
alzheimer	NCT01438060	2000	aripiprazole (bms-337039)	aripiprazole	approved	NA	2299.991786447639	NA	DRD2	approved	repurposing	3
parkinson	NCT01439100	2011	oxycodone/naloxone prolonged release tablets	oxycodone,naloxone	approved	NA	NA	NA	OPRM1	approved	repurposing	3
alzheimer	NCT01439555	2011	l-arginine	arginine	supplement	NA	66.01505817932923	NA	NA	non	novel, unsup	2
parkinson	NCT01442610	2011	rasagiline	rasagiline	approved	2006	117.53593429158111	NA	MAOB	approved	post-approval	7
alzheimer	NCT01453569	2011	sodium oligo-mannurarate 600mg	gv-971	experimental	NA	467.7618069815195	NA	NA	non	novel, unsup	2
alzheimer	NCT01454453	2012	patients- dose titration	amisulpride	approved	NA	202.55715263518138	NA	DRD2	approved	repurposing	3
huntington	NCT01458470	2011	memantine	memantine	approved	NA	22.21218343600274	NA	GRIN1	approved	repurposing	3
alzheimer	NCT01463384	2011	minocycline	minocycline	approved	NA	14.094455852156058	NA	NA	non	repurposing	3
alzheimer	NCT01466088	2011	azd3480	ispronicline	experimental	NA	996.5722108145106	NA	CHRNA4	approved	metoo	5
alzheimer	NCT01469351	2012	liraglutide	liraglutide	approved	NA	42.4476386036961	NA	GLP1R	approved	repurposing	3
parkinson	NCT01470027	2012	n-acetylcysteine	acetylcysteine	approved	NA	229.1581108829569	NA	GSS	approved	repurposing	3
parkinson	NCT01470859	2011	sinemet cr	carbidopa,levodopa	combination	NA	80	NA	DRD1	approved	combination	4
parkinson	NCT01474421	2011	aqw051	aqw051	experimental	NA	102.05338809034907	NA	CHRNA7	approved	metoo	5
alzheimer	NCT01478633	2011	galantamine	galantamine	approved	2001	178.4476386036961	NA	ACHE	approved	post-approval	7
parkinson	NCT01479530	2011	azilect®	rasagiline	approved	2006	481.60985626283366	NA	MAOB	approved	post-approval	7
alzheimer	NCT01482013	2011	hpp854	hpp854	experimental	NA	2.9130732375085557	NA	BACE1	non	novel, unsup	2
alzheimer	NCT01482845	2011	abt-126	abt-126	experimental	NA	6.625598904859685	NA	CHRNA7	approved	metoo	5
parkinson	NCT01484990	2010	levodopa-carbidopa	carbidopa,levodopa	combination	NA	7.958932238193018	NA	DRD1	approved	combination	4
parkinson	NCT01485172	2012	ropinirole monotherapy	ropinirole	approved	1997	417.57700205338807	NA	DRD3	approved	post-approval	7
alzheimer	NCT01485302	2012	sar228810	sar228810	experimental	NA	148.10677618069815	OMIM	APP	non	novel, supported	1
huntington	NCT01485952	2011	sen0014196 (high dose)	ex-527	experimental	NA	36.89253935660506	NA	SIRT1	non	novel, unsup	2
huntington	NCT01485965	2011	sen0014196	ex-527	experimental	NA	28.188911704312115	NA	SIRT1	non	novel, unsup	2
ftd/als	NCT01486849	2011	ck-2017357	tirasemtiv	experimental	NA	8.944558521560575	NA	TNNC1	approved	metoo	5
parkinson	NCT01491022	2012	ampyra first, then placebo	dalfampridine	approved	NA	43.969883641341546	NA	KCNA1	approved	repurposing	3
parkinson	NCT01491529	2012	afq056	mavoglurant	experimental	NA	153.89459274469542	NA	GRM5	approved	metoo	5
parkinson	NCT01491932	2012	afq056	mavoglurant	experimental	NA	204.49281314168377	NA	GRM5	approved	metoo	5
alzheimer	NCT01492374	2012	bms-241027	epothilone d	experimental	NA	66.5845311430527	NA	MAPT	non	novel, unsup	2
ftd/als	NCT01492686	2011	mci-186	edaravone	approved	2017	388.2135523613963	NA	NA	non	pre-approval	6
parkinson	NCT01494532	2012	ropinirole/l-dopa	ropinirole,levodopa	combination	NA	925.1745379876796	NA	DRD1	approved	combination	4
alzheimer	NCT01496170	2011	mk-8931	verubecestat	experimental	NA	16.032854209445585	NA	BACE1	non	novel, unsup	2
parkinson	NCT01497652	2012	rasagiline	rasagiline	approved	2006	107.51540041067761	NA	MAOB	approved	post-approval	7
parkinson	NCT01500707	2013	sch 900800	sch 900800	experimental	NA	0	NA	NA	non	novel, unsup	2
huntington	NCT01502046	2011	delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd)	dronabinol	approved	NA	18.754277891854894	NA	CNR1	approved	repurposing	3
parkinson	NCT01504178	2011	duloxetine	duloxetine	approved	NA	128.40520191649554	NA	SLC6A4	approved	repurposing	3
alzheimer	NCT01504854	2012	resveratrol	resveratrol	supplement	NA	217.96303901437372	NA	NA	non	novel, unsup	2
alzheimer	NCT01513967	2012	rph201, botanical drug product	rph202	experimental	NA	133.14989733059548	NA	NA	non	novel, unsup	2
parkinson	NCT01515410	2012	dm-1992	carbidopa,levodopa	combination	NA	25.505817932922657	NA	DRD1	approved	combination	4
parkinson	NCT01515774	2011	mirapex er	pramipexole	approved	1997	NA	NA	DRD3	approved	post-approval	7
parkinson	NCT01518309	2004	pimavanserin tartrate (acp-103)	pimavanserin	approved	NA	331.3264887063655	NA	HTR2A	approved	repurposing	3
parkinson	NCT01519271	2011	exelon patch (rivastigmine transdermal system)	rivastigmine	approved	NA	69.99041752224504	NA	ACHE	approved	repurposing	3
parkinson	NCT01519882	2012	rotigotine	rotigotine	approved	2007	0.837782340862423	NA	DRD3	approved	post-approval	7
parkinson	NCT01521117	2011	donepezil	donepezil	approved	NA	NA	NA	ACHE	approved	repurposing	3
huntington	NCT01521585	2011	sen0014196	ex-527	experimental	NA	132.07392197125256	NA	SIRT1	non	novel, unsup	2
alzheimer	NCT01522404	2012	atomoxetine	atomoxetine	approved	NA	246.86652977412732	NA	SLC6A2	approved	repurposing	3
parkinson	NCT01523301	2012	rotigotine	rotigotine	approved	2007	949.8699520876112	NA	DRD3	approved	post-approval	7
parkinson	NCT01527695	2012	er tablet 100 mg azd3241	azd3241	experimental	NA	18.069815195071868	NA	MPO	non	novel, unsup	2
alzheimer	NCT01527916	2012	abt-126	abt-126	experimental	NA	766.2751540041068	NA	CHRNA7	approved	metoo	5
parkinson	NCT01528592	2011	carbidopa-levodopa	carbidopa,levodopa	combination	NA	19.515400410677618	NA	DRD1	approved	combination	4
alzheimer	NCT01529619	2012	rivastigmine transdermal patch	rivastigmine	approved	2000	91.11567419575633	NA	ACHE	approved	post-approval	7
parkinson	NCT01536015	2012	rotigotine	rotigotine	approved	2007	43.73716632443532	NA	DRD3	approved	post-approval	7
parkinson	NCT01536574	2010	requip pr	ropinirole	approved	1997	462.7926078028747	NA	DRD3	approved	post-approval	7
parkinson	NCT01538329	2012	amantadine	amantadine	approved	2003	NA	NA	GRIN3A	approved	post-approval	7
alzheimer	NCT01539031	2012	e2020	donepezil	approved	1996	1052.2792607802876	NA	ACHE	approved	post-approval	7
parkinson	NCT01539837	2012	deferiprone	deferiprone	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT01547169	2011	insulin detemir	insulin	approved	NA	105.29774127310061	NA	INSR	approved	repurposing	3
alzheimer	NCT01548287	2012	azd5213	azd5213	experimental	NA	123.47707049965777	NA	HRH3	approved	metoo	5
alzheimer	NCT01548430	2011	ttp4000	ttp4000	experimental	NA	10.710472279260781	NA	NA	non	novel, unsup	2
alzheimer	NCT01549834	2012	abt-126	abt-126	experimental	NA	687.9835728952772	NA	CHRNA7	approved	metoo	5
ftd/als	NCT01551940	2012	botox injection	botulinum toxin a	approved	NA	37.40451745379877	NA	SNAP25	approved	repurposing	3
alzheimer	NCT01554683	2012	low/high/placebo dose keppra (levetiracetam)	levetiracetam	approved	NA	NA	NA	SV2A	approved	repurposing	3
parkinson	NCT01556165	2012	rasagiline	rasagiline	approved	2006	NA	NA	MAOB	approved	post-approval	7
alzheimer	NCT01560585	2012	isotretinoin	isotretinoin	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT01560754	2012	nicotine transdermal patch	nicotine	approved	NA	NA	NA	CHRNA4	approved	repurposing	3
alzheimer	NCT01561430	2012	ly2886721	ly2886721	experimental	NA	99.27446954141	NA	BACE1	non	novel, unsup	2
parkinson	NCT01563913	2012	docosahexaenoic acid (dha)	doconexent	approved	NA	120.97741273100615	NA	PPARA	approved	repurposing	3
other/unspecified	NCT01565395	2012	incobotulinum toxin a	botulinum toxin a	approved	NA	0	NA	SNAP25	approved	repurposing	3
parkinson	NCT01568034	2009	levodopa/benzerazide	levodopa,benserazide	combination	NA	8.37782340862423	NA	DRD1	approved	combination	4
parkinson	NCT01568047	2010	levodopa/benzerazide	levodopa,benserazide	combination	NA	13.141683778234086	NA	DRD1	approved	combination	4
parkinson	NCT01568073	2011	benserazide	benserazide	approved	NA	1603.2854209445586	NA	DDC	approved	repurposing	3
parkinson	NCT01568099	2012	affitope® pd01a	affitope pd01a	experimental	NA	71.84120465434634	OMIM	SNCA	non	novel, supported	1
alzheimer	NCT01569516	2011	octohydroaminoacridine succinate tablets	octohydroaminoacridine	experimental	NA	NA	NA	ACHE	approved	metoo	5
alzheimer	NCT01584440	2012	avp-923 (dextromethorphan/quinidine)	dextromethorphan,quinidine	combination	NA	495.11293634496917	NA	SIGMAR1	approved	combination	4
alzheimer	NCT01585272	2012	ena713	rivastigmine	approved	2000	342.5434633812457	NA	ACHE	approved	post-approval	7
huntington	NCT01590888	2012	pbt2	pbt2	experimental	NA	200.24366872005476	NA	NA	non	novel, unsup	2
alzheimer	NCT01594346	2000	alpha-tocopherol	vitamin e	supplement	NA	3343.3292265571527	NA	NR1I2	approved	metoo	5
alzheimer	NCT01595646	2011	insulin	insulin	approved	NA	124.29568788501027	NA	INSR	approved	repurposing	3
alzheimer	NCT01600469	2012	daoi-b	daoi	experimental	NA	114.43121149897331	NA	NA	non	novel, unsup	2
alzheimer	NCT01600859	2012	e2609	elenbecestat	experimental	NA	81.32785763175907	NA	BACE1	non	novel, unsup	2
other/unspecified	NCT01602393	2012	chf 5074 1x	chf 5074	experimental	NA	72.32854209445586	NA	PSEN1	non	novel, unsup	2
parkinson	NCT01602549	2012	gsk962040 (25 mg tablet)	gsk962040	experimental	NA	106.2340862422998	NA	MLNR	non	novel, unsup	2
parkinson	NCT01603069	2012	azd3241 300 mg bid	verdiperstat	experimental	NA	33.93018480492813	NA	MPO	non	novel, unsup	2
alzheimer	NCT01608217	2012	acetaminophen	acetaminophen	approved	NA	99.9315537303217	NA	NA	non	repurposing	3
alzheimer	NCT01609348	2012	venlafaxine	venlafaxine	approved	NA	23.76454483230664	NA	SLC6A4	approved	repurposing	3
alzheimer	NCT01614886	2012	ena713	rivastigmine	approved	2000	395.63039014373715	NA	ACHE	approved	post-approval	7
parkinson	NCT01617135	2012	sinemet (carbidopa/levodopa)	carbidopa,levodopa	combination	NA	14.647501711156742	NA	DRD1	approved	combination	4
alzheimer	NCT01617577	2009	g-csf; filgrastim	g-csf	approved	NA	21.35523613963039	NA	CSF3R	approved	repurposing	3
parkinson	NCT01621581	2012	convection enhanced delivery/aav2-gdnf	aav2-gdnf	experimental	NA	241.82067077344286	NA	GDNF	non	novel, unsup	2
ftd/als	NCT01622088	2012	dexpramipexole	dexpramipexole	experimental	NA	413.1964407939767	NA	NA	non	novel, unsup	2
ftd/als	NCT01626378	2013	trx0237	lmtm	experimental	NA	605.9411362080766	OMIM	MAPT	non	novel, supported	1
alzheimer	NCT01626391	2012	trx0237	lmtm	experimental	NA	4.459958932238193	NA	MAPT	non	novel, unsup	2
parkinson	NCT01628848	2006	spm 962	rotigotine	approved	2007	290.11909650924025	NA	DRD3	approved	pre-approval	6
parkinson	NCT01628926	2009	ropinirole	ropinirole	approved	1997	803.7782340862423	NA	DRD3	approved	post-approval	7
parkinson	NCT01628965	2008	spm 962	rotigotine	approved	2007	393.07871321013005	NA	DRD3	approved	post-approval	7
parkinson	NCT01631812	2006	spm 962	rotigotine	approved	2007	412.1560574948665	NA	DRD3	approved	pre-approval	6
parkinson	NCT01634243	2005	spm 962	rotigotine	approved	2007	84.98288843258042	NA	DRD3	approved	pre-approval	6
parkinson	NCT01634360	2004	perampanel	perampanel	approved	NA	662.5051334702259	NA	GRIA1	approved	repurposing	3
alzheimer	NCT01636596	2013	insulin lispro	insulin	approved	NA	0	NA	INSR	approved	repurposing	3
parkinson	NCT01646255	2012	l-dopa	levodopa	approved	1975	778.6776180698151	NA	DRD1	approved	post-approval	7
parkinson	NCT01646268	2012	rotigotine	rotigotine	approved	2007	456.07392197125256	NA	DRD3	approved	post-approval	7
parkinson	NCT01652534	2011	amantadine	amantadine	approved	2003	12.501026694045175	NA	GRIN3A	approved	post-approval	7
parkinson	NCT01653132	2012	incobotulinum toxin a	botulinum toxin a	approved	NA	25.023956194387406	NA	SNAP25	approved	repurposing	3
alzheimer	NCT01656525	2012	gantenerumab	gantenerumab	experimental	NA	55.96167008898015	OMIM	APP	non	novel, supported	1
alzheimer	NCT01661673	2012	evp-0962	evp-0962	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT01662791	2012	rifaximin	rifaximin	approved	NA	122.21492128678987	NA	NA	non	repurposing	3
alzheimer	NCT01669876	2012	anatabloc(r)	anatabloc(r)	supplement	NA	212.70362765229294	NA	STAT3	non	novel, unsup	2
parkinson	NCT01673724	2012	bromocriptine	bromocriptine	approved	NA	521.1033538672142	NA	DRD2	approved	repurposing	3
parkinson	NCT01676103	2012	tyrosine	tyrosine	supplement	NA	46.652977412731005	NA	NA	non	novel, unsup	2
alzheimer	NCT01676935	2012	abt-126	abt-126	experimental	NA	551.3292265571527	NA	CHRNA7	approved	metoo	5
alzheimer	NCT01677572	2012	aducanumab (recombinant, fully human anti-aβ igg1 mab)	aducanumab	experimental	NA	1342.9979466119096	OMIM	APP	non	novel, supported	1
alzheimer	NCT01677754	2012	ro4602522	sembragiline	experimental	NA	1426.0424366872005	NA	MAOB	approved	metoo	5
parkinson	NCT01683253	2012	levodopa/carbidopa(200mg/50mg)	carbidopa,levodopa	combination	NA	312.11498973305953	NA	DRD1	approved	combination	4
parkinson	NCT01683292	2006	inhaled vr040	apomorphine	approved	2004	38.507871321013006	NA	DRD4	approved	post-approval	7
parkinson	NCT01684475	2012	cjh1 (clr4001)	cjh1	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT01689233	2012	trx0237 200 mg/day	lmtm	experimental	NA	2864.887063655031	NA	MAPT	non	novel, unsup	2
alzheimer	NCT01689246	2013	trx0237 150 mg/day	lmtm	experimental	NA	2522.3655030800824	NA	MAPT	non	novel, unsup	2
alzheimer	NCT01690195	2012	abt-126	abt-126	experimental	NA	486.44490075290895	NA	CHRNA7	approved	metoo	5
parkinson	NCT01693081	2007	vr040/aspirair® inhaler	apomorphine	approved	2004	109.76317590691308	NA	DRD4	approved	post-approval	7
alzheimer	NCT01696123	2011	mlc601	mlc601	supplement	NA	197.80971937029432	NA	NA	non	novel, unsup	2
alzheimer	NCT01699711	2012	epigallocatechin-3-gallate (egcg)	epigallocatechin gallate	experimental	NA	267.7289527720739	NA	NA	non	novel, unsup	2
alzheimer	NCT01701089	2012	ro4602522	sembragiline	experimental	NA	11.263518138261464	NA	MAOB	approved	metoo	5
alzheimer	NCT01702480	2012	gsk2981710	gsk2981710	experimental	NA	308.06297056810405	NA	NA	non	novel, unsup	2
alzheimer	NCT01703117	2013	riluzole	riluzole	approved	NA	NA	NA	SCN5A	approved	repurposing	3
ftd/als	NCT01709149	2012	ck-2017357	tirasemtiv	experimental	NA	1004.4517453798768	NA	TNNC1	approved	metoo	5
parkinson	NCT01711866	2012	rotigotine	rotigotine	approved	2007	43.1129363449692	NA	DRD3	approved	post-approval	7
alzheimer	NCT01712074	2012	pf-05212377 (sam-760)	sam-760	experimental	NA	526.5544147843942	NA	HTR6	approved	metoo	5
alzheimer	NCT01715350	2012	pm012	pm012	supplement	NA	465.50581793292264	NA	NA	non	novel, unsup	2
alzheimer	NCT01716637	2010	curcum.luteol.theaflav.lip.acid,fishoil,quercet.,resveratr.	curcumin	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT01721460	2012	dexmedetomidine	dexmedetomidine	approved	NA	15.474332648870636	NA	ADRA2A	approved	repurposing	3
parkinson	NCT01723228	2012	rasagiline	rasagiline	approved	2006	368.1587953456537	NA	MAOB	approved	post-approval	7
alzheimer	NCT01723670	2012	chf 5074 1x	chf 5074	experimental	NA	0	OMIM	PSEN1	non	novel, supported	1
alzheimer	NCT01723826	2012	crenezumab	crenezumab	experimental	NA	1502.094455852156	OMIM	APP	non	novel, supported	1
parkinson	NCT01723904	2012	rotigotine	rotigotine	approved	2007	44.84599589322382	NA	DRD3	approved	post-approval	7
parkinson	NCT01725802	2012	levodopa and carbidopa solution for sc administration	carbidopa,levodopa	combination	NA	6.0013689253935665	NA	DRD1	approved	combination	4
alzheimer	NCT01735630	2012	elnd005	scyllo-inositol	experimental	NA	872.9637234770705	NA	NA	non	novel, unsup	2
parkinson	NCT01736176	2013	levodopa-carbidopa immediate release (lc-ir) tablets	carbidopa,levodopa	combination	NA	107.31006160164272	NA	DRD1	approved	combination	4
parkinson	NCT01736891	2011	rasagiline	rasagiline	approved	2006	424.104038329911	NA	MAOB	approved	post-approval	7
parkinson	NCT01738178	2014	caffeine	caffeine	approved	NA	317.65913757700207	NA	ADORA1	approved	repurposing	3
parkinson	NCT01738191	2012	atomoxetine	atomoxetine	approved	NA	52.40246406570842	NA	SLC6A2	approved	repurposing	3
alzheimer	NCT01739348	2012	verubecestat (part i and part ii)	verubecestat	experimental	NA	9661.207392197126	NA	BACE1	non	novel, unsup	2
alzheimer	NCT01741194	2013	ac-1204	tricaprilin	experimental	NA	1722.3545516769336	NA	NA	non	novel, unsup	2
parkinson	NCT01741701	2012	oxaloacetate (oaa)	oxaloacetic acid	supplement	NA	60.4435318275154	NA	NA	non	novel, unsup	2
parkinson	NCT01744496	2012	rotigotine	rotigotine	approved	2007	79.31006160164272	NA	DRD3	approved	post-approval	7
ftd/als	NCT01753076	2012	ozanezumab	ozanezumab	experimental	NA	635.0499657768652	NA	RTN4	non	novel, unsup	2
alzheimer	NCT01760005	2012	gantenerumab	gantenerumab	experimental	NA	NA	OMIM	APP	non	novel, supported	1
alzheimer	NCT01764243	2012	mt-4666	encenicline	experimental	NA	1197.535934291581	NA	CHRNA7	approved	metoo	5
parkinson	NCT01765257	2013	azilect®	rasagiline	approved	2006	NA	NA	MAOB	approved	post-approval	7
parkinson	NCT01766128	2013	zonisamide	zonisamide	approved	NA	NA	NA	SCN1A	approved	repurposing	3
parkinson	NCT01766258	2011	odm-101 105mg carbidopa	carbidopa,levodopa,entacapone	combination	NA	156.64065708418892	NA	DRD1	approved	combination	4
alzheimer	NCT01766336	2013	group 1 elnd005	elnd005	experimental	NA	763.4004106776181	NA	NA	non	novel, unsup	2
parkinson	NCT01767129	2013	avp-923-45	dextromethorphan,quinidine	combination	NA	24.49281314168378	NA	SIGMAR1	approved	combination	4
alzheimer	NCT01767311	2012	ban2401 10 mg/kg	lecanemab	experimental	NA	7792.470910335387	OMIM	APP	non	novel, supported	1
alzheimer	NCT01767909	2014	insulin (humulin® r u-100)	insulin	approved	NA	1176.514715947981	NA	INSR	approved	repurposing	3
parkinson	NCT01770145	2012	trimethobenzamide	trimethobenzamide	approved	NA	168.98562628336757	NA	NA	non	repurposing	3
ftd/als	NCT01776970	2013	cannabis sativa extract oromucosal spray	cannabidiol	approved	NA	174.78439425051334	NA	CNR1	approved	repurposing	3
parkinson	NCT01777555	2013	cvt-301	levodopa	approved	1975	67.00889801505818	NA	DRD1	approved	post-approval	7
alzheimer	NCT01778946	2013	low dose nicotine (7mg)	nicotine	approved	NA	NA	NA	CHRNA4	approved	repurposing	3
alzheimer	NCT01780519	2013	lorazepam	lorazepam	approved	NA	208.96098562628336	NA	GABRA1	approved	repurposing	3
alzheimer	NCT01780974	2013	lipoic acid plus omega-3 fatty acids	lipoic acid	supplement	NA	104.98562628336755	NA	NA	non	novel, unsup	2
parkinson	NCT01782222	2013	rotigotine	rotigotine	approved	2007	131.26899383983573	NA	DRD3	approved	post-approval	7
alzheimer	NCT01782742	2013	bexarotene	bexarotene	approved	NA	36.577686516084874	NA	RXRA	approved	repurposing	3
parkinson	NCT01785628	2010	sarcosine capsule	sarcosine	experimental	NA	57.49486652977413	NA	NA	non	novel, unsup	2
ftd/als	NCT01786174	2013	gilenya	fingolimod	approved	NA	52.40246406570842	NA	S1PR5	approved	repurposing	3
ftd/als	NCT01786603	2013	rasagiline	rasagiline	approved	NA	214.42847364818618	NA	MAOB	approved	repurposing	3
parkinson	NCT01789047	2013	topiramate	topiramate	approved	NA	140.05749486652977	NA	GABRA1	approved	repurposing	3
parkinson	NCT01789385	2013	dexmedetomidine	dexmedetomidine	approved	NA	4.199863107460644	NA	ADRA2A	approved	repurposing	3
alzheimer	NCT01795339	2013	azd3293	lanabecestat	experimental	NA	46.9678302532512	NA	BACE1	non	novel, unsup	2
huntington	NCT01795859	2013	sd-809	deutetrabenazine	approved	2017	120	NA	SLC18A2	approved	pre-approval	6
parkinson	NCT01796483	2012	clonidine (catapressan)	clonidine	approved	NA	135.64134154688568	NA	ADRA2A	approved	repurposing	3
parkinson	NCT01803945	2013	ave8112	ave8112	experimental	NA	NA	NA	PDE4A	approved	metoo	5
ftd/als	NCT01806857	2013	nuedexta	dextromethorphan,quinidine	combination	NA	172.2381930184805	NA	SIGMAR1	approved	combination	4
huntington	NCT01806896	2013	pf-02545920	mardepodect	experimental	NA	49.333333333333336	NA	NA	non	novel, unsup	2
alzheimer	NCT01807026	2013	ly2886721	ly2886721	experimental	NA	6.012320328542095	NA	BACE1	non	novel, unsup	2
ftd/als	NCT01811355	2013	mexiletine	mexiletine	approved	NA	69.01574264202601	NA	SCN5A	approved	repurposing	3
ftd/als	NCT01825551	2012	granulocyte colony stimulating factor	g-csf	approved	NA	39.97262149212868	NA	CSF3R	approved	repurposing	3
alzheimer	NCT01825577	2012	transdermal methylphenidate	methylphenidate	approved	NA	31.50718685831622	NA	SLC6A3	approved	repurposing	3
parkinson	NCT01829867	2013	snn0031	snn0031	experimental	NA	12.498288843258042	NA	PDGFB	non	novel, unsup	2
alzheimer	NCT01832350	2012	nuedexta (20/10)	dextromethorphan,quinidine	combination	NA	144.84325804243667	NA	SIGMAR1	approved	combination	4
ftd/als	NCT01835782	2013	l-serine	serine	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT01837641	2013	ly3002183-sc	donanemab	experimental	NA	NA	OMIM	APP	non	novel, supported	1
alzheimer	NCT01841125	2011	escitalopram	escitalopram	approved	NA	223.7700205338809	NA	SLC6A4	approved	repurposing	3
alzheimer	NCT01843075	2014	liraglutide	liraglutide	approved	NA	1206.406570841889	NA	GLP1R	approved	repurposing	3
parkinson	NCT01844648	2013	nh004 tropicamide	tropicamide	approved	NA	80	NA	CHRM4	approved	repurposing	3
alzheimer	NCT01845636	2012	atropine	atropine	approved	NA	146.82546201232032	NA	CHRM1	approved	repurposing	3
alzheimer	NCT01849042	2013	donepezil	donepezil	approved	1996	NA	NA	ACHE	approved	post-approval	7
ftd/als	NCT01849770	2013	mexiletine	mexiletine	approved	NA	81.3141683778234	NA	SCN5A	approved	repurposing	3
alzheimer	NCT01850238	2013	aadvac1	aadvac1	experimental	NA	54.94866529774127	NA	MAPT	non	novel, unsup	2
parkinson	NCT01850381	2013	gm608	gm608	experimental	NA	6.48870636550308	NA	NA	non	novel, unsup	2
parkinson	NCT01851850	2013	opicapone	opicapone	approved	2020	3.0636550308008212	NA	COMT	approved	pre-approval	6
alzheimer	NCT01852110	2013	mk-7622	mk-7622	experimental	NA	592.6899383983573	NA	CHRM1	approved	metoo	5
ftd/als	NCT01854294	2013	gm604	gm604	experimental	NA	10.973305954825461	NA	NA	non	novel, unsup	2
parkinson	NCT01856439	2011	prosavin	prosavin	experimental	NA	NA	NA	TH	approved	metoo	5
parkinson	NCT01856738	2013	rivastigmine	rivastigmine	approved	NA	439.7399041752225	NA	ACHE	approved	repurposing	3
alzheimer	NCT01862640	2013	brexpiprazole, opc-34712	brexpiprazole	approved	NA	1587.3702943189596	NA	HTR1A	approved	repurposing	3
alzheimer	NCT01864655	2013	saracatinib	saracatinib	experimental	NA	NA	NA	FYN	non	novel, unsup	2
alzheimer	NCT01867775	2012	mirtazapine	mirtazapine	approved	NA	NA	NA	HTR2A	approved	repurposing	3
alzheimer	NCT01872598	2012	masitinib	masitinib	experimental	NA	6068.046543463382	NA	NA	non	novel, unsup	2
alzheimer	NCT01876823	2006	es-citalopram	escitalopram	approved	NA	234.9075975359343	NA	SLC6A4	approved	repurposing	3
ftd/als	NCT01879241	2013	rasagiline	rasagiline	approved	NA	798.258726899384	NA	MAOB	approved	repurposing	3
parkinson	NCT01882010	2013	sargramostim	sargramostim	approved	NA	86.30800821355236	NA	CSF2RA	approved	repurposing	3
huntington	NCT01882062	2013	triheptanoin 1g/kg/day	triheptanoin	approved	NA	1.6700889801505818	NA	NA	non	repurposing	3
parkinson	NCT01883505	2013	levodopa and carbidopa	carbidopa,levodopa	combination	NA	22.50513347022587	NA	DRD1	approved	combination	4
alzheimer	NCT01883648	2013	coconut oil beverage	coconut oil	supplement	NA	77.10061601642711	NA	NA	non	novel, unsup	2
ftd/als	NCT01884571	2013	basiliximab	basiliximab	approved	NA	69.7659137577002	NA	IL2RA	approved	repurposing	3
parkinson	NCT01892176	2012	coenzyme q10	ubidecarenone	supplement	NA	10.020533880903491	NA	NDUFV3	approved	metoo	5
huntington	NCT01897896	2013	sd-809	deutetrabenazine	approved	2017	448.95824777549626	NA	SLC18A2	approved	pre-approval	6
alzheimer	NCT01900665	2013	solanezumab	solanezumab	experimental	NA	7641.667351129364	OMIM	APP	non	novel, supported	1
ftd/als	NCT01906658	2013	repository corticotropin injection	corticotropin	approved	NA	60.982888432580424	NA	MC2R	approved	repurposing	3
alzheimer	NCT01908010	2013	abt-354	abt-354	experimental	NA	6.7351129363449695	NA	HTR6	approved	metoo	5
huntington	NCT01914965	2012	bupropion	bupropion	approved	NA	76.55030800821355	NA	SLC6A3	approved	repurposing	3
alzheimer	NCT01921972	2004	galantamine cr	galantamine	approved	2001	1042.9678302532511	NA	ACHE	approved	post-approval	7
alzheimer	NCT01922258	2013	brexpiprazole, opc-34712	brexpiprazole	approved	NA	943.9835728952772	NA	HTR1A	approved	repurposing	3
parkinson	NCT01923584	2013	epi-743 200mg	vatiquinone	experimental	NA	41.23203285420944	NA	ALOX15	non	novel, unsup	2
parkinson	NCT01927055	2013	droxidopa	droxidopa	approved	NA	76.32306639288159	NA	ADRA1A	approved	repurposing	3
alzheimer	NCT01928420	2007	drug: nic5-15	d-pinitol	supplement	NA	215.03080082135523	NA	NA	non	novel, unsup	2
parkinson	NCT01929317	2013	ropinirole cr 2mg tablet	ropinirole	approved	1997	144.14784394250515	NA	DRD3	approved	post-approval	7
alzheimer	NCT01931566	2013	pioglitazone	pioglitazone	approved	NA	17811.986310746066	NA	PPARG	approved	repurposing	3
ftd/als	NCT01935518	2013	fasudil	fasudil	experimental	NA	NA	NA	NA	non	novel, unsup	2
ftd/als	NCT01937013	2013	intranasal oxytocin	oxytocin	approved	NA	222.23682409308694	NA	OXTR	approved	repurposing	3
parkinson	NCT01937078	2011	famotidine	famotidine	approved	NA	20.410677618069816	NA	HRH2	approved	repurposing	3
alzheimer	NCT01940952	2013	zydena (udenafil) 100mg + donepezil 5mg or 10mg	udenafil	approved	NA	NA	NA	PDE5A	approved	repurposing	3
parkinson	NCT01941732	2003	sildenafil	sildenafil	approved	NA	2.650239561943874	NA	PDE5A	approved	repurposing	3
alzheimer	NCT01948791	2014	ena713	rivastigmine	approved	2000	240.6899383983573	NA	ACHE	approved	post-approval	7
alzheimer	NCT01951118	2013	donepezil	donepezil	approved	1996	675.1485284052019	NA	ACHE	approved	post-approval	7
other/unspecified	NCT01951924	2013	biological : i10e (human normal immunoglobulin for intravenous administration 100mg/ml)	human immunoglobulin g	approved	NA	59.38124572210815	NA	NA	non	repurposing	3
alzheimer	NCT01953601	2013	verubecestat 12 mg (parts 1 and 2)	verubecestat	experimental	NA	6464.876112251883	NA	BACE1	non	novel, unsup	2
alzheimer	NCT01953705	2014	omega 3 pufa	DHA,EPA	approved	NA	535.6221765913758	NA	PPARA	approved	repurposing	3
alzheimer	NCT01955161	2013	idalopirdine	idalopirdine	experimental	NA	2564.6324435318274	NA	HTR6	approved	metoo	5
parkinson	NCT01955616	2013	rm-131	relamorelin	experimental	NA	35.97535934291581	NA	GHSR	non	novel, unsup	2
alzheimer	NCT01965756	2013	metformin	metformin	approved	NA	84.92813141683779	NA	PRKAB1	approved	repurposing	3
alzheimer	NCT01966666	2013	tpi-287 2 mg/m2	tpi-287	experimental	NA	169.1170431211499	NA	MAPT	non	novel, unsup	2
parkinson	NCT01968031	2013	istradefylline 20 mg	istradefylline	approved	2019	1839.419575633128	NA	ADORA2A	approved	pre-approval	6
parkinson	NCT01968460	2013	p2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),	pramipexole,rasagiline	combination	NA	223.14305270362766	NA	DRD3	approved	combination	4
alzheimer	NCT01969123	2013	drug: evp-6124	encenicline	experimental	NA	1541.7166324435318	NA	CHRNA7	approved	metoo	5
alzheimer	NCT01969136	2013	drug: evp-6124	encenicline	experimental	NA	1310.7843942505133	NA	CHRNA7	approved	metoo	5
parkinson	NCT01971242	2014	exenatide	exenatide	approved	NA	130.10266940451746	NA	GLP1R	approved	repurposing	3
parkinson	NCT01973543	2013	vy-aadc01	vy-aadc01	experimental	NA	94.70225872689939	NA	DDC	approved	metoo	5
alzheimer	NCT01978548	2013	jnj-54861911 10 mg	atabecestat	experimental	NA	59.87679671457906	NA	BACE1	non	novel, unsup	2
alzheimer	NCT01982578	2017	genistein	genistein	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT01993680	2012	fludrocortisone	fludrocortisone	approved	NA	NA	NA	NR3C2	approved	repurposing	3
other/unspecified	NCT01994109	2013	myobloc	botulinum toxin b	approved	NA	592.3586584531143	NA	VAMP1	approved	repurposing	3
alzheimer	NCT01998841	2013	crenezumab	crenezumab	experimental	NA	2062.2258726899386	OMIM	APP	non	novel, supported	1
ftd/als	NCT01999803	2014	snn0029	snn0029	experimental	NA	16.2217659137577	NA	VEGFA	approved	metoo	5
alzheimer	NCT02002819	2014	levetiracetam	levetiracetam	approved	NA	NA	NA	SV2A	approved	repurposing	3
alzheimer	NCT02004392	2014	evp-6124	encenicline	experimental	NA	1102.3572895277207	NA	CHRNA7	approved	metoo	5
parkinson	NCT02005029	2013	erythromycin	erythromycin	approved	NA	38.98151950718686	NA	NA	non	repurposing	3
parkinson	NCT02006121	2014	apomorphine hydrochloride	apomorphine	approved	2004	349.4893908281999	NA	DRD4	approved	post-approval	7
parkinson	NCT02006290	2014	pf-06412562	pf-06412562	experimental	NA	7.958932238193018	NA	DRD1	approved	metoo	5
huntington	NCT02006472	2014	pridopidine	pridopidine	experimental	NA	1022.0944558521561	NA	SIGMAR1	approved	metoo	5
alzheimer	NCT02006641	2014	idalopirdine	idalopirdine	experimental	NA	2428.944558521561	NA	HTR6	approved	metoo	5
alzheimer	NCT02006654	2014	idalopirdine	idalopirdine	experimental	NA	2083.937029431896	NA	HTR6	approved	metoo	5
alzheimer	NCT02008357	2014	solanezumab	solanezumab	experimental	NA	NA	OMIM	APP	non	novel, supported	1
alzheimer	NCT02008513	2013	affitope® ad02	affitope ad02	experimental	NA	242.73237508555783	OMIM	APP	non	novel, supported	1
alzheimer	NCT02017340	2013	nilvadipine	nilvadipine	approved	NA	1863.523613963039	NA	CACNA1C	approved	repurposing	3
parkinson	NCT02018406	2013	combination injection of epo and g-csf	erythropoietin	approved	NA	112.01095140314852	NA	EPOR	approved	repurposing	3
alzheimer	NCT02031198	2014	aadvac1	aadvac1	experimental	NA	72.8952772073922	NA	MAPT	non	novel, unsup	2
alzheimer	NCT02033941	2014	meganatural-az grapeseed extract	grape	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT02035553	2013	pimavanserin tartrate	pimavanserin	approved	NA	540.6461327857631	NA	HTR2A	approved	repurposing	3
alzheimer	NCT02035982	2010	cholinesterase inhibitor	galantamine,donepezil,rivastigmine	combination	NA	206.7624914442163	NA	ACHE	approved	combination	4
alzheimer	NCT02036645	2014	medi1814 for iv injection	medi1814	experimental	NA	201.1170431211499	OMIM	APP	non	novel, supported	1
ftd/als	NCT02039401	2014	vm202	vm202	experimental	NA	68.94455852156058	NA	HGF	non	novel, unsup	2
alzheimer	NCT02045056	2014	gemfibrozil	gemfibrozil	approved	NA	366.06160164271046	NA	PPARA	approved	repurposing	3
alzheimer	NCT02051608	2014	gantenerumab	gantenerumab	experimental	NA	2750.956878850103	OMIM	APP	non	novel, supported	1
parkinson	NCT02055274	2013	ly03003	rotigotine	approved	2007	71.43326488706366	NA	DRD3	approved	post-approval	7
ftd/als	NCT02059759	2015	1.0 miu il-2 per day	il-2	approved	NA	23.95071868583162	NA	IL2RA	approved	repurposing	3
alzheimer	NCT02063269	2014	rivastigmine	rivastigmine	approved	2000	NA	NA	ACHE	approved	post-approval	7
alzheimer	NCT02063308	2014	oxaloacetate (oaa)	oxaloacetic acid	supplement	NA	1.9712525667351128	NA	NA	non	novel, unsup	2
parkinson	NCT02064166	2014	intranasal insulin	insulin	approved	NA	23.696098562628336	NA	INSR	approved	repurposing	3
parkinson	NCT02066571	2015	droxidopa	droxidopa	approved	NA	NA	NA	ADRA1A	approved	repurposing	3
huntington	NCT02074410	2014	oms643762	oms824	experimental	NA	17.286789869952088	NA	PDE10A	approved	metoo	5
alzheimer	NCT02078310	2014	iti-007	lumateperone	approved	NA	26.16016427104723	NA	HTR2A	approved	repurposing	3
alzheimer	NCT02079246	2014	idalopirdine 60 mg	idalopirdine	experimental	NA	4750.494182067077	NA	HTR6	approved	metoo	5
alzheimer	NCT02079909	2014	t-817ma-h	edonerpic	experimental	NA	1532.1067761806983	NA	NA	non	novel, unsup	2
alzheimer	NCT02080364	2015	azeliragon	azeliragon	experimental	NA	2787.5701574264203	NA	AGER	non	novel, unsup	2
parkinson	NCT02082249	2014	abt-slv187	carbidopa,levodopa	combination	NA	129.78234086242298	NA	DRD1	approved	combination	4
alzheimer	NCT02085265	2014	perindopril	perindopril	approved	NA	NA	OTG	ACE	approved	repurposing	3
alzheimer	NCT02087865	2014	donepezil hcl	donepezil	approved	1996	NA	NA	ACHE	approved	post-approval	7
parkinson	NCT02091739	2014	incobotulinumtoxina (100 units)	botulinum toxin a	approved	NA	476.0574948665298	NA	SNAP25	approved	repurposing	3
parkinson	NCT02092181	2014	mirabegron	mirabegron	approved	NA	130.02053388090349	NA	ADRB3	approved	repurposing	3
alzheimer	NCT02094729	2013	ban2401 10 mg/kg	lecanemab	experimental	NA	43.20876112251882	OMIM	APP	non	novel, supported	1
parkinson	NCT02096601	2014	oral levodopa and carbidopa	carbidopa,levodopa	approved	NA	22.691307323750856	NA	DRD1	approved	repurposing	3
alzheimer	NCT02097056	2014	donepezil hcl	donepezil	approved	1996	212.55030800821356	NA	ACHE	approved	post-approval	7
huntington	NCT02101957	2010	rp103	calcium carbonate	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT02103465	2013	rotigotine	rotigotine	approved	2007	119.80835044490075	NA	DRD3	approved	post-approval	7
alzheimer	NCT02103673	2014	daoib	daoi	experimental	NA	337.3305954825462	NA	NA	non	novel, unsup	2
parkinson	NCT02108704	2013	helicobacter pylori eradication therapy	amoxycillin,clarithromycin,omeprazole	combination	NA	181.1088295687885	NA	ATP4A	approved	combination	4
parkinson	NCT02111122	2014	sodium oxybate	sodium oxybate	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT02112812	2012	eradication of helcobacter pylori	esomeprazole,clarithromycin,amoxicillin	combination	NA	27.16495550992471	NA	ATP4A	approved	combination	4
ftd/als	NCT02118727	2018	memantine	memantine	approved	NA	NA	NA	GRIN1	approved	repurposing	3
alzheimer	NCT02127476	2014	khk6640	khk6640	experimental	NA	161.5195071868583	OMIM	APP	non	novel, supported	1
alzheimer	NCT02129348	2014	lithium	lithium	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT02136914	2014	ads-5102	amantadine	approved	2003	199.73716632443532	NA	GRIN3A	approved	post-approval	7
alzheimer	NCT02142777	2014	s -equol	equol	experimental	NA	26.28336755646817	NA	NA	non	novel, unsup	2
ftd/als	NCT02149160	2014	frm-0334	frm-0334	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT02153632	2014	amantadine hcl er	amantadine	approved	2003	243.94250513347023	NA	GRIN3A	approved	post-approval	7
parkinson	NCT02153645	2014	240mg amantadine hcl er tablets	amantadine	approved	2003	152.6817248459959	NA	GRIN3A	approved	post-approval	7
parkinson	NCT02157714	2014	prx002	prasinezumab	experimental	NA	NA	OMIM	SNCA	non	novel, supported	1
parkinson	NCT02162979	2002	sildenafil	sildenafil	approved	NA	13.831622176591376	NA	PDE5A	approved	repurposing	3
ftd/als	NCT02164253	2013	deferiprone	deferiprone	approved	NA	74.7460643394935	NA	NA	non	repurposing	3
ftd/als	NCT02166944	2014	tamoxifen 40 mg daily for one year	tamoxifen	approved	NA	109.29500342231348	NA	ESR1	approved	repurposing	3
alzheimer	NCT02167256	2014	azd0530 100mg daily	saracatinib	experimental	NA	515.4168377823408	NA	FYN	non	novel, unsup	2
parkinson	NCT02168842	2014	isradipine	isradipine	approved	NA	1344	NA	CACNA1C	approved	repurposing	3
alzheimer	NCT02168920	2014	2 mg/day aripiprazole	aripiprazole	approved	NA	265.2977412731006	NA	DRD2	approved	repurposing	3
alzheimer	NCT02185053	2014	cpc-201	donepezil,solifenacin	combination	NA	82.0561259411362	NA	CHRM3	approved	combination	4
huntington	NCT02197130	2014	pf-02545920	mardepodect	experimental	NA	566.713210130048	NA	NA	non	novel, unsup	2
parkinson	NCT02202551	2014	ads-5102	amantadine	approved	2003	NA	NA	GRIN3A	approved	post-approval	7
parkinson	NCT02206620	2014	donepezil	donepezil	approved	NA	147.03353867214236	NA	ACHE	approved	repurposing	3
alzheimer	NCT02210286	2014	magtein	magtein	supplement	NA	40.02737850787132	NA	NA	non	novel, unsup	2
parkinson	NCT02212678	2014	n-acetylcysteine capsule	acetylcysteine	approved	NA	7.994524298425736	NA	GSS	approved	repurposing	3
huntington	NCT02215616	2014	laquinimod	laquinimod	experimental	NA	1281.7522245037646	NA	AHR	non	novel, unsup	2
parkinson	NCT02216188	2014	affitope® pd01a	affitope pd01a	experimental	NA	NA	OMIM	SNCA	non	novel, supported	1
alzheimer	NCT02220738	2014	abt-957	alicapistat	experimental	NA	28.45448323066393	NA	CAPN1	non	novel, unsup	2
alzheimer	NCT02221622	2014	allopregnanolone injection (intravenous solution)	brexanolone	approved	NA	84.10677618069815	NA	GABRA1	approved	repurposing	3
alzheimer	NCT02221947	2014	bryostatin 1	bryostatin 1	experimental	NA	4.509240246406571	NA	PRKCA	approved	metoo	5
parkinson	NCT02224664	2014	pf-06649751	tavapadon	experimental	NA	70.77344284736482	NA	DRD1	approved	metoo	5
parkinson	NCT02225548	2014	tadalafil	tadalafil	approved	NA	NA	NA	PDE5A	approved	repurposing	3
parkinson	NCT02228590	2014	apl-130277	apomorphine	experimental	2004	6.346338124572211	NA	DRD4	approved	post-approval	7
huntington	NCT02231580	2014	bn82451b	bn82451b	experimental	NA	26.855578370978783	NA	NA	non	novel, unsup	2
parkinson	NCT02231905	2004	bi-sifrol®	pramipexole	approved	1997	NA	NA	DRD3	approved	post-approval	7
ftd/als	NCT02238626	2014	mn-166	ibudilast	approved	NA	230.7378507871321	NA	PDE4A	approved	repurposing	3
parkinson	NCT02240030	2014	cvt-301 high dose	levodopa	approved	1975	731.3100616016427	NA	DRD1	approved	post-approval	7
alzheimer	NCT02240693	2015	bi 409306	bi 409306	experimental	NA	349.74401095140314	NA	PDE9A	non	novel, unsup	2
parkinson	NCT02242487	2015	cvt-301	levodopa	approved	1975	1029.5003422313484	NA	DRD1	approved	post-approval	7
alzheimer	NCT02244541	2014	anavex2-73 intravenous	anavex2-73	experimental	NA	61.4154688569473	NA	SIGMAR1	approved	metoo	5
other/unspecified	NCT02245568	2014	trx0237	lmtm	experimental	NA	2509.656399726215	NA	MAPT	non	novel, unsup	2
alzheimer	NCT02245737	2014	lanabecestat	lanabecestat	experimental	NA	8896.290212183436	NA	BACE1	non	novel, unsup	2
alzheimer	NCT02246075	2015	evp-6124	encenicline	experimental	NA	NA	NA	CHRNA7	approved	metoo	5
alzheimer	NCT02248636	2015	cholinesterase inhibitor	galantamine,donepezil,rivastigmine	combination	NA	337.67556468172484	NA	ACHE	approved	combination	4
parkinson	NCT02256319	2014	dexmedetomidine	dexmedetomidine	approved	NA	14.981519507186858	NA	ADRA2A	approved	repurposing	3
parkinson	NCT02258152	2014	syn120	landipirdine	experimental	NA	228.09582477754964	NA	HTR2A	approved	metoo	5
parkinson	NCT02259049	2014	l-tyrosine	tyrosine	supplement	NA	5.503080082135524	NA	NA	non	novel, unsup	2
alzheimer	NCT02260141	2014	d-ribose	ribose	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT02260674	2014	jnj-54861911, 10 milligram (mg)	atabecestat	experimental	NA	180.40246406570841	NA	BACE1	non	novel, unsup	2
alzheimer	NCT02267057	2014	buprenorphine	buprenorphine	approved	NA	389.5934291581109	NA	OPRM1	approved	repurposing	3
parkinson	NCT02267434	2014	high dose affitope® pd03a + adjuvant	pd03a	experimental	NA	60.02464065708419	OMIM	SNCA	non	novel, supported	1
ftd/als	NCT02269436	2015	snn0030	snn0029	experimental	NA	8.2217659137577	NA	VEGFA	approved	metoo	5
parkinson	NCT02271503	2015	cd-ld ir	carbidopa,levodopa	combination	NA	19.50444900752909	NA	DRD1	approved	combination	4
parkinson	NCT02274766	2014	ads-5102	amantadine	approved	2003	110.88843258042436	NA	GRIN3A	approved	post-approval	7
parkinson	NCT02275884	2013	dark chocolate (85% cocoa)	chocolate	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT02279511	2014	adenosine triphosphate	adenosine triphosphate	supplement	NA	23.381245722108144	NA	ABL2	non	novel, unsup	2
parkinson	NCT02281474	2014	nilotinib	nilotinib	approved	NA	NA	NA	ABL1	approved	repurposing	3
alzheimer	NCT02284906	2015	pioglitazone	pioglitazone	approved	NA	129.33607118412047	NA	PPARG	approved	repurposing	3
ftd/als	NCT02288091	2015	inosine	inosine	approved	NA	37.23477070499658	NA	NA	non	repurposing	3
alzheimer	NCT02292238	2014	benfotiamine	benfotiamine	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT02293915	2014	sodium oligo-mannurarate 900mg	gv-971	experimental	NA	3675.1211498973307	NA	NA	non	novel, unsup	2
ftd/als	NCT02306590	2015	calogen	calogen	supplement	NA	741.2895277207392	NA	NA	non	novel, unsup	2
parkinson	NCT02312908	2015	clonazepam	clonazepam	approved	NA	40.082135523613964	NA	GABRA1	approved	repurposing	3
alzheimer	NCT02322021	2014	elenbecestat (e2609)	elenbecestat	experimental	NA	352.63518138261463	NA	BACE1	non	novel, unsup	2
alzheimer	NCT02323334	2014	ly3202626	ly3202626	experimental	NA	158.99247091033538	NA	BACE1	non	novel, unsup	2
parkinson	NCT02324426	2014	reduced glutathione	glutathione	supplement	NA	3.696098562628337	NA	NA	non	novel, unsup	2
alzheimer	NCT02327182	2014	mt-4666	encenicline	experimental	NA	97.37987679671458	NA	CHRNA7	approved	metoo	5
huntington	NCT02336633	2015	resveratrol	resveratrol	supplement	NA	459.38398357289526	NA	NA	non	novel, unsup	2
parkinson	NCT02337725	2015	tvp-1012	rasagiline	approved	2006	391.4688569472964	NA	MAOB	approved	post-approval	7
parkinson	NCT02337738	2015	tvp-1012 0.5mg	rasagiline	approved	2006	662.54893908282	NA	MAOB	approved	post-approval	7
parkinson	NCT02337751	2015	tvp-1012 1mg	rasagiline	approved	2006	332.3039014373717	NA	MAOB	approved	post-approval	7
parkinson	NCT02337764	2015	tvp-1012 1mg	rasagiline	approved	2006	367.11293634496917	NA	MAOB	approved	post-approval	7
alzheimer	NCT02337907	2015	bi 409306	bi 409306	experimental	NA	894.4476386036961	NA	PDE9A	non	novel, unsup	2
parkinson	NCT02339064	2015	apomorphine infusion	apomorphine	approved	2004	651.5975359342916	NA	DRD4	approved	post-approval	7
huntington	NCT02342548	2015	20 mg bid of pf-02545920	mardepodect	experimental	NA	366.47775496235454	NA	NA	non	novel, unsup	2
alzheimer	NCT02346201	2016	methylphenidate	methylphenidate	approved	NA	883.2306639288158	NA	SLC6A3	approved	repurposing	3
parkinson	NCT02347059	2015	dopamine agonists (pramipexole, ropirinole)	pramipexole	approved	1997	NA	NA	DRD3	approved	post-approval	7
alzheimer	NCT02351882	2015	nabilone	nabilone	approved	NA	158.13826146475017	NA	CNR2	approved	repurposing	3
parkinson	NCT02352363	2015	cvt-301	levodopa	approved	1975	884.6981519507187	NA	DRD1	approved	post-approval	7
alzheimer	NCT02353598	2015	crenezumab dose level 1	crenezumab	experimental	NA	313.9028062970568	OMIM	APP	non	novel, supported	1
parkinson	NCT02359448	2015	melatonin	melatonin	supplement	NA	NA	NA	MTNR1A	approved	metoo	5
alzheimer	NCT02359552	2015	rasagiline	rasagiline	approved	NA	99.35112936344969	NA	MAOB	approved	repurposing	3
alzheimer	NCT02360657	2015	jnj-54861911, 10 mg	atabecestat	experimental	NA	10.053388090349076	NA	BACE1	non	novel, unsup	2
alzheimer	NCT02361242	2013	pxt00864	acamprosate,baclofen	combination	NA	112.48459958932239	NA	GABBR2	approved	combination	4
alzheimer	NCT02361424	2013	pxt00864	acamprosate,baclofen	combination	NA	109.37713894592744	NA	GABBR2	approved	combination	4
parkinson	NCT02365012	2014	midodrine	midodrine	approved	NA	NA	NA	ADRA1A	approved	repurposing	3
parkinson	NCT02365870	2016	rotigotine transdermal patch	rotigotine	approved	2007	11.652292950034223	NA	DRD3	approved	post-approval	7
parkinson	NCT02373072	2015	trimethobenzamide hydrochloride	trimethobenzamide	approved	NA	18.036960985626283	NA	NA	non	repurposing	3
alzheimer	NCT02377713	2015	khk6640	khk6640	experimental	NA	30.116358658453116	OMIM	APP	non	novel, supported	1
alzheimer	NCT02380573	2015	methylene blue	methylene blue	approved	NA	936	NA	GUCY1A2	approved	repurposing	3
parkinson	NCT02382198	2016	glycopyrrolate	glycopyrrolate	approved	NA	NA	NA	CHRM1	approved	repurposing	3
parkinson	NCT02385500	2016	fesoterodine	fesoterodine	approved	NA	13.81245722108145	NA	CHRM3	approved	repurposing	3
alzheimer	NCT02386306	2015	gc021109	gc021109	experimental	NA	25.83983572895277	NA	P2RY6	non	novel, unsup	2
alzheimer	NCT02388152	2015	lu af20513, double high dose	lu af20513	experimental	NA	217.11156741957564	OMIM	APP	non	novel, supported	1
alzheimer	NCT02389413	2015	pq912 oral	varoglutamstat	experimental	NA	250.34907597535934	NA	QPCT	non	novel, unsup	2
alzheimer	NCT02392468	2015	bi 409306	bi 409306	experimental	NA	141.62354551676933	NA	PDE9A	non	novel, unsup	2
alzheimer	NCT02406027	2015	jnj-54861911, 10 mg	atabecestat	experimental	NA	269.0759753593429	NA	BACE1	non	novel, unsup	2
alzheimer	NCT02414607	2016	elderberry juice	elderberry	supplement	NA	77.93018480492813	NA	NA	non	novel, unsup	2
parkinson	NCT02415062	2015	donepezil	donepezil	approved	NA	NA	NA	ACHE	approved	repurposing	3
parkinson	NCT02418598	2015	cohort1	aav-haadc-2	experimental	NA	5.924709103353867	NA	DDC	approved	metoo	5
parkinson	NCT02419313	2012	incobotulinumtoxina	botulinum toxin a	approved	NA	101.73305954825462	NA	SNAP25	approved	repurposing	3
alzheimer	NCT02423122	2015	vx-745	neflamapimod	experimental	NA	22.73511293634497	NA	NA	non	novel, unsup	2
alzheimer	NCT02423200	2015	vx-745	neflamapimod	experimental	NA	25.4072553045859	NA	NA	non	novel, unsup	2
parkinson	NCT02424708	2015	reduced glutathione 100mg	glutathione	supplement	NA	45.09240246406571	NA	NA	non	novel, unsup	2
parkinson	NCT02427646	2011	bont-a	botulinum toxin a	approved	NA	468.07392197125256	NA	SNAP25	approved	repurposing	3
alzheimer	NCT02431468	2015	bryostatin 1	bryostatin 1	experimental	NA	184.32854209445586	NA	PRKCA	approved	metoo	5
alzheimer	NCT02434666	2015	cpc-201	donepezil,solifenacin	combination	NA	39.3264887063655	NA	CHRM3	approved	combination	4
alzheimer	NCT02434718	2015	aducanumab	aducanumab	experimental	NA	30.357289527720738	OMIM	APP	non	novel, supported	1
ftd/als	NCT02437110	2015	darunavir	darunavir	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT02438215	2014	irx4204	irx4204	experimental	NA	11.211498973305956	NA	RXRA	approved	metoo	5
parkinson	NCT02439125	2015	eltoprazine hcl	eltoprazine	experimental	NA	NA	NA	HTR1A	approved	metoo	5
parkinson	NCT02439203	2015	jm-010	buspirone,zolmitriptan	combination	NA	20.123203285420946	NA	HTR1A	approved	combination	4
alzheimer	NCT02442765	2015	avp-786	avp-786	combination	NA	1431.2114989733059	NA	SIGMAR1	approved	combination	4
alzheimer	NCT02442778	2015	avp-786	avp-786	combination	NA	2099.4332648870636	NA	SIGMAR1	approved	combination	4
alzheimer	NCT02444637	2015	rivastigmine	rivastigmine	approved	2000	NA	NA	ACHE	approved	post-approval	7
parkinson	NCT02445651	2014	intravenous and oral n—acetyl cysteine	acetylcysteine	approved	NA	NA	NA	GSS	approved	repurposing	3
alzheimer	NCT02446132	2015	avp-786	avp-786	combination	NA	NA	NA	SIGMAR1	approved	combination	4
parkinson	NCT02448914	2015	trigel	doxorubicin,combretastatin-a4,dexamethasone	combination	NA	1.83709787816564	NA	TOP2A	approved	combination	4
ftd/als	NCT02450552	2015	ezogabine	ezogabine	approved	NA	173.6892539356605	NA	NA	non	repurposing	3
parkinson	NCT02450786	2015	donepezil	donepezil	approved	NA	333.36071184120465	NA	ACHE	approved	repurposing	3
parkinson	NCT02452125	2015	nicotine gum	nicotine	approved	NA	20.862422997946613	NA	CHRNA4	approved	repurposing	3
parkinson	NCT02452606	2015	stalevo®	carbidopa,levodopa,entacapone	combination	NA	NA	NA	DRD1	approved	combination	4
huntington	NCT02453061	2015	triheptanoin oil	triheptanoin	approved	NA	550.8555783709788	NA	NA	non	repurposing	3
parkinson	NCT02453386	2015	tozadenant	tozadenant	experimental	NA	1138.3271731690622	NA	ADORA2A	approved	metoo	5
parkinson	NCT02459717	2015	probiotics and prebiotic	probiotic	supplement	NA	40.082135523613964	NA	NA	non	novel, unsup	2
parkinson	NCT02459886	2015	biib054	cinpanemab	experimental	NA	157.74948665297742	OMIM	SNCA	non	novel, supported	1
ftd/als	NCT02460679	2015	epi-589	epi-589	experimental	NA	53.27857631759069	NA	NA	non	novel, unsup	2
alzheimer	NCT02462161	2015	insulin aspart	insulin	approved	NA	97.7741273100616	NA	INSR	approved	repurposing	3
parkinson	NCT02462603	2016	epi-589	epi-589	experimental	NA	165.03764544832308	NA	NA	non	novel, unsup	2
ftd/als	NCT02463825	2015	pimozide 2 mg per day	pimozide	approved	NA	NA	NA	DRD2	approved	repurposing	3
alzheimer	NCT02467413	2019	bac	bac	experimental	NA	0	NA	NA	non	novel, unsup	2
parkinson	NCT02469090	2015	apl-130277	apomorphine	experimental	2004	536.6324435318276	NA	DRD4	approved	post-approval	7
ftd/als	NCT02469896	2015	tocilizumab	tocilizumab	approved	NA	59.20876112251882	NA	IL6R	approved	repurposing	3
parkinson	NCT02470780	2015	rifaximin	rifaximin	approved	NA	40.016427104722794	NA	NA	non	repurposing	3
alzheimer	NCT02471196	2015	orm-12741	orm-12741	experimental	NA	710.8665297741273	NA	ADRA2C	approved	metoo	5
alzheimer	NCT02471833	2015	telmisartan 20mg	telmisartan	approved	NA	NA	NA	PPARG	approved	repurposing	3
parkinson	NCT02472210	2014	botulinum toxin	botulinum toxin a	approved	NA	16.366872005475702	NA	SNAP25	approved	repurposing	3
parkinson	NCT02473562	2013	varenicline	varenicline	approved	NA	102.75701574264203	NA	CHRNA4	approved	repurposing	3
alzheimer	NCT02477800	2015	aducanumab (biib037)	aducanumab	experimental	NA	6484.287474332649	OMIM	APP	non	novel, supported	1
ftd/als	NCT02479802	2014	albumin	albumin	approved	NA	20.57221081451061	NA	NA	non	repurposing	3
huntington	NCT02481674	2015	vx15/2503	pepinemab	experimental	NA	1455.3483915126626	NA	SEMA4D	non	novel, unsup	2
alzheimer	NCT02484547	2015	aducanumab (biib037)	aducanumab	experimental	NA	6300.862422997947	OMIM	APP	non	novel, supported	1
ftd/als	NCT02487407	2015	odm-109	levosimendan	approved	NA	126.6694045174538	NA	TNNC1	approved	repurposing	3
huntington	NCT02494778	2015	pridopidine	pridopidine	experimental	NA	571.0280629705682	NA	SIGMAR1	approved	metoo	5
ftd/als	NCT02496767	2015	tirasemtiv	tirasemtiv	experimental	NA	1535.8384668035592	NA	TNNC1	approved	metoo	5
alzheimer	NCT02502253	2015	grape seed polyphenolic extract, resveratrol	grape	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT02503501	2015	insulin glulisine	insulin	approved	NA	165.81519507186857	NA	INSR	approved	repurposing	3
huntington	NCT02507284	2016	srx246	srx246	experimental	NA	277.1526351813826	NA	AVPR1A	approved	metoo	5
huntington	NCT02509793	2018	tetrabenazine	tetrabenazine	approved	2008	NA	NA	SLC18A2	approved	post-approval	7
huntington	NCT02519036	2015	isis 443139 10 mg	isis 443139	experimental	NA	103.90143737166325	OMIM	HTT	non	novel, supported	1
ftd/als	NCT02525471	2015	rns60	rns60	experimental	NA	49.14989733059548	NA	NA	non	novel, unsup	2
alzheimer	NCT02530255	2016	cycloastragenol	cycloastragenol	supplement	NA	99.87679671457906	NA	NA	non	novel, unsup	2
parkinson	NCT02536976	2015	mirabegron	mirabegron	approved	NA	18.666666666666668	NA	ADRB3	approved	repurposing	3
alzheimer	NCT02541929	2016	docosahexaenoic acid	doconexent	approved	NA	100.74469541409994	NA	PPARA	approved	repurposing	3
parkinson	NCT02542696	2015	apl-130277	apomorphine	experimental	2004	NA	NA	DRD4	approved	post-approval	7
alzheimer	NCT02547818	2015	alzt-op1a	cromolyn,ibuprofen	combination	NA	3255.7426420260094	NA	S100P	approved	combination	4
parkinson	NCT02549092	2015	abt-slv187	carbidopa,levodopa	combination	NA	418.135523613963	NA	DRD1	approved	combination	4
alzheimer	NCT02549196	2015	solifenacin	solifenacin	approved	NA	55.34839151266256	NA	CHRM3	approved	repurposing	3
alzheimer	NCT02550665	2014	donepezil	donepezil	approved	1996	322.8473648186174	NA	ACHE	approved	post-approval	7
alzheimer	NCT02551809	2015	ub-311	ub-311	experimental	NA	121.84804928131418	OMIM	APP	non	novel, supported	1
alzheimer	NCT02553928	2015	memantine (once daily)	memantine	approved	2003	46.510609171800134	NA	GRIN1	approved	post-approval	7
alzheimer	NCT02560753	2015	t3d-959	t3d-959	experimental	NA	35.97535934291581	NA	PPARD	approved	metoo	5
parkinson	NCT02562768	2015	ly3154207	mevidalen	experimental	NA	113.89459274469542	NA	DRD1	approved	metoo	5
alzheimer	NCT02565511	2015	cad106 immunotherapy	cad106	experimental	NA	4480	NA	NA	non	novel, unsup	2
parkinson	NCT02565628	2015	pf-06669571	pf-06669571	experimental	NA	9.801505817932922	NA	DRD1	approved	metoo	5
alzheimer	NCT02569398	2015	atabecestat, 25 mg	atabecestat	experimental	NA	1750.6803559206023	NA	BACE1	non	novel, unsup	2
alzheimer	NCT02573740	2015	abt-957	alicapistat	experimental	NA	4.008213552361396	NA	CAPN1	non	novel, unsup	2
parkinson	NCT02577523	2015	nd0612 (levodopa/carbidopa solution)	carbidopa,levodopa	combination	NA	44.42436687200548	NA	DRD1	approved	combination	4
alzheimer	NCT02579252	2016	aadvac1	aadvac1	experimental	NA	675.9644079397673	NA	MAPT	non	novel, unsup	2
parkinson	NCT02579473	2016	ser-214	ser-214	experimental	NA	NA	NA	DRD2	approved	metoo	5
alzheimer	NCT02580305	2015	suvn-502	suvn-502	experimental	NA	2355.27446954141	NA	NA	non	novel, unsup	2
alzheimer	NCT02585934	2015	rvt-101	intepirdine	experimental	NA	2523.791923340178	NA	HTR6	approved	metoo	5
alzheimer	NCT02586909	2016	rvt-101 35 mg tablets	intepirdine	experimental	NA	2105.1334702258728	NA	HTR6	approved	metoo	5
ftd/als	NCT02588677	2013	masitinib (3.0)	masitinib	experimental	NA	1936.290212183436	NA	NA	non	novel, unsup	2
parkinson	NCT02589340	2016	buspirone	buspirone	approved	NA	NA	NA	HTR1A	approved	repurposing	3
alzheimer	NCT02593318	2015	oxaloacetate (oaa)	oxaloacetic acid	supplement	NA	87.5564681724846	NA	NA	non	novel, unsup	2
parkinson	NCT02601586	2016	pr oxycodone	oxycodone	approved	NA	NA	NA	OPRM1	approved	repurposing	3
parkinson	NCT02605434	2016	accordion pill™ carbidopa/levodopa	carbidopa,levodopa	combination	NA	NA	NA	DRD1	approved	combination	4
parkinson	NCT02610231	2015	istradefylline 20 mg or 40 mg	istradefylline	approved	2019	490.75975359342914	NA	ADORA2A	approved	pre-approval	6
other/unspecified	NCT02610868	2015	myobloc	botulinum toxin b	approved	NA	311.7946611909651	NA	VAMP1	approved	repurposing	3
alzheimer	NCT02614131	2015	ly2599666	ly2599666	experimental	NA	50.10266940451746	OMIM	APP	non	novel, supported	1
alzheimer	NCT02615002	2015	piromelatine	piromelatine	experimental	NA	NA	NA	MTNR1A	approved	metoo	5
parkinson	NCT02615873	2016	accordion pill™ carbidopa/levodopa	carbidopa,levodopa	combination	NA	NA	NA	DRD1	approved	combination	4
parkinson	NCT02616120	2015	sqjz herbal mixtures	sqjz herbal mixtures	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT02617017	2016	buspirone	buspirone	approved	NA	NA	NA	HTR1A	approved	repurposing	3
parkinson	NCT02618941	2016	affitope® pd01a	affitope pd01a	experimental	NA	27.904175222450377	OMIM	SNCA	non	novel, supported	1
ftd/als	NCT02623699	2016	biib067	tofersen	experimental	NA	NA	OMIM	SOD1	non	novel, supported	1
alzheimer	NCT02624778	2015	ly3002813	donanemab	experimental	NA	224.62696783025325	OMIM	APP	non	novel, supported	1
alzheimer	NCT02626572	2015	s47445 15mg	s47445	experimental	NA	NA	NA	GRIA1	approved	metoo	5
ftd/als	NCT02640729	2015	nelotanserin	nelotanserin	experimental	NA	57.57700205338809	NA	HTR2A	approved	metoo	5
parkinson	NCT02641054	2016	cvxl-0107	naftazone	approved	NA	29.66735112936345	NA	NA	non	repurposing	3
parkinson	NCT02642393	2016	inosine	inosine	approved	NA	NA	NA	NA	non	repurposing	3
ftd/als	NCT02645461	2014	endocannabinoid palmitoylethanolamide (pea)	palmidrol	supplement	NA	95.68788501026694	NA	NA	non	novel, unsup	2
alzheimer	NCT02646982	2016	candesartan	candesartan	experimental	NA	NA	NA	AGTR1	approved	metoo	5
alzheimer	NCT02648906	2015	choline alfoscerate	choline alfoscerate	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT02649608	2016	0.04 mg lu ae04621	ae04621	experimental	NA	13.757700205338809	NA	DRD1	approved	metoo	5
parkinson	NCT02655315	2016	deferiprone	deferiprone	approved	NA	1920.8542094455852	NA	NA	non	repurposing	3
ftd/als	NCT02655614	2016	gdc-0134	gdc-0134	experimental	NA	225.16632443531827	NA	MAP3K12	non	novel, unsup	2
alzheimer	NCT02667496	2016	sargramostim gz402664	sargramostim	approved	NA	0	NA	CSF2RA	approved	repurposing	3
parkinson	NCT02668497	2016	botulinum toxin type a	botulinum toxin a	approved	NA	NA	NA	SNAP25	approved	repurposing	3
alzheimer	NCT02670083	2016	crenezumab	crenezumab	experimental	NA	2593.141683778234	OMIM	APP	non	novel, supported	1
parkinson	NCT02680977	2016	mp-equivalent	mucuna pruriens	supplement	NA	10.496919917864476	NA	NA	non	novel, unsup	2
parkinson	NCT02687542	2016	pf-06649751 high dose (15 mg qd)	tavapadon	experimental	NA	182.4394250513347	NA	DRD1	approved	metoo	5
parkinson	NCT02688465	2016	apomorphine	apomorphine	approved	2004	12.279260780287474	NA	DRD4	approved	post-approval	7
parkinson	NCT02702076	2017	apomorphine	apomorphine	approved	2004	NA	NA	DRD4	approved	post-approval	7
alzheimer	NCT02702817	2012	naproxen	naproxen	approved	NA	990.5544147843942	NA	PTGS1	approved	repurposing	3
alzheimer	NCT02703636	2016	rivastigmine patch	rivastigmine	approved	2000	235.19233401779604	NA	ACHE	approved	post-approval	7
parkinson	NCT02705755	2016	td-9855	ampreloxetine	experimental	NA	87.87405886379193	NA	SLC6A2	approved	metoo	5
alzheimer	NCT02707458	2016	probucol	probucol	approved	NA	21.032169746748803	NA	ABCA1	approved	repurposing	3
parkinson	NCT02708186	2016	nelotanserin	nelotanserin	experimental	NA	62.80355920602327	NA	HTR2A	approved	metoo	5
ftd/als	NCT02709330	2016	lunasin regimen	lunasin	experimental	NA	87.06365503080082	NA	NA	non	novel, unsup	2
alzheimer	NCT02709356	2015	1-month of 60-40 mct oil	mct oil	supplement	NA	46.76249144421629	NA	NA	non	novel, unsup	2
ftd/als	NCT02714036	2016	ibudilast	ibudilast	approved	NA	151.59479808350446	NA	PDE4A	approved	repurposing	3
ftd/als	NCT02716662	2016	axona	axona	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT02719327	2017	icosapent ethyl (ipe)	icosapent ethyl	approved	NA	NA	NA	PTGS2	approved	repurposing	3
parkinson	NCT02719496	2016	iberogast	stw 5	supplement	NA	89.93839835728953	NA	NA	non	novel, unsup	2
alzheimer	NCT02720445	2017	nicotine transdermal patch	nicotine	approved	NA	NA	NA	CHRNA4	approved	repurposing	3
parkinson	NCT02726386	2016	nd0612	carbidopa,levodopa	combination	NA	NA	NA	DRD1	approved	combination	4
alzheimer	NCT02727699	2017	xanamem™	xanamem	experimental	NA	367.6714579055442	NA	HSD11B1	approved	metoo	5
parkinson	NCT02728843	2016	deferiprone	deferiprone	approved	NA	405.14715947980835	NA	NA	non	repurposing	3
parkinson	NCT02728947	2016	rotigotine	rotigotine	approved	2007	9.429158110882957	NA	DRD3	approved	post-approval	7
parkinson	NCT02729714	2016	suvorexant	suvorexant	approved	NA	NA	NA	HCRTR1	approved	repurposing	3
parkinson	NCT02741947	2014	levodopa benserazide madopar	levodopa,benserazide	combination	NA	73.36344969199179	NA	DRD1	approved	combination	4
alzheimer	NCT02750306	2016	suvorexant	suvorexant	approved	2020	671.047227926078	NA	HCRTR1	approved	pre-approval	6
alzheimer	NCT02754830	2016	ly3303560 - iv	zagotenemab	experimental	NA	242.7378507871321	NA	MAPT	non	novel, unsup	2
ftd/als	NCT02756104	2016	supplementation in vitamin d	vitamin d	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT02756858	2016	anavex2-73	anavex2-73	experimental	NA	NA	NA	SIGMAR1	approved	metoo	5
alzheimer	NCT02760602	2016	solanezumab	solanezumab	experimental	NA	23.77549623545517	OMIM	APP	non	novel, supported	1
parkinson	NCT02763137	2015	semi continuous intra-oral administration of ld/cd	carbidopa,levodopa	combination	NA	13.453798767967145	NA	DRD1	approved	combination	4
parkinson	NCT02764125	2016	stalevo	carbidopa,levodopa,entacapone	combination	NA	165.1252566735113	NA	DRD1	approved	combination	4
parkinson	NCT02768077	2016	melatonin(circadin®)	melatonin	supplement	NA	NA	NA	MTNR1A	approved	metoo	5
parkinson	NCT02769793	2015	levodopa	levodopa	approved	1975	NA	NA	DRD1	approved	post-approval	7
parkinson	NCT02775591	2016	da-9701	da-9701	supplement	NA	392	NA	NA	non	novel, unsup	2
alzheimer	NCT02778581	2016	lipidic blend 1	lipidic blend 1	supplement	NA	NA	NA	NA	non	novel, unsup	2
ftd/als	NCT02781454	2016	mexiletine	mexiletine	approved	NA	39.917864476386036	NA	SCN5A	approved	repurposing	3
parkinson	NCT02782481	2016	nd0612	carbidopa,levodopa	combination	NA	0	NA	DRD1	approved	combination	4
alzheimer	NCT02783573	2016	lanabecestat	lanabecestat	experimental	NA	3861.240246406571	NA	BACE1	non	novel, unsup	2
parkinson	NCT02786667	2012	rotigotine	rotigotine	approved	2007	1094.56810403833	NA	DRD3	approved	post-approval	7
parkinson	NCT02787590	2016	simvastatin	simvastatin	approved	NA	966.3791923340178	NA	HMGCR	approved	repurposing	3
alzheimer	NCT02787746	2016	donepezil	donepezil	approved	1996	702.050650239562	NA	ACHE	approved	post-approval	7
alzheimer	NCT02788513	2016	bi 425809 dose 1	bi 425809	experimental	NA	1933.7878165639972	NA	SLC6A9	non	novel, unsup	2
parkinson	NCT02789592	2016	clonazepam	clonazepam	approved	NA	NA	NA	GABRA1	approved	repurposing	3
alzheimer	NCT02791191	2016	ly3202626	ly3202626	experimental	NA	645.4099931553731	NA	BACE1	non	novel, unsup	2
alzheimer	NCT02792257	2017	dronabinol (marinol®)	dronabinol	approved	NA	NA	NA	CNR1	approved	repurposing	3
ftd/als	NCT02794857	2016	np001	np001	experimental	NA	177.5770020533881	NA	NA	non	novel, unsup	2
parkinson	NCT02799381	2017	abt-slv187	carbidopa,levodopa	combination	NA	164.2053388090349	NA	DRD1	approved	combination	4
parkinson	NCT02803749	2016	buspirone	buspirone	approved	NA	48.64065708418891	NA	HTR1A	approved	repurposing	3
parkinson	NCT02807675	2016	cvt-301, lip	levodopa	approved	1975	15.080082135523615	NA	DRD1	approved	post-approval	7
parkinson	NCT02812147	2016	l-dops	droxidopa	approved	NA	NA	NA	ADRA1A	approved	repurposing	3
parkinson	NCT02815800	2016	ethnodyne visio	withania somnifera,emblica oficinalis,bacopa monnieri	supplement	NA	36.53388090349076	NA	NA	non	novel, unsup	2
alzheimer	NCT02817906	2016	iti-007	lumateperone	approved	NA	442.4394250513347	NA	HTR2A	approved	repurposing	3
parkinson	NCT02818777	2016	cannabidiol	cannabidiol	approved	NA	14.094455852156058	NA	CNR1	approved	repurposing	3
alzheimer	NCT02820896	2016	ro7105705	semorinemab	experimental	NA	73.34154688569473	NA	MAPT	non	novel, unsup	2
parkinson	NCT02834507	2005	sinemet®	carbidopa,levodopa	combination	NA	12.744695414099931	NA	DRD1	approved	combination	4
parkinson	NCT02838797	2016	rq-00000010	rq10	experimental	NA	164.06570841889118	NA	HTR4	approved	metoo	5
parkinson	NCT02847442	2016	bia 9-1067	opicapone	approved	2020	833.9055441478439	NA	COMT	approved	pre-approval	6
parkinson	NCT02847650	2016	pf-06649751	tavapadon	experimental	NA	73.19096509240246	NA	DRD1	approved	metoo	5
ftd/als	NCT02851914	2015	selective serotonin uptake inhibitors (""ssri"")	ssri	approved	NA	7.715263518138261	NA	SLC6A4	approved	repurposing	3
parkinson	NCT02857244	2016	donepezil	donepezil	approved	NA	0	NA	ACHE	approved	repurposing	3
alzheimer	NCT02860065	2016	cpc-201	donepezil,solifenacin	combination	NA	0	NA	CHRM3	approved	combination	4
other/unspecified	NCT02862210	2017	lithium carbonate	lithium	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT02864004	2017	apomorphine	apomorphine	approved	2004	NA	NA	DRD4	approved	post-approval	7
other/unspecified	NCT02868567	2016	dalfampridine	dalfampridine	approved	NA	NA	NA	KCNA1	approved	repurposing	3
ftd/als	NCT02868580	2016	triumeq	dolutegravir	approved	NA	93.12251882272416	NA	NA	non	repurposing	3
ftd/als	NCT02870634	2016	cu(ii)atsm	Cu(II)atsm	experimental	NA	NA	NA	NA	non	novel, unsup	2
other/unspecified	NCT02871427	2016	nelotanserin	nelotanserin	experimental	NA	NA	NA	HTR2A	approved	metoo	5
ftd/als	NCT02872142	2016	albutein 5%	albumin	approved	NA	35.05544147843943	NA	NA	non	repurposing	3
other/unspecified	NCT02880033	2011	deferiprone	deferiprone	approved	NA	817.0841889117044	NA	NA	non	repurposing	3
alzheimer	NCT02880956	2016	abbv-8e12	tilavonemab	experimental	NA	2164.229979466119	NA	MAPT	non	novel, unsup	2
alzheimer	NCT02886494	2016	bac	bac	experimental	NA	153.31964407939768	NA	NA	non	novel, unsup	2
parkinson	NCT02897063	2016	droxidopa	droxidopa	approved	NA	NA	NA	ADRA1A	approved	repurposing	3
parkinson	NCT02906020	2016	gz/sar402671	venglustat	experimental	NA	1655.1129363449693	NA	UGCG	approved	metoo	5
alzheimer	NCT02907567	2016	ct1812	elayta	experimental	NA	18.986995208761122	NA	NA	non	novel, unsup	2
other/unspecified	NCT02910102	2016	rvt-101 35 mg	intepirdine	experimental	NA	41.19917864476386	NA	HTR6	approved	metoo	5
alzheimer	NCT02912936	2016	ketogenic medium chain triglyceride drink (mct drink)	mct oil	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT02914366	2015	ambroxol	ambroxol	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT02916056	2016	azeliragon 5mg	azeliragon	experimental	NA	446.2861054072553	NA	AGER	non	novel, unsup	2
alzheimer	NCT02925650	2017	posiphen	posiphen	experimental	NA	NA	OMIM	APP	non	novel, supported	1
parkinson	NCT02933372	2015	varenicline	varenicline	approved	NA	255.02532511978097	NA	CHRNA4	approved	repurposing	3
parkinson	NCT02934919	2016	nalmefene	nalmefene	approved	NA	NA	NA	OPRM1	approved	repurposing	3
ftd/als	NCT02936635	2016	tirasemtiv	tirasemtiv	experimental	NA	566.5160848733744	NA	TNNC1	approved	metoo	5
parkinson	NCT02939391	2016	kw-6356	kw-6356	experimental	NA	221.8343600273785	NA	ADORA2A	approved	metoo	5
parkinson	NCT02940912	2016	apomorphine	apomorphine	approved	2004	NA	NA	DRD4	approved	post-approval	7
parkinson	NCT02941822	2016	ambroxol	ambroxol	approved	NA	32.492813141683776	NA	NA	non	repurposing	3
alzheimer	NCT02947893	2017	nilotinib capsule(s) once a day by mouth	nilotinib	approved	NA	NA	NA	ABL1	approved	repurposing	3
parkinson	NCT02953665	2017	liraglutide	liraglutide	approved	NA	NA	NA	GLP1R	approved	repurposing	3
parkinson	NCT02954978	2017	nilotinib 150mg oral capsule [tasigna]	nilotinib	approved	NA	262.217659137577	NA	ABL1	approved	repurposing	3
alzheimer	NCT02955706	2016	acetyl-l-carnitine	acetyl-l-carnitine	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT02956486	2016	elenbecestat (e2609)	elenbecestat	experimental	NA	8368.043805612595	NA	BACE1	non	novel, unsup	2
parkinson	NCT02969369	2016	sep-363856	ulotaront	experimental	NA	NA	NA	HTR1A	approved	metoo	5
parkinson	NCT02970019	2017	k0706	k0706	experimental	NA	129.6098562628337	NA	ABL1	approved	metoo	5
alzheimer	NCT02972658	2017	lanabecestat	lanabecestat	experimental	NA	652.3915126625599	NA	BACE1	non	novel, unsup	2
parkinson	NCT02982512	2017	dexmedetomidine	dexmedetomidine	approved	NA	NA	NA	ADRA2A	approved	repurposing	3
ftd/als	NCT02988297	2020	rns60	rns60	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT02989402	2018	rivastigmine	rivastigmine	approved	2000	NA	NA	ACHE	approved	post-approval	7
alzheimer	NCT02991235	2016	prj212	prj212	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT02992132	2016	pimavanserin 20 mg	pimavanserin	approved	NA	143.44147843942505	NA	HTR2A	approved	repurposing	3
alzheimer	NCT02997982	2016	valaciclovir 500mg tablet	valaciclovir	approved	NA	107.42505133470226	NA	NA	non	repurposing	3
parkinson	NCT03000569	2016	sage-217	sage-217	experimental	NA	23.104722792607802	NA	GABRA1	approved	metoo	5
alzheimer	NCT03001557	2016	lemborexant 10 mg	lemborexant	approved	NA	209.39630390143736	NA	HCRTR1	approved	repurposing	3
parkinson	NCT03007888	2016	er cd-ld	carbidopa,levodopa	combination	NA	19.9315537303217	NA	DRD1	approved	combination	4
alzheimer	NCT03008161	2016	npt088	npt088	experimental	NA	181.11156741957564	NA	NA	non	novel, unsup	2
parkinson	NCT03011476	2017	donepezil	donepezil	approved	NA	NA	NA	ACHE	approved	repurposing	3
ftd/als	NCT03019419	2017	perampanel	perampanel	approved	NA	NA	NA	GRIA1	approved	repurposing	3
alzheimer	NCT03019536	2017	ly3303560 - iv	zagotenemab	experimental	NA	56.18069815195072	NA	MAPT	non	novel, unsup	2
ftd/als	NCT03020797	2016	perampanel	perampanel	approved	NA	NA	NA	GRIA1	approved	repurposing	3
parkinson	NCT03022201	2013	da-9701	da-9701	supplement	NA	123.42231348391513	NA	NA	non	novel, unsup	2
alzheimer	NCT03031184	2017	mirtazapine	mirtazapine	approved	NA	NA	NA	HTR2A	approved	repurposing	3
parkinson	NCT03033498	2017	abbv-951	abbv-951	experimental	NA	59.70704996577687	NA	DDC	approved	metoo	5
parkinson	NCT03034538	2016	zonegran	zonisamide	approved	NA	NA	NA	SCN1A	approved	repurposing	3
parkinson	NCT03034564	2017	northera	droxidopa	approved	NA	NA	NA	ADRA1A	approved	repurposing	3
alzheimer	NCT03036280	2016	elenbecestat (e2609)	elenbecestat	experimental	NA	7017.998631074606	NA	BACE1	non	novel, unsup	2
parkinson	NCT03037203	2017	jzp-110	solriamfetol	approved	NA	104.26283367556468	NA	NA	non	repurposing	3
alzheimer	NCT03038035	2016	mlc901	mlc901	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT03038334	2017	magnesium sulfate	magnesium sulfate	supplement	NA	NA	NA	CACNA1C	approved	metoo	5
ftd/als	NCT03039673	2017	il-2	aldesleukin	approved	NA	1277.5906913073238	NA	IL2RB	approved	repurposing	3
other/unspecified	NCT03044249	2017	mp-101	mp-101	experimental	NA	230.2094455852156	NA	NA	non	novel, unsup	2
parkinson	NCT03047629	2017	ent-01	ent-01	experimental	NA	54.620123203285424	NA	NA	non	novel, unsup	2
ftd/als	NCT03049046	2017	cc100	cc100	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT03051607	2017	tozadenant	tozadenant	experimental	NA	50.776180698151954	NA	ADORA2A	approved	metoo	5
alzheimer	NCT03055741	2016	dhp1401	spinosin	supplement	NA	466.2012320328542	NA	NA	non	novel, unsup	2
alzheimer	NCT03056495	2017	n-hydroxy-n'-phenyl-octanediamide (vorinostat)	vorinostat	approved	NA	NA	NA	HDAC1	approved	repurposing	3
alzheimer	NCT03056729	2017	biib076	biib076	experimental	NA	139.7946611909651	NA	MAPT	non	novel, unsup	2
alzheimer	NCT03061474	2017	nicotinamide	nicotinamide	approved	NA	NA	NA	BST1	approved	repurposing	3
parkinson	NCT03061513	2012	ubiquinol	ubiquinol	supplement	NA	53.24572210814511	NA	NA	non	novel, unsup	2
alzheimer	NCT03062449	2017	l-serine	serine	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT03065192	2017	vy-aadc01	vy-aadc01	experimental	NA	NA	NA	DDC	approved	metoo	5
parkinson	NCT03068481	2017	kdt-3594	am006	experimental	NA	53.125256673511295	NA	DRD2	approved	metoo	5
ftd/als	NCT03068754	2017	acthar	corticotropin	approved	NA	323.78097193702945	NA	MC2R	approved	repurposing	3
alzheimer	NCT03069014	2017	400mg lm11a-31-bhs	LM11A-31	experimental	NA	876.5667351129364	NA	NGFR	non	novel, unsup	2
parkinson	NCT03069911	2018	onabotulinumtoxina	botulinum toxin a	approved	NA	1.7412731006160165	NA	SNAP25	approved	repurposing	3
ftd/als	NCT03070119	2017	biib067	tofersen	experimental	NA	NA	OMIM	SOD1	non	novel, supported	1
alzheimer	NCT03073876	2005	donepezil hydrochloride	donepezil	approved	1996	377.07049965776866	NA	ACHE	approved	post-approval	7
alzheimer	NCT03075241	2016	zolpidem	zolpidem	approved	NA	NA	NA	GABRA1	approved	repurposing	3
alzheimer	NCT03082755	2017	gabapentin enacarbil	gabapentin	approved	NA	NA	NA	CACNA2D1	approved	repurposing	3
parkinson	NCT03083132	2017	modafinil 50mg	modafinil	approved	NA	55.540041067761805	NA	SLC6A3	approved	repurposing	3
alzheimer	NCT03090516	2016	ginkgo biloba dispersible tablets	ginkgo biloba	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT03093519	2017	khk6640	khk6640	experimental	NA	15.983572895277208	OMIM	APP	non	novel, supported	1
alzheimer	NCT03094546	2017	polyamine	polyamine	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT03098368	2016	rotigotine	rotigotine	approved	2007	NA	NA	DRD3	approved	post-approval	7
parkinson	NCT03100149	2017	ro7046015	prasinezumab	experimental	NA	1152.394250513347	OMIM	SNCA	non	novel, supported	1
alzheimer	NCT03101085	2017	s-equol	equol	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT03103399	2006	nebicapone	nebicapone	experimental	NA	250.34907597535934	NA	COMT	approved	metoo	5
ftd/als	NCT03103815	2017	amivita	amivita	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT03104725	2017	n-acetylcysteine	acetylcysteine	approved	NA	14.537987679671458	NA	GSS	approved	repurposing	3
alzheimer	NCT03108846	2018	escitalopram	escitalopram	approved	NA	NA	NA	SLC6A4	approved	repurposing	3
parkinson	NCT03111485	2017	sinemet cr	carbidopa,levodopa	combination	NA	NA	NA	DRD1	approved	combination	4
alzheimer	NCT03113812	2014	abvac40	abvac41	experimental	NA	37.782340862423	OMIM	APP	non	novel, supported	1
ftd/als	NCT03114215	2016	md1003	biotin	supplement	NA	42.71047227926078	NA	NA	non	novel, unsup	2
alzheimer	NCT03114657	2017	crenezumab	crenezumab	experimental	NA	1774.1930184804928	OMIM	APP	non	novel, supported	1
parkinson	NCT03115827	2017	droxidopa	droxidopa	approved	NA	25.13347022587269	NA	ADRA1A	approved	repurposing	3
alzheimer	NCT03116126	2019	guanfacine	guanfacine	approved	NA	NA	NA	ADRA2A	approved	repurposing	3
alzheimer	NCT03118947	2017	pimavanserin	pimavanserin	approved	NA	158.32443531827516	NA	HTR2A	approved	repurposing	3
ftd/als	NCT03127514	2017	amx0035	sodium phenylbutyrate,tudca	combination	NA	NA	NA	NA	non	combination	4
alzheimer	NCT03131453	2017	cnp520 15mg	umibecestat	experimental	NA	3143.4551676933606	NA	BACE1	non	novel, unsup	2
ftd/als	NCT03136809	2018	cu(ii)atsm	Cu(II)atsm	experimental	NA	82.63928815879535	NA	NA	non	novel, unsup	2
alzheimer	NCT03151382	2017	tandospirone citrate	tandospirone	approved	NA	NA	NA	HTR1A	approved	repurposing	3
parkinson	NCT03151460	2014	dopamine agent	levodopa	approved	1975	63.29911019849418	NA	DRD1	approved	post-approval	7
ftd/als	NCT03160898	2017	ck-2127107	reldesemtiv	experimental	NA	741.0759753593429	NA	TNNT3	non	novel, unsup	2
parkinson	NCT03162874	2017	pxt002331 - dose 1	foliglurax	experimental	NA	417.8069815195072	NA	GRM4	non	novel, unsup	2
ftd/als	NCT03168711	2017	inosine	inosine	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT03168997	2017	memantine hydrochloride	memantine	approved	2003	NA	NA	GRIN1	approved	post-approval	7
parkinson	NCT03173781	2016	droxidopa	droxidopa	approved	NA	31.50718685831622	NA	ADRA1A	approved	repurposing	3
other/unspecified	NCT03174886	2017	aadvac1 160 µg	aadvac1	experimental	NA	107.42505133470226	NA	MAPT	non	novel, unsup	2
alzheimer	NCT03179501	2017	np001	np001	experimental	NA	3.646817248459959	NA	NA	non	novel, unsup	2
alzheimer	NCT03184467	2017	gv1001 0.56 mg	gv1001	experimental	NA	NA	NA	TERT	non	novel, unsup	2
alzheimer	NCT03185208	2017	lithium carbonate	lithium	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT03185481	2017	1 mg qd to 15 mg qd pf-06649751	tavapadon	experimental	NA	1.5195071868583163	NA	DRD1	approved	metoo	5
ftd/als	NCT03186040	2017	lacosamide	lacosamide	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT03186989	2017	ionis maptrx	biib080	experimental	NA	225.5605749486653	NA	MAPT	non	novel, unsup	2
parkinson	NCT03187301	2017	moxifloxacin	moxifloxacin	approved	NA	16.098562628336754	NA	NA	non	repurposing	3
parkinson	NCT03189563	2018	da-9805 45mg	da-9805	supplement	NA	70.30800821355236	NA	NA	non	novel, unsup	2
parkinson	NCT03194217	2017	ben-2001	bavisant	experimental	NA	382.9486652977413	NA	HRH3	approved	metoo	5
parkinson	NCT03195231	2017	wuling powder	wuling	supplement	NA	NA	NA	NA	non	novel, unsup	2
ftd/als	NCT03196375	2017	flx-787-odt (orally disintegrating tablet)	flx-788	experimental	NA	53.81519507186858	NA	TRPA1	approved	metoo	5
alzheimer	NCT03197740	2017	aricept tab	donepezil	approved	1996	NA	NA	ACHE	approved	post-approval	7
ftd/als	NCT03204500	2016	active treatment with dual therapy	valproic acid,lithium carbonate	combination	NA	NA	NA	NA	non	combination	4
parkinson	NCT03204929	2017	cu(ii)atsm	Cu(II)atsm	experimental	NA	78.84736481861738	NA	NA	non	novel, unsup	2
parkinson	NCT03205488	2017	cohort 1:nilotinib oral capsules (150mg or 300mg)	nilotinib	approved	NA	221.9712525667351	NA	ABL1	approved	repurposing	3
huntington	NCT03225833	2017	wve-120101	wve-120101	experimental	NA	NA	OMIM	HTT	non	novel, supported	1
huntington	NCT03225846	2017	wve-120102	wve-120102	experimental	NA	NA	OMIM	HTT	non	novel, supported	1
alzheimer	NCT03226522	2017	bupropion	bupropion	approved	NA	NA	NA	SLC6A3	approved	repurposing	3
parkinson	NCT03229174	2018	droxidopa	droxidopa	approved	NA	NA	NA	ADRA1A	approved	repurposing	3
alzheimer	NCT03234686	2018	deferiprone 600mg delayed release tablets	deferiprone	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT03242499	2017	lovastatin	lovastatin	approved	NA	NA	NA	HMGCR	approved	repurposing	3
parkinson	NCT03250117	2017	ropinirole implant	ropinirole	approved	1997	1.839835728952772	NA	DRD3	approved	post-approval	7
alzheimer	NCT03250741	2016	rotigotine transdermal patch	rotigotine	approved	NA	227.24709103353868	NA	DRD3	approved	repurposing	3
parkinson	NCT03257046	2017	iti-214	lenrispodun	experimental	NA	39.97262149212868	NA	PDE1C	non	novel, unsup	2
parkinson	NCT03258294	2016	melatonin(circadin®)	melatonin	supplement	NA	NA	NA	MTNR1A	approved	metoo	5
ftd/als	NCT03260920	2018	syntocinon	oxytocin	approved	NA	NA	NA	OXTR	approved	repurposing	3
ftd/als	NCT03272503	2017	pimozide 2mg/day (current) or 4 mg/day (study initiation)	pimozide	approved	NA	NA	NA	DRD2	approved	repurposing	3
ftd/als	NCT03272802	2017	edaravone	edaravone	approved	2017	NA	NA	NA	non	post-approval	7
alzheimer	NCT03274817	2017	escitalopram pill	escitalopram	approved	NA	NA	NA	SLC6A4	approved	repurposing	3
alzheimer	NCT03277573	2017	salsalate	salsalate	approved	NA	NA	NA	PTGS2	approved	repurposing	3
alzheimer	NCT03282916	2018	valacyclovir	valacyclovir	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT03283059	2017	octohydroaminoacridine succinate	octohydroaminoacridine	experimental	NA	NA	NA	ACHE	approved	metoo	5
parkinson	NCT03288155	2017	cocoa	chocolate	supplement	NA	45.09240246406571	NA	NA	non	novel, unsup	2
alzheimer	NCT03289143	2017	semorinemab	semorinemab	experimental	NA	2153.3114305270365	NA	MAPT	non	novel, unsup	2
parkinson	NCT03292016	2017	apl-130277	apomorphine	experimental	2004	12.265571526351813	NA	DRD4	approved	post-approval	7
ftd/als	NCT03293069	2019	deferiprone	deferiprone	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT03298672	2017	ndx-1017	carbidopa,levodopa	combination	NA	167.68788501026694	NA	DRD1	approved	combination	4
parkinson	NCT03301272	2018	onabotulinumtoxin a injection	botulinum toxin a	approved	NA	22.647501711156742	NA	SNAP25	approved	repurposing	3
parkinson	NCT03305809	2017	ly3154207	mevidalen	experimental	NA	NA	NA	DRD1	approved	metoo	5
parkinson	NCT03306329	2017	dns-7801 (high dose)	dns-7801	experimental	NA	1.4921286789869952	NA	NA	non	novel, unsup	2
alzheimer	NCT03307993	2017	idalopirdine	idalopirdine	experimental	NA	1.2320328542094456	NA	HTR6	approved	metoo	5
alzheimer	NCT03316898	2018	agn-242071	agn-242071	experimental	NA	0	NA	NA	non	novel, unsup	2
parkinson	NCT03318523	2018	biib054	cinpanemab	experimental	NA	NA	OMIM	SNCA	non	novel, supported	1
alzheimer	NCT03319810	2018	octagam 10%	octagam 10%	experimental	NA	2.6830937713894594	NA	NA	non	novel, unsup	2
ftd/als	NCT03324399	2017	probiotic	probiotic	supplement	NA	10.335386721423683	NA	NA	non	novel, unsup	2
alzheimer	NCT03325556	2017	pimavanserin 20 mg	pimavanserin	approved	NA	818.8802190280629	NA	HTR2A	approved	repurposing	3
parkinson	NCT03329508	2018	p2b001	pramipexole,rasagiline	combination	NA	NA	NA	DRD3	approved	combination	4
parkinson	NCT03331848	2018	pxt002331 - 20mg	foliglurax	experimental	NA	0	NA	GRM4	non	novel, unsup	2
ftd/als	NCT03334786	2018	flx-787-odt	flx-787	experimental	NA	1.1498973305954825	NA	TRPA1	approved	metoo	5
ftd/als	NCT03338114	2017	flx-787-odt (orally disintigrating tablet)	flx-789	experimental	NA	0	NA	TRPA1	approved	metoo	5
huntington	NCT03342053	2017	ro7234292 (rg6042)	rg6042	experimental	NA	85.63997262149213	OMIM	HTT	non	novel, supported	1
alzheimer	NCT03352557	2018	biib092	gosuranemab	experimental	NA	3856.854209445585	NA	MAPT	non	novel, unsup	2
ftd/als	NCT03359538	2017	rapamycin	sirolimus	approved	NA	209.39630390143736	NA	MTOR	approved	repurposing	3
alzheimer	NCT03361410	2017	grape powder	grape	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT03363269	2016	id1201	melia toosendan	supplement	NA	349.34976043805614	NA	NA	non	novel, unsup	2
alzheimer	NCT03367403	2017	ly3002813	donanemab	experimental	NA	NA	OMIM	APP	non	novel, supported	1
parkinson	NCT03368170	2018	mesdopetam (irl790)	mesdopetam	experimental	NA	96.50924024640658	NA	DRD3	approved	metoo	5
parkinson	NCT03374917	2018	abbv-951	abbv-951	experimental	NA	17.522245037645447	NA	DDC	approved	metoo	5
alzheimer	NCT03375697	2017	jnj-63733657	jnj-63733657	experimental	NA	142.71868583162217	NA	MAPT	non	novel, unsup	2
ftd/als	NCT03377309	2017	fycompa	perampanel	approved	NA	NA	NA	GRIA1	approved	repurposing	3
parkinson	NCT03391882	2018	apl-130277	apomorphine	experimental	2004	NA	NA	DRD4	approved	post-approval	7
alzheimer	NCT03393520	2017	avp-786	avp-786	combination	NA	NA	NA	SIGMAR1	approved	combination	4
alzheimer	NCT03402503	2018	montelukast buccal film	montelukast	approved	NA	NA	NA	CYSLTR1	approved	repurposing	3
alzheimer	NCT03402659	2017	neflamapimod	neflamapimod	experimental	NA	255.21971252566735	NA	MAPK14	non	novel, unsup	2
parkinson	NCT03407378	2018	ipt803	ipt803	experimental	NA	193.94934976043805	NA	NA	non	novel, unsup	2
parkinson	NCT03412513	2017	mirabegron	mirabegron	approved	NA	NA	NA	ADRB3	approved	repurposing	3
alzheimer	NCT03413384	2019	ceftriaxone	ceftriaxone	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT03417986	2017	tep	thiethylperazine	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT03418688	2018	cor388	atuzaginstat	experimental	NA	20.147843942505133	NA	NA	non	novel, unsup	2
parkinson	NCT03419806	2018	infudopa i.v.	carbidopa,levodopa	combination	NA	53.045859000684466	NA	DRD1	approved	combination	4
ftd/als	NCT03427086	2018	biotin	biotin	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT03435861	2018	vx-745	neflamapimod	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT03436953	2019	cx-8998	cx-8998	experimental	NA	NA	NA	CACNA1I	approved	metoo	5
parkinson	NCT03439943	2018	lixisenatide	lixisenatide	approved	NA	NA	NA	GLP1R	approved	repurposing	3
parkinson	NCT03440112	2018	clarithromycin	clarithromycin	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT03441516	2018	alfoatirin® tab. + aripezil® tab.	donepezil,choline alphoscerate	combination	NA	167.19233401779604	NA	NA	non	combination	4
alzheimer	NCT03443973	2018	gantenerumab	gantenerumab	experimental	NA	NA	OMIM	APP	non	novel, supported	1
alzheimer	NCT03444870	2018	gantenerumab	gantenerumab	experimental	NA	NA	OMIM	APP	non	novel, supported	1
alzheimer	NCT03446001	2018	trx0237 16 mg/day	lmtm	experimental	NA	NA	NA	MAPT	non	novel, unsup	2
parkinson	NCT03446807	2020	droxidopa	droxidopa	approved	NA	NA	NA	ADRA1A	approved	repurposing	3
alzheimer	NCT03454646	2018	cholinesterase inhibitors (ci) (donepezil, galantamine or rivastigmine)	donepezil	approved	1996	NA	NA	ACHE	approved	post-approval	7
alzheimer	NCT03456349	2017	htl0018318	htl0018318	experimental	NA	40.73921971252567	NA	CHRM1	approved	metoo	5
parkinson	NCT03456687	2018	exenatide	exenatide	approved	NA	NA	NA	GLP1R	approved	repurposing	3
ftd/als	NCT03456882	2016	rns60	rns60	experimental	NA	643.0335386721424	NA	NA	non	novel, unsup	2
ftd/als	NCT03457753	2018	riluzole oral soluble film	riluzole	approved	1995	0	NA	SCN5A	approved	post-approval	7
alzheimer	NCT03461276	2018	abvac40	abvac40	experimental	NA	NA	OMIM	APP	non	novel, supported	1
alzheimer	NCT03461861	2019	agb101 220 mg	levetiracetam	approved	NA	NA	NA	SV2A	approved	repurposing	3
parkinson	NCT03462043	2018	cles	carbidopa,levodopa	combination	NA	0	NA	DRD1	approved	combination	4
alzheimer	NCT03462121	2018	rph201	rph201	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT03462641	2018	flumazenil	flumazenil	approved	NA	NA	NA	GABRA1	approved	repurposing	3
parkinson	NCT03462680	2016	niacin	niacin	supplement	NA	NA	NA	HCAR3	approved	metoo	5
ftd/als	NCT03472950	2018	ranolazine 1000 mg	ranolazine	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT03482882	2018	pimavanserin	pimavanserin	approved	NA	64.5968514715948	NA	HTR2A	approved	repurposing	3
alzheimer	NCT03486938	2019	agb101 220 mg tablet	levetiracetam	approved	NA	NA	NA	SV2A	approved	repurposing	3
other/unspecified	NCT03487263	2017	ic14	atibuclimab	experimental	NA	12.457221081451062	NA	NA	non	novel, unsup	2
ftd/als	NCT03488524	2018	amx0035	sodium phenylbutyrate,tudca	combination	NA	NA	NA	NA	non	combination	4
alzheimer	NCT03489044	2018	levetiracetam	levetiracetam	approved	NA	NA	NA	SV2A	approved	repurposing	3
ftd/als	NCT03489200	2017	eh301	nicotinamide riboside,pterostilbene	supplement	NA	13.229295003422314	NA	NA	non	novel, unsup	2
alzheimer	NCT03491150	2018	crenezumab (ro5490245)	crenezumab	experimental	NA	169.29500342231347	OMIM	APP	non	novel, supported	1
ftd/als	NCT03491462	2018	arimoclomol	arimoclomol	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT03493282	2018	active treatment- ct1812 100 mg	ct1812	experimental	NA	65.8672142368241	NA	TMEM97	non	novel, unsup	2
parkinson	NCT03496870	2018	carbidopa levodopa	carbidopa,levodopa	combination	NA	6.308008213552362	NA	DRD1	approved	combination	4
ftd/als	NCT03505021	2018	levosimendan	levosimendan	approved	NA	NA	NA	TNNC1	approved	repurposing	3
ftd/als	NCT03506425	2018	triheptanoin	triheptanoin	approved	NA	11.498973305954825	NA	NA	non	repurposing	3
alzheimer	NCT03507790	2018	ct1812	elayta	experimental	NA	NA	NA	NA	non	novel, unsup	2
other/unspecified	NCT03508453	2018	ic14	atibuclimab	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT03514875	2019	mitoq	mitoq	supplement	NA	NA	NA	NA	non	novel, unsup	2
huntington	NCT03515213	2017	fenofibrate	fenofibrate	approved	NA	NA	NA	PPARA	approved	repurposing	3
alzheimer	NCT03518073	2018	ly3303560	zagotenemab	experimental	NA	NA	NA	MAPT	non	novel, unsup	2
ftd/als	NCT03520517	2018	bhv-0223	riluzole	approved	1995	14.937713894592745	NA	SCN5A	approved	post-approval	7
alzheimer	NCT03520998	2018	grf6019	grf6019	experimental	NA	44.134154688569474	NA	NA	non	novel, unsup	2
parkinson	NCT03521635	2018	pramipexole ir	pramipexole	approved	1997	148.3750855578371	NA	DRD3	approved	post-approval	7
alzheimer	NCT03522129	2018	ct1812	elayta	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT03531060	2016	irl790	mesdopetam	experimental	NA	6.365503080082136	NA	DRD3	approved	metoo	5
alzheimer	NCT03531684	2018	mmfs-205-sr	l-tams	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT03531710	2018	ub-311	ub-311	experimental	NA	41.609856262833674	OMIM	APP	non	novel, supported	1
alzheimer	NCT03533257	2018	amx0035	sodium phenylbutyrate,tudca	combination	NA	NA	NA	NA	non	combination	4
alzheimer	NCT03538522	2018	n-831(traneurocin) 10 mg qd	na-831	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT03541356	2018	experimental: inp103	carbidopa,levodopa	combination	NA	34.95687885010267	NA	DRD1	approved	combination	4
ftd/als	NCT03548311	2017	methylcobalamin	vitamin b12	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT03548584	2018	brexpiprazole	brexpiprazole	approved	NA	NA	NA	HTR1A	approved	repurposing	3
parkinson	NCT03552068	2019	clonidine	clonidine	approved	NA	NA	NA	ADRA2A	approved	repurposing	3
alzheimer	NCT03560245	2018	bryostatin	bryostatin 1	experimental	NA	118.27515400410678	NA	PRKCA	approved	metoo	5
parkinson	NCT03562494	2018	vy-aadc02	vy-aadc02	experimental	NA	NA	NA	DDC	approved	metoo	5
parkinson	NCT03566589	2018	lactobacillus plantarum ps128	lactobacillus	supplement	NA	14.86652977412731	NA	NA	non	novel, unsup	2
parkinson	NCT03567447	2018	droxidopa	droxidopa	approved	NA	NA	NA	ADRA1A	approved	repurposing	3
parkinson	NCT03568968	2020	nicotinamide riboside	nicotinamide	approved	NA	NA	OTG	BST1	approved	repurposing	3
parkinson	NCT03575195	2019	rifaximin	rifaximin	approved	NA	NA	NA	NA	non	repurposing	3
huntington	NCT03575676	2018	som3355 100mg bid	bevantolol	experimental	NA	33.204654346338124	NA	ADRB1	approved	metoo	5
parkinson	NCT03576638	2018	accordion pill carbidopa/levodopa	carbidopa,levodopa	combination	NA	NA	NA	DRD1	approved	combination	4
ftd/als	NCT03580616	2018	l-serine	serine	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT03582137	2018	cannabidiol	cannabidiol	approved	NA	NA	NA	CNR1	approved	repurposing	3
alzheimer	NCT03587376	2018	atabecestat	atabecestat	experimental	NA	2.0944558521560577	NA	BACE1	non	novel, unsup	2
parkinson	NCT03589066	2018	ly03003	rotigotine	approved	2007	11.104722792607802	NA	DRD3	approved	post-approval	7
alzheimer	NCT03594123	2018	brexpiprazole	brexpiprazole	approved	NA	NA	NA	HTR1A	approved	repurposing	3
parkinson	NCT03594656	2018	ganoderma	ganoderma	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT03599726	2018	donepezil	donepezil	approved	NA	NA	NA	ACHE	approved	repurposing	3
alzheimer	NCT03605667	2018	troriluzole	troriluzole	experimental	NA	836.5503080082135	NA	SCN5A	approved	metoo	5
parkinson	NCT03608371	2018	btrx-246040	btrx-246040	experimental	NA	15.441478439425051	NA	OPRL1	non	novel, unsup	2
alzheimer	NCT03611439	2013	rebuilder	methyl b-12,methyl folate,selenium glycinate chelate,lithium orotate,astragalus,gastrodia elata,schisandra chinensis,vaccinium uliginosum,berberine hcl,l-theanine	supplement	NA	111.56741957563312	NA	NA	non	novel, unsup	2
parkinson	NCT03611569	2018	lu af82422	lu af82422	experimental	NA	NA	OMIM	SNCA	non	novel, supported	1
ftd/als	NCT03613571	2018	ilb	dextran	approved	NA	13.169062286105408	NA	NA	non	repurposing	3
alzheimer	NCT03613844	2018	dha	docosahexaenoic acid	approved	NA	NA	NA	PPARA	approved	repurposing	3
alzheimer	NCT03620981	2018	brexpiprazole	brexpiprazole	approved	NA	NA	NA	HTR1A	approved	repurposing	3
parkinson	NCT03621046	2018	zolpidem	zolpidem	approved	NA	40.016427104722794	NA	GABRA1	approved	repurposing	3
parkinson	NCT03624920	2018	thn102 dosage a	modafinil,flecainide	combination	NA	110.60643394934976	NA	SLC6A3	approved	combination	4
alzheimer	NCT03625401	2018	ad-35 60mg group	ad-35	experimental	NA	NA	OMIM	APP	non	novel, supported	1
alzheimer	NCT03625622	2019	ar1001	ar1001	experimental	NA	NA	NA	PDE5A	approved	metoo	5
ftd/als	NCT03626012	2018	biib078	biib078	experimental	NA	NA	OMIM	C9orf72	non	novel, supported	1
alzheimer	NCT03634007	2019	aavrh.10hpoe2 vector	aavrh.10hpoe2	experimental	NA	NA	OMIM	APOE	non	novel, supported	1
alzheimer	NCT03635047	2018	al002	al002	experimental	NA	NA	OMIM	TREM2	non	novel, supported	1
parkinson	NCT03639064	2018	cannabis oil	cannabidiol	approved	NA	NA	NA	CNR1	approved	repurposing	3
alzheimer	NCT03639987	2018	aducanumab	aducanumab	experimental	NA	303.90143737166323	OMIM	APP	non	novel, supported	1
alzheimer	NCT03649724	2020	eligard 22.5mg suspension for injection	leuprorelin	approved	NA	NA	NA	GNRHR	approved	repurposing	3
parkinson	NCT03651856	2013	atm fog in pd	atomoxetine	approved	NA	10.841889117043122	NA	SLC6A2	approved	repurposing	3
parkinson	NCT03652363	2012	glial cell line-derived neurotrophic factor	gdnf	experimental	NA	144.1971252566735	NA	GDNF	non	novel, unsup	2
ftd/als	NCT03652805	2018	ipl344	ipl344	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT03652870	2019	escitalopram	escitalopram	approved	NA	NA	NA	SLC6A4	approved	repurposing	3
parkinson	NCT03655236	2019	k0706	k0706	experimental	NA	NA	NA	ABL1	approved	metoo	5
alzheimer	NCT03656042	2009	filgrastim (75mcg/0.3ml)	filgrastim	approved	NA	113.782340862423	NA	CSF3R	approved	repurposing	3
alzheimer	NCT03658135	2018	biib092	gosuranemab	experimental	NA	27.526351813826146	NA	MAPT	non	novel, unsup	2
parkinson	NCT03659682	2019	semaglutide	semaglutide	approved	NA	NA	NA	GLP1R	approved	repurposing	3
parkinson	NCT03661125	2019	saracatinib	saracatinib	experimental	NA	NA	NA	FYN	non	novel, unsup	2
parkinson	NCT03665454	2018	pf-06412562	pf-06412562	experimental	NA	4.577686516084873	NA	DRD1	approved	metoo	5
parkinson	NCT03667404	2018	maltodextrin	maltodextrin	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT03668405	2018	lu af20513	lu af20513	experimental	NA	16.50924024640657	OMIM	APP	non	novel, supported	1
parkinson	NCT03670953	2018	ipx203 er cd-ld	carbidopa,levodopa	combination	NA	NA	NA	DRD1	approved	combination	4
ftd/als	NCT03679975	2018	riluzole oral soluble film (rosf) 50 mg	riluzole	approved	1995	6.431211498973306	NA	SCN5A	approved	post-approval	7
parkinson	NCT03683225	2019	ctc-413	pramipexole,aprepitant	combination	NA	NA	NA	TACR1	approved	combination	4
ftd/als	NCT03690791	2019	canntrust cbd oil (capsule)	cannabidiol	approved	NA	NA	NA	CNR1	approved	repurposing	3
alzheimer	NCT03691519	2018	omega-3 treatment (DHA/EPA)	DHA,EPA	approved	NA	NA	NA	PPARA	approved	repurposing	3
ftd/als	NCT03693781	2019	colchicine 1 mg oral tablet	colchicine	approved	NA	NA	NA	TUBB	approved	repurposing	3
parkinson	NCT03693872	2019	apomorphine	apomorphine	approved	2004	NA	NA	DRD4	approved	post-approval	7
parkinson	NCT03703570	2018	kw-6356	kw-6356	experimental	NA	797.1526351813826	NA	ADORA2A	approved	metoo	5
alzheimer	NCT03703856	2019	memantine	memantine	approved	2003	NA	NA	GRIN1	approved	post-approval	7
ftd/als	NCT03705390	2019	ilb	dextran	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT03706885	2018	sustiva pill	efavirenz	approved	NA	NA	NA	NA	non	repurposing	3
ftd/als	NCT03707795	2017	betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days	betamethasone	approved	NA	8.328542094455852	NA	NR3C1	approved	repurposing	3
alzheimer	NCT03710642	2018	prazosin	prazosin	approved	NA	NA	NA	ADRA1A	approved	repurposing	3
parkinson	NCT03710707	2018	dnl201	dnl201	experimental	NA	29.138945927446954	OMIM	LRRK2	non	novel, supported	1
alzheimer	NCT03712787	2019	abbv-8e12	tilavonemab	experimental	NA	NA	NA	MAPT	non	novel, unsup	2
parkinson	NCT03713957	2018	grf6021	grf6021	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT03716570	2019	biib054	cinpanemab	experimental	NA	55.65503080082136	OMIM	SNCA	non	novel, supported	1
parkinson	NCT03720418	2018	oxb-102	oxb-102	experimental	NA	NA	NA	TH	approved	metoo	5
alzheimer	NCT03720548	2018	ly3372993	ly3372993	experimental	NA	18.72689938398357	OMIM	APP	non	novel, supported	1
alzheimer	NCT03740178	2019	mk-4334	mk-4334	experimental	NA	NA	NA	NR3C1	approved	metoo	5
alzheimer	NCT03748303	2019	allopregnanolone	brexanolone	approved	NA	NA	NA	GABRA1	approved	repurposing	3
alzheimer	NCT03748706	2019	pti-125, 100 mg tablets	simufilam	experimental	NA	2.0369609856262834	NA	FLNA	non	novel, unsup	2
parkinson	NCT03750552	2019	ampreloxetine	ampreloxetine	experimental	NA	NA	NA	SLC6A2	approved	metoo	5
alzheimer	NCT03752294	2018	dabigatran	dabigatran	approved	NA	NA	NA	F2	approved	repurposing	3
alzheimer	NCT03752463	2015	daoi-a group	daoi	experimental	NA	NA	NA	NA	non	novel, unsup	2
ftd/als	NCT03755167	2018	ipl344	ipl344	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT03757325	2019	dnl747	dnl747	experimental	NA	12.922655715263518	NA	RIPK1	non	novel, unsup	2
ftd/als	NCT03757351	2018	dnl747	dnl747	experimental	NA	36.139630390143736	NA	RIPK1	non	novel, unsup	2
huntington	NCT03761849	2019	ro7234292	rg6042	experimental	NA	NA	OMIM	HTT	non	novel, supported	1
huntington	NCT03764215	2018	nilotinib 150 mg	nilotinib	approved	NA	NA	NA	ABL1	approved	repurposing	3
alzheimer	NCT03765762	2019	grf6019	grf6019	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT03769896	2017	nabilone 0.25 mg	nabilone	approved	NA	85.42094455852155	NA	CNR2	approved	repurposing	3
parkinson	NCT03773796	2018	nabilone 0.25 mg	nabilone	approved	NA	NA	NA	CNR2	approved	repurposing	3
parkinson	NCT03774459	2018	high dose anavex2-73	blarcamesine	experimental	NA	NA	NA	SIGMAR1	approved	metoo	5
parkinson	NCT03775096	2019	carvedilol	carvedilol	approved	NA	NA	NA	ADRB1	approved	repurposing	3
parkinson	NCT03781167	2019	abbv-951	abbv-951	experimental	NA	NA	NA	DDC	approved	metoo	5
parkinson	NCT03781791	2018	active investigational treatment: ent-01	ent-01	experimental	NA	NA	NA	NA	non	novel, unsup	2
huntington	NCT03787758	2019	sage-718	sage-718	experimental	NA	3.6303901437371664	NA	GRIN2A	approved	metoo	5
parkinson	NCT03790670	2019	sargramostim	sargramostim	approved	NA	9.582477754962355	NA	CSF2RA	approved	repurposing	3
alzheimer	NCT03790709	2018	high dose anavex2-73	blarcamesine	experimental	NA	NA	NA	SIGMAR1	approved	metoo	5
alzheimer	NCT03790982	2018	ad-35 30 mg + placebo of ad-35 30 mg	ad-35	experimental	NA	NA	OMIM	APP	non	novel, supported	1
ftd/als	NCT03792490	2019	fasudil	fasudil	experimental	NA	NA	NA	NA	non	novel, unsup	2
ftd/als	NCT03793868	2018	perampanel	perampanel	approved	NA	NA	NA	GRIA1	approved	repurposing	3
ftd/als	NCT03800524	2019	tauroursodeoxycholic acid	tudca	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT03801642	2019	dapagliflozin	dapagliflozin	approved	NA	NA	NA	SLC5A2	approved	repurposing	3
parkinson	NCT03808961	2020	niacin	niacin	supplement	NA	NA	NA	HCAR3	approved	metoo	5
alzheimer	NCT03811847	2019	methylphenidate extended release oral capsule	methylphenidate	approved	NA	NA	NA	SLC6A3	approved	repurposing	3
parkinson	NCT03816020	2019	nicotinamide riboside	nicotinamide	approved	NA	27.761806981519506	OTG	BST1	approved	repurposing	3
alzheimer	NCT03817684	2019	bpn14770	bpn14770	experimental	NA	193.38809034907598	NA	PDE4D	approved	metoo	5
alzheimer	NCT03819699	2018	booster vaccine	lu af20513	experimental	NA	1.6180698151950719	OMIM	APP	non	novel, supported	1
alzheimer	NCT03822208	2019	al003	al003	experimental	NA	NA	OTG	CD33	approved	metoo	5
alzheimer	NCT03823404	2019	cor388 capsule	atuzaginstat	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT03824197	2019	extra virgin olive oil (evoo)	oleic acid	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT03828747	2019	semorinemab	semorinemab	experimental	NA	NA	NA	MAPT	non	novel, unsup	2
other/unspecified	NCT03829657	2019	ampreloxetine	ampreloxetine	experimental	NA	NA	NA	SLC6A2	approved	metoo	5
ftd/als	NCT03836716	2019	arimoclomol	arimoclomol	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT03838952	2019	herbal medicine	jiaweixiaoyaosan,gouteng,bajitian	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT03840005	2018	ursonorm	ursodiol	approved	NA	NA	NA	AKR1C2	approved	repurposing	3
parkinson	NCT03840837	2019	rivastigmine transdermal patch	rivastigmine	approved	NA	NA	NA	ACHE	approved	repurposing	3
parkinson	NCT03841604	2019	safinamide methanesulfonate	safinamide	approved	2017	NA	NA	MAOB	approved	post-approval	7
huntington	NCT03842969	2019	ro7234292 (rg6042)	rg6042	experimental	NA	NA	OMIM	HTT	non	novel, supported	1
parkinson	NCT03843944	2018	safinamide	safinamide	approved	2017	21.6290212183436	NA	MAOB	approved	post-approval	7
parkinson	NCT03845387	2019	kdt-3594	am006	experimental	NA	NA	NA	DRD2	approved	metoo	5
huntington	NCT03854019	2019	dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg)	dextromethorphan,quinidine	combination	NA	NA	NA	SIGMAR1	approved	combination	4
alzheimer	NCT03856359	2019	rifaximin 550 milligrams (mg)	rifaximin	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT03858270	2019	memantine	memantine	approved	NA	NA	NA	GRIN1	approved	repurposing	3
parkinson	NCT03865121	2019	nicotine nasal spray 10 mg/ml (0.5 mg/spray)	nicotine	approved	NA	3.991786447638604	NA	CHRNA4	approved	repurposing	3
alzheimer	NCT03867253	2019	ory-2001 high dose	vafidemstat	experimental	NA	NA	NA	KDM1A	non	novel, unsup	2
alzheimer	NCT03875638	2019	levetiracetam	levetiracetam	approved	NA	NA	NA	SV2A	approved	repurposing	3
parkinson	NCT03877510	2019	ipx203 140 mg	carbidopa,levodopa	combination	NA	NA	NA	DRD1	approved	combination	4
parkinson	NCT03881371	2019	safinamide	safinamide	approved	2017	NA	NA	MAOB	approved	post-approval	7
ftd/als	NCT03883581	2019	dextromethorphan hbr and quinidine sulfate	dextromethorphan	approved	2010	NA	NA	SIGMAR1	approved	post-approval	7
alzheimer	NCT03887455	2019	ban2401	lecanemab	experimental	NA	NA	OMIM	APP	non	novel, supported	1
parkinson	NCT03887884	2019	sinemet	carbidopa,levodopa	combination	NA	7.241615331964408	NA	DRD1	approved	combination	4
parkinson	NCT03899324	2019	bumetanide white, oblong, scored tablet	bumetanide	approved	NA	NA	NA	SLC12A1	approved	repurposing	3
parkinson	NCT03905811	2019	terazosin 5 mg	terazosin	approved	NA	NA	NA	ADRA1A	approved	repurposing	3
parkinson	NCT03922711	2019	pridopidine	pridopidine	experimental	NA	NA	NA	SIGMAR1	approved	metoo	5
parkinson	NCT03924414	2019	zoledronic acid 5mg/bag 100ml inj	zoledronic acid	approved	NA	NA	NA	FDPS	approved	repurposing	3
ftd/als	NCT03929068	2019	carbidopa-levodopa	carbidopa,levodopa	combination	NA	NA	NA	DRD1	approved	combination	4
parkinson	NCT03938922	2019	active investigational treatment: ent-01	ent-01	experimental	NA	28.145106091718002	NA	NA	non	novel, unsup	2
alzheimer	NCT03943264	2019	xpro1595	xpro1595	experimental	NA	NA	NA	TNF	approved	metoo	5
ftd/als	NCT03945279	2019	biib100	biib100	experimental	NA	NA	NA	XPO1	approved	metoo	5
ftd/als	NCT03948178	2019	levosimendan	levosimendan	approved	NA	NA	NA	TNNC1	approved	repurposing	3
alzheimer	NCT03954613	2019	ebicomb	memantine,donepezil	combination	NA	NA	NA	GRIN1	approved	combination	4
alzheimer	NCT03954899	2019	melatonin	melatonin	supplement	NA	NA	NA	MTNR1A	approved	metoo	5
parkinson	NCT03956979	2019	jm-010 a group	buspirone,zolmitriptan	combination	NA	NA	NA	HTR1A	approved	combination	4
parkinson	NCT03958708	2019	rifaximin 550 mg	rifaximin	approved	NA	NA	NA	NA	non	repurposing	3
alzheimer	NCT03959553	2019	gv1001	gv1001	experimental	NA	NA	NA	TERT	non	novel, unsup	2
parkinson	NCT03968133	2019	probiotic	probiotic	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT03968744	2019	safinamide	safinamide	approved	2017	NA	NA	MAOB	approved	post-approval	7
parkinson	NCT03971617	2019	hydrogen	hydrogen	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT03976349	2019	biib094	biib094	experimental	NA	NA	OMIM	LRRK2	non	novel, supported	1
parkinson	NCT03977441	2019	agomelatine or piacebo	agomelatine	approved	NA	NA	NA	HTR2C	approved	repurposing	3
alzheimer	NCT03978338	2019	brain polypeptide solution	brain polypeptide solution	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT03980730	2019	azeliragon	azeliragon	experimental	NA	NA	NA	AGER	non	novel, unsup	2
huntington	NCT03980938	2019	neflamapimod	neflamapimod	experimental	NA	NA	NA	MAPK14	non	novel, unsup	2
ftd/als	NCT03981536	2019	ap-101	ap-101	experimental	NA	NA	OMIM	SOD1	non	novel, supported	1
other/unspecified	NCT03987295	2019	al001	al001	experimental	NA	NA	NA	SORT1	non	novel, unsup	2
parkinson	NCT03987750	2019	safinamide methanesulfonate 100mg	safinamide	approved	2017	NA	NA	MAOB	approved	post-approval	7
alzheimer	NCT03991195	2019	probiotic supplemented intervention	probiotic	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT03991988	2019	montelukast	montelukast	approved	NA	NA	NA	CYSLTR1	approved	repurposing	3
huntington	NCT04000594	2019	ro7234292 (rg6042)	rg6042	experimental	NA	NA	OMIM	HTT	non	novel, supported	1
alzheimer	NCT04004702	2020	levetiracetam	levetiracetam	approved	NA	NA	NA	SV2A	approved	repurposing	3
parkinson	NCT04006210	2019	carbidopa and levodopa 25mg/100mg	carbidopa,levodopa	combination	NA	NA	NA	DRD1	approved	combination	4
other/unspecified	NCT04044131	2019	metabolic cofactor supplementation	n-acetylcysteine,l-carnitine tartrate, nicotinamide riboside,serine	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT04044547	2013	rotigotine, extended-release microspheres	rotigotine	approved	2007	92.97741273100615	NA	DRD3	approved	post-approval	7
parkinson	NCT04045678	2017	ly03003 ( rotigotine, extended-release microspheres)	rotigotine	approved	2007	50.841889117043124	NA	DRD3	approved	post-approval	7
alzheimer	NCT04052737	2018	pmz-1620 (sovateltide) along with standard treatment	sovateltide	experimental	NA	NA	NA	EDNRB	approved	metoo	5
parkinson	NCT04056689	2019	dnl151	dnl151	experimental	NA	NA	OMIM	LRRK2	non	novel, supported	1
ftd/als	NCT04057898	2020	mn-166	ibudilast	approved	NA	NA	NA	PDE4A	approved	repurposing	3
alzheimer	NCT04063124	2020	dasatinib + quercetin	dasatinib	combination	NA	NA	NA	ABL1	approved	combination	4
alzheimer	NCT04065061	2015	erinacine a-enriched hericium erinaceus mycelia	hericium erinaceus	supplement	NA	133.8590006844627	NA	NA	non	novel, unsup	2
ftd/als	NCT04066244	2019	blz945	blz945	experimental	NA	NA	NA	CSF1R	approved	metoo	5
alzheimer	NCT04070378	2019	daratumumab injection	daratumumab	approved	NA	NA	NA	CD38	non	repurposing	3
huntington	NCT04071639	2019	haloperidol	haloperidol	approved	NA	NA	NA	DRD2	approved	repurposing	3
parkinson	NCT04075318	2019	ub-312	ub-312	experimental	NA	NA	OMIM	SNCA	non	novel, supported	1
alzheimer	NCT04075435	2020	high cbd/low thc sublingual solution	cannabidiol	approved	NA	NA	NA	CNR1	approved	repurposing	3
alzheimer	NCT04079803	2019	pti-125 100 mg oral tablet	simufilam	experimental	NA	NA	NA	FLNA	non	novel, unsup	2
ftd/als	NCT04082832	2019	cu(ii)atsm	Cu(II)atsm	experimental	NA	NA	NA	NA	non	novel, unsup	2
ftd/als	NCT04090684	2019	fixed dose combination ciprofloxacin/celecoxib	ciprofloxacin,celecoxib	combination	NA	NA	NA	PTGS2	approved	combination	4
alzheimer	NCT04094129	2020	wismemo	lactobacillus acidophilus,lactobacillus casei,bifidobacteria bifidum,bactobacillus fermentum	supplement	NA	0	NA	NA	non	novel, unsup	2
parkinson	NCT04095793	2019	ampreloxetine	ampreloxetine	experimental	NA	NA	NA	SLC6A2	approved	metoo	5
parkinson	NCT04097080	2019	nbtx-001	xenon	experimental	NA	NA	NA	NA	non	novel, unsup	2
ftd/als	NCT04098406	2020	cnm-au8	gold nanoparticles	experimental	NA	NA	NA	NA	non	novel, unsup	2
huntington	NCT04102579	2019	valbenazine	valbenazine	approved	NA	NA	NA	SLC16A2	non	repurposing	3
parkinson	NCT04110678	2015	neuroepo	neuroepo	experimental	NA	30.39561943874059	NA	EPOR	approved	metoo	5
ftd/als	NCT04115384	2019	novolin-r insulin	insulin	approved	NA	NA	NA	INSR	approved	repurposing	3
other/unspecified	NCT04117178	2019	donepezil	donepezil	approved	NA	NA	NA	ACHE	approved	repurposing	3
huntington	NCT04120493	2019	raav5-mihtt	raav5-mihtt	experimental	NA	NA	OMIM	HTT	non	novel, supported	1
parkinson	NCT04127578	2019	pr001a	pr001a	experimental	NA	NA	OMIM	GBA	non	novel, supported	1
parkinson	NCT04127695	2020	abbv-0805	abbv-0805	experimental	NA	NA	OMIM	SNCA	non	novel, supported	1
alzheimer	NCT04133454	2019	aav-htert	aav-htert	experimental	NA	NA	NA	TERT	non	novel, unsup	2
ftd/als	NCT04140136	2019	tocotrienols	tocotrienols	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT04148391	2019	nyx-458	nyx-458	experimental	NA	NA	NA	GRIN2A	approved	metoo	5
alzheimer	NCT04149639	2019	neuroq	gotu kola,turmeric,ginkgo biloba,phosphatidylserine,coffee fruit,propolis	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT04149860	2019	lu af87908	lu af87908	experimental	NA	NA	NA	MAPT	non	novel, unsup	2
parkinson	NCT04152655	2020	idebenone	idebenone	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT04154072	2020	nly01	nly01	experimental	NA	NA	NA	GLP1R	approved	metoo	5
parkinson	NCT04157933	2019	009-a0 (Apomorphine)	apomorphine	approved	2004	NA	NA	DRD4	approved	post-approval	7
parkinson	NCT04164758	2019	pimavanserin	pimavanserin	approved	NA	NA	NA	HTR2A	approved	repurposing	3
ftd/als	NCT04165824	2019	mt-1186	edaravone	approved	2017	NA	NA	NA	non	post-approval	7
ftd/als	NCT04165850	2019	fixed dose combination ciprofloxacin/celecoxib	ciprofloxacin,celecoxib	combination	NA	22.910335386721425	NA	PTGS2	approved	combination	4
parkinson	NCT04175132	2019	foliglurax	foliglurax	experimental	NA	NA	NA	GRM4	non	novel, unsup	2
ftd/als	NCT04176224	2019	mt-1186	edaravone	approved	2017	3.4496919917864477	NA	NA	non	post-approval	7
parkinson	NCT04183634	2019	neupro (reference)	rotigotine	approved	2007	NA	NA	DRD3	approved	post-approval	7
other/unspecified	NCT04184063	2019	nbmi	nbmi	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT04191486	2019	t-817ma	edonerpic	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT04191577	2019	cvn424 high dose	cvn424	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT04201093	2019	tavapadon	tavapadon	experimental	NA	NA	NA	DRD1	approved	metoo	5
ftd/als	NCT04204889	2020	oxaloacetic acid	oxaloacetic acid	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT04213391	2020	sulforaphane	sulforaphane	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT04218968	2019	carvedilol	carvedilol	approved	NA	45.01026694045174	NA	ADRB1	approved	repurposing	3
ftd/als	NCT04220021	2020	metformin	metformin	approved	NA	NA	NA	PRKAB1	approved	repurposing	3
parkinson	NCT04220762	2020	win-1001x	polygala tenuifolia,angelica tenuissima,dimocarpus longan	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT04223193	2020	tavapadon	tavapadon	experimental	NA	NA	NA	DRD1	approved	metoo	5
parkinson	NCT04226248	2020	rivastigmine transdermal system	rivastigmine	approved	NA	NA	NA	ACHE	approved	repurposing	3
alzheimer	NCT04229186	2020	roo	oleic acid	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT04229927	2020	bpdo-1603	bpdo-1603	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT04232969	2020	exenatide extended release 2mg (bydureon)	exenatide	approved	NA	NA	NA	GLP1R	approved	repurposing	3
alzheimer	NCT04241068	2020	aducanumab	aducanumab	experimental	NA	NA	OMIM	APP	non	novel, supported	1
ftd/als	NCT04244630	2020	antioxidants	ubidecarenone,vitamin e,nac cysteine,l-cystine	supplement	NA	NA	NA	NDUFV3	approved	metoo	5
ftd/als	NCT04245709	2020	clenbuterol	clenbuterol	approved	NA	NA	NA	ADRB2	approved	repurposing	3
ftd/als	NCT04248465	2020	ravulizumab	ravulizumab	approved	NA	NA	NA	C5	approved	repurposing	3
parkinson	NCT04249544	2020	pramipexole	pramipexole	approved	1997	NA	NA	DRD3	approved	post-approval	7
alzheimer	NCT04249869	2020	vgh-ad1	vgh-ad1	supplement	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT04251182	2020	15mg t3d-959	t3d-959	experimental	NA	NA	NA	PPARD	approved	metoo	5
ftd/als	NCT04254913	2020	mt-1186	edaravone	approved	2017	NA	NA	NA	non	post-approval	7
parkinson	NCT04273932	2019	lithium	lithium	approved	NA	NA	NA	NA	non	repurposing	3
parkinson	NCT04277247	2020	botulinum toxin type a	botulinum toxin a	approved	NA	NA	NA	SNAP25	approved	repurposing	3
parkinson	NCT04291859	2020	lu af28996	lu af28996	experimental	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT04292223	2020	pimavanserin	pimavanserin	approved	NA	NA	NA	HTR2A	approved	repurposing	3
parkinson	NCT04293159	2019	lactobacillus casei dg (enterolactis duo®)	lactobacillus	supplement	NA	NA	NA	NA	non	novel, unsup	2
parkinson	NCT04295642	2020	cvl-751	tavapadon	experimental	NA	NA	NA	DRD1	approved	metoo	5
parkinson	NCT04301492	2020	vortioxetine	vortioxetine	approved	NA	NA	NA	SLC6A4	approved	repurposing	3
ftd/als	NCT04302870	2020	memantine hydrochloride oral solution	memantine	approved	NA	NA	NA	GRIN1	approved	repurposing	3
parkinson	NCT04305002	2020	exenatide	exenatide	approved	NA	NA	NA	GLP1R	approved	repurposing	3
ftd/als	NCT04313166	2020	cu(ii)atsm	Cu(II)atsm	experimental	NA	NA	NA	NA	non	novel, unsup	2
alzheimer	NCT04314934	2019	anavex2-73	anavex2-73	experimental	NA	NA	NA	SIGMAR1	approved	metoo	5
ftd/als	NCT04322149	2020	at-1501	at-1501	experimental	NA	NA	NA	CD40LG	non	novel, unsup	2
parkinson	NCT04322227	2020	foliglurax 10 mg (treatment a)	foliglurax	experimental	NA	NA	NA	GRM4	non	novel, unsup	2
